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A large proportion of women of childbearing age are vitamin D deficient. There is 
an increasing evidence base suggesting that maternal 25-hydroxyvitamin D 
(25(OH)D) is associated with not only offspring bone, but also other measures of 
offspring health. Furthermore, some evidence has suggested that other dietary 
factors may influence offspring bone, independent of 25(OH)D. Most literature to 
date has examined 25(OH)D at a single time point in pregnancy within 
individuals. However, establishing the temporality of the association is important 
in order to inform relevant policy with regards to vitamin D during pregnancy. 
Thus the aims of this thesis were to establish the prevalence of deficiency of 
nutrients which may be important for bone development, the association between 
these nutrients and offspring measures and birth at 11 years, and the association 
between maternal 25(OH)D during early and late pregnancy and offspring bone 
and body composition. 
Data was collected from the Vitamin D in Pregnancy Study. Women were 
recruited over an 18 month period (2002-04; n=475) before 16 weeks gestation 
and provided a blood sample, both at recruitment and 28-32 weeks gestation. 
Samples were analysed with radioimmunoassay (Immunodiagnostic Systems, 
Tyne and Wear, UK) for 25(OH)D.  Detailed information about maternal 
sociodemographic characteristics and anthropometric measures were also 
collected at each visit. Furthermore, women provided current dietary information 
with the Victorian Cancer Council Food Frequency Questionnaire during 
pregnancy. At birth, trained personnel measured infants within 72 hours after 
delivery.   Mother-child pairs were invited to return 11 years post-birth (2013-16; 
 
 
n=209). At this follow-up dual energy X-ray absorptiometry scans were 
performed on the offspring and analysed for bone mineral content (BMC) and 
density (BMD), and lean and fat tissue (GE Lunar Prodigy, WI USA). Lumbar 
spine scans were further analysed to obtain trabecular bone score (TBS) on 
iNsight software (v. 2.2; Med-Imaps, France). Mother-child pairs provided 
anthropometric measures, sociodemographic data and duplicate quantitative heel 
ultrasound (QUS) measures. For comparative purposes, dietary information from 
non-pregnant participants at the 10 year follow-up (2004-08) of the Geelong 
Osteoporosis Study was collected in women aged 20-40 years. 
Manuscript II found that after adjustment for increased energy intake pregnant 
women were consuming more carbohydrates, fat, potassium and calcium. 
However pregnant women were less likely to meet national recommendations for 
all nutrients which have an increased demand during pregnancy (protein, 
magnesium, phosphorus and zinc). Following on from this manuscript III 
explored the associations of the nutrients examined in manuscript II with 
offspring birth measures and bone mass at age 11. Persistent effects on linear 
growth were observed with some, but not all nutrients, however no sustained 
associations were observed with measures of offspring bone mass. 
Manuscript IV further examined the association between 25(OH)D at recruitment 
and 28-32 weeks gestation and saw sustained associations of 25(OH)D at 
recruitment with offspring BMC and BMD, but not with 25(OH)D at 28-32 
weeks. Furthermore this association appeared more robust in boys than girls. 
Manuscript V further examined TBS. Similar patterns of associations as seen in 
manuscript IV were observed. Maternal 25(OH)D at recruitment, but not 28-32 
weeks was associated with offspring TBS. Again, these findings appeared more 
 
 
robust in boys. Manuscript VI further investigated if associations between 
maternal 25(OH)D and measures of offspring bone, by QUS, were independent of 
maternal QUS measures. All significant associations remained independent of the 
relevant QUS. The final manuscript (manuscript VII) examined between maternal 
25(OH)D and offspring fat and lean mass percentage. Consistent with the findings 
in the previous manuscripts ( IV-VI), maternal 25(OH)D at recruitment, but not 
28-32 weeks was favourably associated with offspring fat and lean mass 
percentage. Furthermore, maternal smoking status during pregnancy, appeared to 
be an effect modifier in these associations. 
Together, these findings suggest that the critical time period for maternal 
25(OH)D status is in early pregnancy. Furthermore, these data suggest that 
maternal diet during late pregnancy, may effect offspring linear growth, but may 












Table 3.1: Characteristics and differences between responders and 
non-responders at the 11-year follow-up 
51 
Table 3.2.1: Inclusion and exclusion criteria for recruitment of 
pregnant mothers into the study 
67 
Table 3.2.2: Participant characteristics at each clinical follow-up 69 
Table 3.2.3: Schedule of measurements collected at each follow-
up appointment of the VIP study 
70 
Table 4.1: 2006 National Health and Medical Research council 
dietary recommendations for the pregnant and non-pregnant 
population 
91 
Table 4.2: Characteristics and differences between the pregnant 
(cases) and non-pregnant controls 
92 
Table 4.3: Multivariate modelling for dietary intake  93 
Table 4.4: National recommendations and percentage of cases and 
controls meeting Estimated Average Requirements (EAR) or 
Adequate Intakes (AI) of nutrients 
93 
Table 5.1: Maternal and offspring characteristics of the 




Table 5.2: Correlations and regression modelling for associations 
between maternal dietary nutrients and offspring measures of 
linear growth 
103 
Table 5.3: Correlations and regression modelling for associations 
between maternal dietary nutrients and offspring bone measures 
by dual energy x-ray absorptiometry at 11 years  
105 
Table 6. 1: Characteristics and differences between the current sample 
(n=181) and those excluded and lost to follow-up since birth (n=221) 
120 
Table 6.2: Maternal serum levels of vitamin D (25(OH)D), parathyroid 
hormone (PTH) and calcium (adjusted for albumin) by season of blood 
collection at time points 1 (recruitment) and 2 (28-32 weeks gestation) 
121 
Table 6.3: Sex differences in offspring clinical measures 122 
Table 6.4: Expected differences in offspring of mothers with serum 
hydroxyvitamin D levels greater than 28nmol/L 
127 
Table 7.1: Maternal characteristics stratified by vitamin D 
sufficiency at recruitment and 28-32 weeks gestation  
149 
Table 7.2: Offspring characteristics at the 11 year follow-up 150 
Table 7.3: Spearman’s rho correlations between TBS and 
anthropometric and bone measures 
150 
Table 7.4: Expected difference in trabecular bone score per 
10nmol/L of maternal 25(OH)D 
151 
Table 8.1: Characteristics of mother-child pairs 171 
Table 8.2: Correlations between measures by dual energy X-ray 







Table 9.1: Maternal and offspring characteristics for the whole 
group, and by offspring sex. 
190 
Table 9.2: Regression modelling of offspring fat and lean mass 
percentage 
192 
Table 9.3: Lean and fat mass of boys and girls predicted from regression 

























Figure 3.2: Participation rates at clinical follow-ups 65 
Figure 6.1: Differences in bone measures per 10nmol/L maternal 
25(OH)D at recruitment as measured by dual energy x-ray 
absorptiometry  
124 
Figure 6.2: Differences in bone measures per 10nmol/L maternal 
25(OH)D at 28-32 weeks as measured by dual energy x-ray 
absorptiometry  
125 
Figure 8.1: Differences in quantitative ultrasound measurements 








LIST OF ABBREVIATIONS 
 
1,25(OH)2D- Calcitriol  
25(OH)D- 25-hydroxyvitamin D 
95% CI- 95% confidence intervals 
aBMD- Areal Bone Mineral Density 
ABS- Australian Bureau of Statistics 
BUA- Broadband Ultrasound Attenuation 
ALSPAC- Avon Longitudinal Study of Parents and Children 
BMAD- Bone Mineral Apparent Density 
BMC- Bone Mineral Content 
BMD- Bone Mineral Density 
BMI- Body Mass Index 
CSA- Cross-sectional Area 
DOHAD- Developmental Origins of Health and Disease 
DSM- Diagnostic and Statistical Manual of Mental Disorders 
DXA- Dual Energy X-ray Absorptiometry  
EAR- Estimated Average Requirement 
 
 
FFQ- Food Frequency Questionnaire 
 GH/IGF-1- Growth hormone-insulin-like growth factor-1 axis 
GOS- Geelong Osteoporosis Study 
HLQ- Health Literacy Questionnaire  
IU- International Units 
IRSD- Index of Relative Socioeconomic Disadvantage 
MPS- Mysore Parthenon Study 
mmol/L- millimoles per litre 
NHANES- National Health and Nutrition Examination Survey 
nmol/L- nanomoles per litre 
pmol/L- picomoles per litre 
PTH- Parathyroid Hormone 
pQCT- Peripheral Quantitative Computer Tomography 
QUS- Quantitative Ultrasound 
RCT- Randomised Control Trial 
RDI- Recommended Dietary Intake 
SD- Standard Deviation 
SE- Standard Error 
SI- Stiffness Index 
 
 
SOS- Speed of Sound 
SEIFA- Socioeconomic Index for Area 
SWS- Southampton Women’s Study 
TBLH- Total Body Less Head 
TBS- Trabecular Bone Score 
UK- United Kingdom 
US- United Stated 
vBMD- Volumetric Bone Mineral Density 
VDR- Vitamin D Receptor/s 












TABLE OF CONTENTS 
 Page 
Chapter 1: Thesis Overview and Introduction 1 
1.1 Thesis overview 2 
1.2 Introduction 5 
1.2.1 Osteoporosis and its associated burden 5 
1.2.2 Osteoporosis as a paediatric disease 5 
1.2.3 The foetal origins of disease: The Barker Hypothesis and 
Developmental Origins of Health and disease paradigm 
6 
1.2.4 The foetal origins of osteoporosis 8 
1.2.5 Maternal vitamin D 8 
1.3 Purpose of this review 10 
Chapter 2: Literature review 11 
2.1 Vitamin D 12 
2.1.1 Vitamin D deficiency, sources and metabolism 12 
2.2 Vitamin D and disease 15 
2.3 Vitamin D physiology and recommendations during pregnancy 16 
2.3.1 Vitamin D and calcium metabolism during pregnancy 16 
2.3.2 Vitamin D recommendations 18 
2.3.3 Prevalence of vitamin D deficiency during pregnancy 19 
2.4 Bone Health 20 
2.4.1 Establishing the link between offspring bone health and 






2.4.2 Maternal vitamin D and bone health in neonates and infancy 
2.4.3 Maternal vitamin D and bone health in childhood 
21 
27 
2.4.4 Maternal vitamin D and bone health in early adulthood 30 
2.4.5 Impact of poor bone health in childhood 31 
2.4.6 Summary of maternal vitamin D status and offspring bone 
health 
32 
2.5 Lean mass and muscle development 33 
2.5.1 Vitamin D and muscle development in utero 33 
2.5.2 The role of vitamin D in skeletal muscle 35 
2.5.3 Implications of decreased muscle mass and strength 36 
2.5.4 Summary of maternal vitamin D status and muscle strength and 
function 
37 
2.6 Fat mass and adiposity 37 
2.6.1 Maternal Vitamin D and adiposity 37 
2.6.2 Vitamin D and its role in adiposity 41 
2.6.3 The impact of adiposity and associated obesity 42 
2.6.4 Summary of maternal vitamin D and adiposity in the offspring 44 
2.7 Other maternal dietary factors and offspring bone 44 
2.7.1 Maternal diet and offspring bone mass 45 
2.8 Summary of findings and gaps in the literature 46 
2.9 Research questions and aims 47 
Chapter 3: Methods 49 
3.1 Overview of methods 50 




3.2.1 Recruitment for the 11-year follow-up 51 
3.2.2 Participant measures 52 
3.2.2.1 Offspring measures 52 
3.2.2.2.1 DXA 52 
3.2.2.2.2 Body composition 53 
3.2.2.2.3 Trabecular bone score (TBS) 54 
3.2.2.1 Maternal measures 54 
3.2.2.1.1Maternal serum measures 54 
3.2.2.1.2 Anthropometric measures 54 
3.2.2.1.3 Maternal sociodemographic characteristics 55 
3.2.2.1.4 Maternal diet 56 
3.3 Geelong Osteoporosis Study (GOS) 56 
3.3.1 Measurements used from the GOS 57 
3.3.1.1 Women’s diet 57 
3.3.1.2 Anthropometric measures 57 
3.3.1.3 Smoking status 57 
3.3.1.4 Alcohol intake 58 
3.3.1.5 Socioeconomic status 58 
3.4 Data storage 58 
3.5 Ethical considerations 58 
3.6 Statistical analyses 59 
3.7 The Vitamin D in Pregnancy Study 60 






Chapter 4  
Manuscript II: Maternal nutrition during pregnancy; intake of 
nutrients important for bone development 
Chapter 5 
Manuscript III: Maternal Dietary Nutrient Intake During Pregnancy 







Manuscript IV: Maternal Vitamin D in pregnancy and offspring bone 









Manuscript VI: Gestational Vitamin D and offspring bone measures; 
does maternal bone quality mediate the association? 
163 
Chapter 9 180 
Manuscript VII: Vitamin D during pregnancy and offspring body 
composition 
181 
Chapter 10: Final discussion 203 
10.1 Aim 1 and 2: Prevalence of dietary deficiencies and changes 
in dietary behaviours during pregnancy and the associations with 







10.2 Aims 3-6: Maternal 25(OH)D and offspring outcomes 
(Manuscripts IV-VII) 
206 
10.3 Methodological considerations 210 
10.3.1 Vitamin D assay 210 
10.3.2 DXA 211 
10.3.3 Confounding and establishing causation 214 
10.3.4 Multiple comparisons 218 
10.4 Directions for future research 218 























  Chapter 1: Thesis overview and introduction 
2 
 
1.1 Thesis overview 
This thesis aims to describe the cross-sectional and longitudinal associations 
between maternal vitamin D status and dietary factors during pregnancy and 
offspring musculoskeletal and body composition. Furthermore, it explores the 
prevalence of pregnant women who do not meet national recommendations for 
dietary factors that may play an important role in the bone health of their 
offspring. 
Chapter Two provides a brief introduction to vitamin D and its role in bone 
health and beyond. The current literature surrounding maternal vitamin D and diet 
and its relationship to offspring health outcomes is then synthesised and critically 
appraised. 
Chapter Three describes the methods and study designs of the two studies 
utilised for analyses in this thesis. The Vitamin D in Pregnancy (VIP) Study 
methods are presented in Manuscript I, followed by a more detailed explanation 
of methodology of pertinent measurements used. Following this, is a brief 
description of the Geelong Osteoporosis Study (GOS), from which Manuscript II 
utilised data to compare diet between pregnant women and their non-pregnant 
peers. 
Chapter Four investigates the prevalence of pregnant women in VIP who 
meet dietary intakes for nutrients important for bone health (Manuscript II). These 
are then compared to intakes of their non-pregnant peers in GOS. 
Chapter Five investigates if the maternal dietary intakes of those nutrients 
examined in Manuscript II are associated with offspring birth measures, such as 
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birth weight, which have previously been identified as being associated with adult 
bone mass (Manuscript III). Furthermore, associations with maternal nutrient 
intake are then further examined with measures of offspring linear growth and 
bone mass at age 11 years. 
Chapter Six then examines the associations between maternal vitamin D 
status at two time points in pregnancy with measures of offspring bone mass by 
dual-energy X-ray absorptiometry (DXA) at 11 years (Manuscript IV). 
Associations between concurrent maternal calcium and parathyroid hormone 
(PTH) levels are also reported. 
Chapter Seven reports on similar associations between maternal vitamin D 
and offspring bone measures but using measurements of bone by quantitative 
ultrasound (QUS) (Manuscript V). Maternal QUS measures were also collected at 
the 11 year follow-up, thus this chapter examines whether any observed 
relationships between maternal vitamin D and offspring bone remain independent 
after adjusting for measures of maternal bone 
Chapter Eight reports on associations between maternal vitamin D and 
indicators of vertebral microarchitecture using offspring trabecular bone score 
(TBS) (Manuscript VI). Furthermore, associations with maternal calcium and 
PTH are explored. This study aims to determine if there are possible associations 
with maternal vitamin D beyond measures of bone mass. 
Chapter Nine assesses associations between maternal vitamin D and 
offspring body composition (Manuscript VII). The effect of maternal vitamin D at 
two time points on absolute and relative lean and fat mass is described. 
Furthermore, the associations with fat distribution are discussed. 
  Chapter 1: Thesis overview and introduction 
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Chapter Ten presents a summary and synthesis of the key findings presented 
in this thesis. Overall strengths and limitations are discussed, as well as potential 
directions for future research. 
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1.2  Introduction 
1.2.1 Osteoporosis and its associated burden 
Osteoporosis, is derived from the Greek words, ‘osteo’ meaning bone and 
‘por’ meaning passage, thus quite literally means porous bone. The disease is 
characterised by a reduction in bone mass, and deterioration in microarchitecture
1
. 
Subsequently, there is an increased risk of ‘fragility’ fracture, whereby ‘fragility’ 
is defined as a fracture occurring after minimal trauma
1
. Osteoporosis is often 
termed, the ‘silent disease’ because of a lack of overt symptoms prior to fracture
2
, 
thus prevalence can be difficult to quantify. Internationally, there has been 
significant mortality and morbidity associated with this disease
3
. The most recent 
figures that 66% of Australians aged over 60 have poor bone health  (22% with 
osteoporosis, and a further 78% with osteopenia)
4
. Moreover, there are substantial 
costs associated with the care and management of poor bone health, estimated at 
$2.75 billion. The total indirect and direct cost of osteoporosis, osteopenia and the 




1.2.2 Osteoporosis as a paediatric disease  
The prevalence of osteoporosis rises steadily as the population ages
5
, and 
thus a common misconception is that osteoporosis is a geriatric disease. However, 
it was almost 45 years ago when Charles Dent first proclaimed: 
“Osteoporosis is a paediatric disease”
6
 
Peak bone mass is attained when the age-related bone change is no longer 
positive and instead reaches a plateau, prior to the commencement of age-related 





. Increasing and achieving maximal peak bone mass is an integral 
approach to osteoporosis prevention
8, 9
. During growth, bones expand and 
lengthen through the synchronised action of both bone deposition and resorption. 
Peak bone mass is reached at epiphyseal fusion, which typically corresponds with 
the end of the second decade of life
10
. Peak bone gain, the maximal velocity of 
bone accrual, occurs in adolescence, and typically occurs about 1.5 years earlier 
in girls than boys
11
. Four years after peak bone gain, approximately 95% of adult 
peak bone mass has been acquired
12
. Thus, osteoporosis prevention efforts are 




1.2.3 The foetal origins of disease: The Barker Hypothesis 
and Developmental Origins of Health and disease paradigm 
Early schools recognised that the foetal disease may be in part arising 
from nourishment from ‘maternal fluids’ that may be diseased
14
. However, the 
modern origins of disease hypothesis begun with seminal work conducted by 
Barker et al.
15
. This work noted that, in the early twentieth century, the regions of 
England which had the highest infant mortality coincided with the regions which 
had the highest rate of mortality associated with coronary heart disease in later 
life. The authors concluded that this association may reflect the differences in 
nutrition in early life, with the potential for maternal malnourishment playing a 
role
15
. From this, the “Barker hypothesis” was born, whereby it was suggested 
that: 
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 “…adverse environmental influences in utero and during infancy, 




These seminal findings were primarily focused around coronary heart 
disease and further resulted in the development of the “thrifty phenotype” 
hypothesis
17
, describing the aetiology of Type 2 diabetes mellitus. Since the 
development of these initial hypotheses, studies have linked the environment in 
utero to several non-communicable diseases
18
. This original hypothesis has since 
resulted in the Developmental Origins of Health and Disease (DOHAD) 
paradigm
19
, whereby it is suggested that foetal growth and development was 
determined not only by the foetal genome, but also by its interactions with the 
environment in utero. Lucas first termed this biological phenomenon as  
‘programming’
20
. Beginning at conception, the developing foetus is at the mercy 
of a series of biological events, stimulus and insults in the prenatal environment 
and this multifactorial phenomenon represents an interaction between nutritional, 
environmental and genetic influences in utero, all of which may have persist to 
have a long-term or permanent impact upon offspring health outcomes
21
. The 
mechanism by which this has been postulated from an evolutionary perspective to 
describe such changes has been termed predictive adaptive response
19
. In 
response to adversity, the developing foetus may make adaptive responses which 
may have no short term benefit, however will confer long-term survival 
advantage. However, ‘mismatch’
22
 between predictions and reality may occur, 
whereby early predictions about future environment may be incorrect, in which 
case the adaptations may be inappropriate during post-natal life and may actually 
increase disease risk. 
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1.2.4 The foetal origins of osteoporosis 
Following the descriptions of developmental origins of cardiovascular 
disease and diabetes, it was postulated that there were plausible developmental 
origins in the attainment of peak bone mass
22-23
. The first evidence to suggest a 
link between early life and later bone mass described an association between 
weight at one year, as a marker of early-life growth, and bone mineral content 
(BMC) at 21 years of age
23
. 
There are three lines of evidence which initially aided in determining the 
existence of developmental origins in utero for osteoporosis
24
: 
1. The association between preserved birth measures, as a measure of 
adversity in utero and adult bone mass;  
2. Physiological studies of endocrine systems which may have 
developmentally programmed responses, such as the hypothalamic-
pituitary adrenal or growth hormone-insulin-like growth factor-1 
(GH/IGF-1) axes, and thus may increase the risk of osteoporosis in 
later life. Lastly, the focus of the current review; 
3. Studies investigating maternal nutritional and lifestyle exposures, such 
as diet and maternal vitamin D levels, during pregnancy and the 
association with measures of bone mass in their offspring. 
1.2.5 Maternal vitamin D  
The role of maternal vitamin D during pregnancy has been a particular 
focus in the developmental origins of osteoporosis
25
. A growing body of evidence 
has linked maternal vitamin D levels during gestation to measures of offspring 
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bone; this will be discussed later in the review. Furthermore, it has been 
hypothesised that maternal vitamin D  may play a role in both classically related 
health outcomes in the offspring, such as bone health, but may extend to other 
components of body composition, including adiposity and muscle mass
26
.  
In 2013, Osteoporosis Australia released an evidence-informed prevention 
strategy target at a whole of life approach in recognition of the risk factors in 
early life
27
. One of their three affordable strategies was maintaining adequate 
vitamin D levels throughout the life course. Indeed, a recent Cochrane review 
presented evidence from eight trials (n=10,380) that vitamin D in conjunction 
with calcium reduced the risk of non-vertebral fracture. Furthermore, the risk of 
hip fracture was also shown to be reduced in nine trials (n=49,853), by 
approximately 15%
28
. In a systematic review of vitamin D supplementation in a 
paediatric population, supplementation was reportedly associated with mean 
increases in bone mineral density (BMD) of 1.7% at the spine, and 2.6% at the 
total body in low serum vitamin D study subgroups, but no effect was seen in 
those who were sufficient
29
.  
In 2016, the National Osteoporosis Foundation (US) released a position 
statement on the development of peak bone mass
9
. Future suggested research 
agendas including addressing the question: 
“Is there an influence of foetal programming (on peak bone mass)?”  
It is thus timely that the evidence is reviewed in relation to bone mineral 
accrual and maternal vitamin D and dietary exposures at the earliest stage of life, 
in utero. The largest body of evidence primarily focuses on bone health; however, 
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maternal vitamin D status during pregnancy may also play a role in morbidity and 
mortality related to osteoporosis in later life
26
 
1.3 Purpose of this review 
Emerging evidence has suggested a possible link between poor gestational 
vitamin D status and adverse developmental outcomes in the offspring. Those 
outcomes, including osteoporosis and subsequent fractures and metabolic 
disturbances, have an extremely high direct and indirect burden
4
, therefore it is 
imperative to public health that those possible relationships are elucidated. 
Without that information, we are limited in our ability to inform an evidence-
based approach to best-practice guidelines regarding optimising vitamin D levels 
during pregnancy. Furthermore, whilst the primary focus of this review will be 
bone outcomes related to future progression to osteoporosis in the offspring, it is 
important to also acknowledge other factors which may contribute to the mortality 
and morbidity of osteoporosis, such as body composition. Moreover, standalone, 
adiposity and sarcopenia are associated with a substantial burden of disease.  The 
purpose of this review is to identify and address the key literature concerning 
gestational vitamin D status in relation to musculoskeletal health and body 
composition outcomes in the offspring in infancy and childhood. Furthermore, the 
role of other nutritional factors during pregnancy will also be discussed. 
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2.1 Vitamin D 
2.1.1 Vitamin D deficiency, sources and metabolism 
Globally vitamin D deficiency and insufficiency is being consistently 
recognised as a substantial public health issue
30-32
. Epidemiological studies have 
reported that from 5%-99% of people are deficient, dependent on criteria for 
deficiency and country of origin and population group
32
. Internationally, 1-99% 




There are two main forms of vitamin D, cholecalciferol (vitamin D3) and 
ergocalciferol (vitamin D2). Cholecalciferol is endogenously produced by the 
epidermal cells which contain a compound 7-dehydrocholesterol that is converted 
to pre-vitamin D3 upon irradiation by ultraviolet light
33
. Ring B of the cholesterol 
ring is broken and, after thermal rearrangement of the triene system, 
cholecalciferol is released into the bloodstream
33
. The amount of cholecalciferol 
produced in the skin is governed by several varying geographical, physical and 
cultural variables
33
. Moreover, twin studies have shown that circulating 25(OH)D 
levels have clear genetic influences
34-37
, with up to 80% of variation of explained 
by heritable characteristics and genetic traits. Ergocalciferol is primarily derived 
from food sources, such as fatty fish, and irradiated plant sources
38
. 
Cholecalciferol is first hydroxylated in the liver to 25-hydroxyvitamin D3 (25-
OHD), the major circulating vitamin D derivative, and then converted to the 
metabolically active molecule of vitamin D, calcitriol (1,25(OH)2D), which is 
responsible for most of its biological action. This is completed by 1α-
hydroxylation of its inactive form (25(OH)D), primarily occurring in the kidneys 




. The main effect of 1,25-dihydroxyvitamin D is to increase the efficiency of 
intestinal calcium absorption
39
. 1,25-dihydroxyvitamin D binds to the vitamin D 
receptors (VDR) in the intestines activating calcium binding proteins which help 
to regulate absorption
39
. Calcium and 1,25-dihydroxyvitamin D regulation is 
intertwined and involves several feedback loops. Parathyroid hormone (PTH) is 
signalled to be released in conjunction with a decline in extracellular Ca level
39
. 
PTH works to restore calcium serum levels by increasing bone resorption and 
renal calcium absorption and promoting renal hydroxylation of 25(OH)D to the 
biologically active 1,25-dihydroxyvitamin D by inducing CYP24A1 expression
39
.  
Given that sunlight is the major source for the endogenous synthesis of 
vitamin D, and that there is an abundance of sunlight hours in Australia, vitamin 
D deficiency was once thought to be an uncommon occurrence in this country
40
. 
However a resurgence in cases of vitamin D deficiency rickets in Australia, in 
high-risk populations, suggested this assumption may be ill-founded
41, 42
. The first 
Australian study to be conducted in the general population nationwide revealed 
that approximately one third of the Australian population was deficient
43
. 
However, given that those prevalence data rely on decade-old data, it is plausible 
that vitamin D deficiency could have underestimated current day figures. Data 
from a population-based study in the US (n= 13,369) indicated that vitamin D 
deficiency may be a growing epidemic
44
. A mean decrease of vitamin D levels 
from 1988-2004 was observed in the National Health and Nutrition Examination 
Survey (NHANES)
44
. However, the most recent nationwide survey conducted by 
the Australian Bureau of Statistics, the Australian Health Survey, showed that in 
2011-12, 25% of Australians aged over 18 years were insufficient (<50 
nanomoles per litre; nmol/L). Although, as expected the vitamin D levels varied 
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by season, and in winter the prevalence of deficiency reached almost 50% in most 
of the southern states
45
. 
  Latitude plays a vital role in the availability of appropriate levels of 
ultraviolet-B (UV-B) radiation to allow appropriate levels of endogenous 
synthesis of vitamin D for sufficiency; however, as demonstrated in the 
Australian population, where sunlight hours are sufficient, there are likely to be 
other factors at play. A plausible hypothesis is a change in “sun-seeking” 
behaviours brought about by the Australian SunSmart campaign
46
. Since the 
introduction of this campaign, targeted at reducing skin cancer rates, sun-
avoidance behaviours have increased
47, 48
. Whilst prevention of skin cancer in 
important, these simplistic health messages may be causing unintended harm by 
increasing vitamin D deficiency throughout the population
49
. Recent guidelines 
stress a more balanced approach to UV-B exposure
50, 51
.  Another  modifiable 
factor to reduce vitamin D deficiency is dietary intake, however, most foods, with 
few exceptions, are vitamin D poor.  Australia’s voluntary and mandatory vitamin 
D fortification differ from countries such as the US and Canada, and at present 
only edible oil spreads are required to be fortified and at lower levels than that of 
other countries
52, 53
.  The effect of the less wide-spread fortification policy is 
reflected in the average Australian intake. Australian vitamin D intakes are 
reported as substantially lower (1.2-2.6µg) in comparison to our US and Canadian 
counterparts (4.3-6.2µg)
52, 54, 55
. Supplementation may be used to counteract low 
dietary intakes of vitamin D; however, supplementation levels in Australia were 
shown to be low in the early 2000s
40
. The purchase of vitamin D supplements has 
increased since then; however, in light of the most recent evidence suggesting that 
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a quarter of adult Australians are deficient
45
, this does not seem to have translated 
into  a notable change in the prevalence of deficiency.    
2.2 Vitamin D and disease 
Vitamin D has most often thought to play a role in the pathogenesis of 
musculoskeletal diseases. The active metabolite of vitamin D, 1,25(OH)2D, plays 
an integral part in the regulation of calcium and phosphorus and thus bone 
metabolism across the life span
38
. In the absence of 1,25(OH)2D, intestinal 
absorption of calcium and phosphorus decreases
56
. From this, secondary 
hyperparathyroidism arises and resorbs the mineral from existing bone in an 
attempt to restore the mineral equilibrium. 
 Severe vitamin D deficiency is most commonly associated with 
osteomalacia or rickets, diseases of impaired bone mineralisation
38
. Vitamin D 
deficiency stimulates increased secretion of PTH which increases bone turnover 
and resorption. The result is bone loss, primarily from cortical bone, which has 
the potential to contribute to the pathogenesis of osteoporosis
38
. In turn the risk of 
fracture in later life is substantially increased
38
. Aside from bone health, there has 
been an increasing interest in recent years of the potential role for vitamin D in 
several other diseases
57
. In particular the discovery of an extra-renal conversion of 
vitamin D metabolites may make it relevant to several more facets of human 
health and disease than previously thought. Vitamin D receptors have been found 
in several cells within the body including sites within skeletal muscle, brain, 
heart, skin, parathyroid gland, lymphocytes, liver, pituitary gland, kidney, 
intestine, bone and ovaries
58, 59
: these data support a potential role for the 
pathogenesis of disease in other systems; however, the evidence is conflicting
60
. 
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The health effect that vitamin D deficiency has on the individual has been 
extensively studied. In recent years increasing attention has been drawn to the 
effects deficiency has in utero
26
. Prevention of a disease is a far superior outcome 
than cure thus it is important from a public health perspective to identify potential 
preventative measures in utero in relation to vitamin D in order to prevent disease 
from occurring in later life. 
2.3 Vitamin D physiology and recommendations during 
pregnancy 
In order to understand the potential mechanisms and relationships between 
gestational vitamin D levels and offspring outcomes, it is essential to understand 
the physiology of vitamin D and the biological adaptations and processes which 
occur during pregnancy and in utero. For the purpose of this review, maternal 
vitamin D will be referred to as gestational vitamin D status. 
2.3.1 Vitamin D and calcium metabolism during pregnancy 
Pregnancy is a unique and dynamic stage of life. The growing foetus is 
relies on maternal sources for vitamins and minerals for growth and development. 
Readily crossing the placenta is 25(OH)D, but not 1,25(OH)2D, and foetal levels 




Foetal Ca deposition peaks in the third trimester, and approximately 
250mg/day is transferred to support bone development
64
. By the end of gestation, 
approximately 25-30g of Ca has been transferred to the foetal skeleton
64
. Judging 
by the increased demand for maternal Ca in order to meet foetal needs it could be 
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inferred that maternal 1,25(OH)2D levels will ultimately determine the level of 
maternal Ca intestinal absorption and thus the rate of transfer to the foetal 
skeleton. Based on these classical regulatory assumptions, one would hypothesis 
that foetal bone health is dependent on maternal vitamin D status. It is observed 
that foetal Ca serum levels are higher during the third trimester than maternal 
levels, and that maternal serum levels progressively diminish throughout 
gestation,
65, 66
. The fall in maternal levels is likely physiologically unimportant 
and a major contributor to the fall is the hemodilution associated with 
pregnancy
67
.  However the higher foetal levels, as compared to maternal levels, 
support the suggestion that there is active transport of Ca across the placenta
68
. 
Maternal serum 25(OH)D levels do not deviate substantially from that of the non-
pregnant population
69
; however, there is a marked increase in 1,25(OH)2D levels 
in pregnant women 
70, 71
.  Maternal 1,25(OH)2D requirements can increase four to 
five times, to aid intestinal Ca absorption in order to facilitate foetal skeletal 
development
72
. This has previously been thought to be as a result of increased 
expression of 1α-hydroxylase and VDRs in the decidual and placental cells and 
production from the foetal kidneys
73
. However, there is also evidence to suggest 




 Whilst the increase in Ca levels has been attributed to the increase in 
1,25(OH)2D absorption during pregnancy, VDR-null or vitamin D deficient 
animal models have shown a similar upregulation of Ca absorption. Given these 
data, it has been hypothesised that prolactin and/or placental lactogen may have a 
stimulatory effect on intestinal absorption that is independent of vitamin D
74
. In  
earlier studies, however, it was reported that there was an association between the 
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amount of maternal exposure to sunlight during the last trimester of pregnancy, as 
a proxy measurement of vitamin D status, and the occurrence of neonate tetany, a 
sign of hypocalcaemia
75
. Subsequent studies reiterated these findings and showed 
hypocalcaemia in either cord or neonate blood during first weeks of life in 
vitamin D deficient mothers
76-78
. 
2.3.2 Vitamin D recommendations 
There has been much conjecture in recent times as to the ideal serum 
levels of 25(OH)D. Whilst some recommend optimal levels at 75nmol/L
30
, the 
2012 position statement, endorsed by the Working Group of Australia and New 
Zealand Bone and Mineral Society, Endocrine Society of Australia and 
Osteoporosis Australia, is in line with the US Institute of Medicine’s 
recommendations of 50nmol/L required for optimal musculoskeletal health in 
adults
50
. Whilst there is recognition that higher levels may prevent some disease 
states beyond the musculoskeletal system, at present there is not enough evidence 
from randomized control trials to endorse higher targets. Despite this, it is 
recommended that Vitamin D levels are 10-20nmol/L higher at the end of 
summer, to allow for a seasonal decrease during winter months
50
. 
Recommendations during pregnancy are identical to that of the recommended 
adult levels
51
. Supplementation with 1000IU is recommended when levels are 
below 50nmol/L, and 2000IU is recommended for those under 30nmol/L to raise 
both maternal and infant levels
51
. Indeed, maternal vitamin D supplementation 
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2.3.3 Prevalence of vitamin D deficiency during pregnancy 
Vitamin D deficiency has been reported as high among the general 
Australian adult population
43
. Several epidemiological studies have examined 
vitamin D deficiency in pregnant populations at different geographical locations 
within Australia. The cohort of women for the present study, VIP, based in a 
semi-urban region of Victoria, reported that 7.3% women during early, and 6.8% 
in late, pregnancy were deficient, when using a cut-off point of <28 nmol/L for 
deficiency, the lower limit of normal for the laboratory
79
.   A study in rural 
Victoria found a similar percentage of severely deficient pregnant women (cut off 
point <25nmol/L) of 5.8%
80
. Furthermore, they found 39.7% were vitamin D 
insufficient (between 50 and 75.9 nmol/L) and another 20.6% had mild deficiency 
(25-49.9 nmol/L). The reported prevalence of suboptimal vitamin D levels (<50 
nmol/L)  in New South Wales,  among two ante-natal clinics based in Canberra 
and Sydney was 35% and 25.7% of the pregnant population, respectively
81
. 
However in the northern state of Queensland, deficiency was reported to be 
10%
82
. In all of the aforementioned studies season was a significant predictor of 
vitamin D levels, whereby observed means were lower in serum samples 
collected during the winter months. Studies across Australia and New Zealand 
have also identified that up to 60-80% of pregnant dark-skinned and/or veiled 
women have vitamin D levels <25nmol/L, indicating that these are particularly 
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2.4 Bone Health 
2.4.1 Establishing the link between offspring bone health 
and maternal vitamin D status 
The link between vitamin D and bone health has a historical context. In 
the mid-1600s a large proportion of children in industrialised areas in Northern 
Europe developed severe bone deforming diseases, primarily rickets
85
. Gradually 
the importance of sun-exposure was realised in the prevention of this disease. In 
1918 rickets was prevented in puppies through use of cod liver oil
86
 and 
subsequently this nutritional factor was named vitamin D. Early case studies 
revealed the association between insufficient maternal vitamin D status and the 
development of rickets in offspring
87, 88
. This provided the first evidence that 
maternal vitamin D status has the potential to adversely affect foetal skeletal 
development in utero. More recent studies have demonstrated changes in bone 
geometry in utero analogous to those seen in rickets using high-resolution 3D 
ultrasound
89
.  Whilst rickets was thought to be largely a childhood disease of the 
past, given preventative strategies and a stronger understanding of associated risk 
factors, there is a re-emergence of this disease in the developed world in 
populations at high risk of vitamin D deficiency
41, 42, 85
. Children who develop 
vitamin-D deficient rickets commonly display delayed growth and motor function 
alongside weak muscles which may impair the child’s mobility or promote 
instability
85, 90
.  The high prevalence of vitamin D deficiency among pregnant 
women, in at risk populations, may be playing an important role in this re-
emergence. Furthermore some, but not all, animal models have shown an 
association between maternal vitamin D and offspring bone
91
.  It is thus important 
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that other aspects of skeletal development, which may not have as severe clinical 
manifestations in early life, but will present with a high burden of disease in later 
life, are investigated.  
2.4.2 Maternal vitamin D and bone health in neonates and 
infancy 
In the early 1980s, a seminal study to examine the hypothesis that 
maternal vitamin D impacts upon offspring bone health was conducted. Congdon 
et al. collected cord blood at term and measured bone mineral content of the right 
forearm of the infants within the first five days of life
78
.  Mothers were divided 
into three separate groups; 45 Asian women who had received no vitamin D 
supplements, 19 Asian women, who had received 1000 International Units (IU) of 
vitamin D daily through supplementation and 12 Caucasian non-supplemented 
women. No significant differences in foetal skeletal mineralisation were seen 
between the groups. However, there were several limitations in that study. As 
there was a small sample size, the study may have been underpowered to detect 
any significant associations. A second consequential flaw was that cord blood 
concentrations were deficient in vitamin D across all of the groups (mean serum 
25(OH)D 5.9-33.4 nmol/L), and thus comparisons could not be made between 
deficient and sufficient groups. A further flaw relates to the method used to 
calculate bone mass; scintillation counts, expressed BMC as arbitrary units, which 
is considered to be an inaccurate measurement when compared to the current 
clinical gold standard DXA.  A further study, conducted almost two decades later 
in the US a comprising a multi-ethnic population (n=120), concurred Congdon et 
al’s initial findings that there were no associations between gestational 25(OH)D 
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and neonate bone mass
92
. Using only a whole body BMC of the offspring 
obtained from DXA at age 8-21 days there was no significant associations with 
maternal serum vitamin D. 
Namgung et al.
93
 were the second group to examine this association, 
almost two decades later than Congdon et al. Working under the assumption that 
their study population, Korean women, were unlikely to be taking vitamin D 
supplements the authors hypothesised that total body BMC would be reduced in 
winter-born newborns in comparison to born in summer. Seventy-two infants (37 
winter-born, 34 summer-born) were measured by DXA before three days of age. 
It was reported that infants born in winter had a 8% lower total body BMC than 
those born in summer and a lower cord-serum 25(OH)D, and was suggested that 
low maternal vitamin D is resultant in a marked reduction of total body BMC in 
newborns
93
. Similar to the previous study both groups were deficient in vitamin D 
(winter: 10.7±7.5 nmol/L vs summer; 30±15 nmol/L). Whilst results were 
adjusted to account for weight, other potentially confounding factors, such as 
gestational age and sex, were not. Nevertheless, the results of that study suggested 
a link between vitamin D status during pregnancy and foetal bone mineralisation, 
contrary to Congdon et al. findings
78
, and signalled the necessity for further 
research into this area. 
Namgung et al. then retrospectively examined these associations in a US 
population
94
, after commencing a second larger study to examine the effects of 
season on infant BMC
95
. 55 healthy newborns were recruited (19 African-
American, 36 Caucasian). The newborns were dichotomised into summer (July-
September) and winter-born (January-March). Contrary to their a priori 
hypothesis, that winter-born babies would have a lower BMC, summer-born 
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babies had a lower BMC (75.9 ± SD17.42 vs. 86.55±17.54 mg/cm) at the one-
third distal radius measurement site. This observed seasonal effect, gave rise to 
the hypothesis that perhaps seasonal differences in maternal vitamin D in early 
pregnancy may play an important role in offspring bone mass.   Namgung et al.
95
 
then reported on the second larger population at the same US hospital to further 
examine these associations (n=246, 115 African-American, 131 Caucasian). 
Again, contrary to the a priori hypothesis, summer-born babies had a lower BMC 
than winter-born (82.7 ± SE 1.4 vs. 89.9±2.3 mg/cm). These results were also 
reiterated the findings of another parallel study in small-for-gestational age babies 
conducted by the authors, that reported that summer-born babies had lower BMC 
than their winter-born counterparts
96
. Together, these findings suggest that 
perhaps the potential programming effect of maternal vitamin D is in earlier 
pregnancy, as opposed to later pregnancy.  
The first study to objectively measure 25(OH)D in a non-Asian population 
was a sample of 50 pregnant women in Winnipeg, Canada
97
.  This study found 
that infant vitamin D deficiency was associated with a lower BMC, in relation to 
mass; however, maternal vitamin D status was inversely related. The authors 
hypothesised that this seemingly paradoxical relationship may be mediated by 
infant birth weight. Infant vitamin D levels, as measured by cord blood, were 
inversely associated with infant birth weight
98
. It has previously been reported 
that women within the healthy body mass index (BMI) range (20.0-24.9 
[weight(kg)/height (cm)
2
]) range have higher vitamin D intakes
99
 and lower 
weight babies than women with a higher BMI
100
. Thus, because BMC was shown 
to be dependent on birth weight these infants would be expected to have lower 
BMC. Though these conclusions could not be substantiated as maternal BMI was 
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not collected.  Another interesting point to note is that maternal vitamin D levels 
were determined within 48 hours of birth within this cohort. Thus, within the 
context of the seasonal findings of Namgung et al. in the US populations, it is also 
plausible that perhaps those mothers who had a higher vitamin D levels at later 
gestation, had lower vitamin D levels in earlier stages of pregnancy, due to 
seasonal fluctuations. If this were to be the case, this would explain the inverse 
relationship with maternal vitamin D levels in later pregnancy and offspring BMC 
at birth. 
The only study to date to objectively examine gestational vitamin D status 
at two time points (20 and 36 weeks gestation) was a study of infants in 
Gambia
101
. There was no association detected between gestational vitamin D 
status and offspring bone mass as measured by DXA at the mid-radius shaft and 
whole body. However, there is tropical sunshine all year round and many women 
are outdoor workers. Furthermore, local female dress allows UV-exposure to a 
large-surface area of skin. This was reflected in the mean vitamin D levels 
(103±25 and 111±27 nmol/L, at 20 and 36 weeks; respectively)
101
. There were no 
women who had serum levels less than 50nmol/L, thus the absence of any 
deficiency in the study population may explain why there were null associations. 
Given the economic climate in Gambia, foetal growth restriction is common and 
thus the association between maternal vitamin D and offspring bone mass may be 
further obscured by this. However, it is the void of any vitamin D deficiency in 
this population that would likely bias any potential associations towards the null. 
A further study in Turkey, reported no correlation between vitamin D status of the 
mother shortly following delivery
102
. However, the large majority of women in 
this study were deficient, as women were primarily covered by protective 
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clothing, such as veils. Thus, there may have been no observed effect as none of 
the mothers had vitamin D levels high enough to confer a protective effect. 
The only baseline and subsequent follow-up during infancy studies were 
conducted in a Finnish population (n=124) by Viljakainen et al. using peripheral 
quantitative computer tomography (pQCT)
103, 104
. Unlike DXA, pQCT allows for 
measures for the actual bone density in cubic centimetres rather than the projected 
density in centimetres squared calculated by DXA
21
. This is particularly important 
in a paediatric population because of the changing dimensions in developing 
bones. It is impossible to be able to differentiate between growth and real changes 
in bone density during the growth period. An arbitrary cut off using the median 
maternal value of vitamin D (42.6 nmol/L) was used to define two equal sized 
groups, using a sample collected two days post-partum. It was found that the 
neonates of the mothers higher in vitamin D had an increased tibial BMC by 
13.9% and cross-sectional area (CSA), but not BMD.  A year later the same group 
conducted a follow up of their study in the infantile offspring, aged 14 months
104
. 
All infants were supplemented with vitamin D after birth. Only 54 (43.5%) 
neonates had complete data at follow-up. It was observed that the infants born of 
the mothers with lower vitamin D had an increase in BMC such that there were no 
observable differences between the two groups at 14 months. Infants of mothers 
with low vitamin D status had smaller tibial CSA. Whist there was an observed 
steep increase and what could potentially be seen as “catch up growth” exhibited 
in the lower vitamin D infants given the low return rate the study was may have 
been underpowered to detect differences between the groups. The observed 
retention of a difference in tibial CSA, despite supplementation, may also suggest 
that maternal vitamin D status is implicated in not only bone development in 
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utero but may also have effects that persist long term or permanently. These 
effects may persist even with supplementation soon after birth, given there were 
no longer any significant differences in infant vitamin D levels between groups at 
follow-up. However, it should also be noted that the study by Mahon et. al 
reported an increased femur CSA, as opposed to the decrease in femoral CSA, in 
infants born to mothers with lower vitamin D as being analogous with rachitic 
changes. Thus, with no clear defined measures of rachitic changes, it is 
problematic to draw definitive conclusions from these findings. 
Indirect measures of bone have also been measured in neonates with 
relation to gestational vitamin D status as reflected by cord blood concentrations. 
A study in the Netherlands found that bone turnover markers, more specifically 
alkaline phosphatase concentrations, were borderline significantly (p=0.05) higher 
in mothers who were vitamin D deficient
56
. However, both deficient and 
sufficient groups were still within normal clinical ranges (161U/L (124-21) 
sufficient vs 177U/L (156-217) deficient), thus the clinical significance of these 
findings may be of little relevance. 
The most recent evidence comes from a randomised control trial (RCT) 
examining maternal supplementation during pregnancy and offspring bone
105
. 
There was an overall null effect of vitamin D supplementation commencing 
before 17 weeks gestation compared with placebo
106
. However, in a predefined 
sub-analysis there was an observed interaction with season of birth. Mothers in 
the supplementation group, who gave birth in winter, had infants with a higher 
BMC, BMD and bone area. Therefore, it was concluded that preventing a nadir of 
serum vitamin D levels in late pregnancy had favourable effects on offspring bone 
mass. However, using the same logic, this same effect would have been expected 
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in spring-born babies; however, there were no significant associations within that 
sub-group. It could be argued that the high percentage of women who were 
vitamin D sufficient enrolled in the trial, owing to ethical restrictions, may have 
obscured results, however there were no interactions with baseline 25(OH)D 
measurements, suggesting this not to be the case. Given an RCT is the strongest 
level of evidence, these findings hold merit. However, observational evidence 
also suggests the possibility of long-term effects on bone mass as will be 
discussed below. Therefore the planned 4-year follow-up may further clarify these 
associations. 
The Vitamin D in pregnancy cohort reported that there was a reduced 
knee-heel length in infants, as a proxy measure of bone development
79
. 
Interestingly, there was no association with maternal vitamin D measured in early 
pregnancy in contrast to Namgang et al.’s findings which appeared to signal an 
effect in early pregnancy. However, objective measures of infant bone mass were 
not collected, and the association was largely attenuated after adjustment for 
gestation length. The 11 year follow-up of this study will assist with further 
elucidating associations. 
2.4.3 Maternal vitamin D and bone health in childhood 
In order to investigate whether the potential effects of skeletal 
development persist into later childhood, Javaid and colleagues investigated these 
outcomes in a UK-based cohort of children nine years of age born to Caucasian 
women at Princess Anne Hospital, UK (n=198)
107
. Using DXA measurements it 
was seen that reduced concentrations of maternal vitamin D during late pregnancy 
corresponded to a reduction in whole body BMC and lumbar spine. This 
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supported the previous findings of Viljakainen et al
103
 that maternal vitamin D 
status could impact upon skeletal growth beyond the earliest stages of life. The 
results were challenged as to the conclusions drawn and the lack of multivariate 
analysis
108
. It was suggested that mothers may have passed a genetic trait to do 
with either BMC or serum 25(OH)D levels. The authors confirmed however that 
multivariate analysis was performed and several potential confounders, such as 
maternal smoking, nutrition physical activity and socioeconomic status, did not 
account for this relationship
109
. It was also postulated that a genetic trait was a 
more plausible explanation and that maternal vitamin D accounted for these 
observed effects given that the identified genetic markers only accounted for a 
small percentage of variation in bone mass and fracture risk. These findings 
informed vitamin D recommendations during pregnancy in the UK for many 
years. 
A more recently published study directly contradicted the findings of 
Javaid et al. Using data collected from the Avon Longitudinal Study of Parents 
and Children (ALSPAC) (n=3196), Lawlor et al. found no  associations in 
children of a similar age group in total body BMC by use of DXA
110
. This is by 
far the largest study conducted to-date and the most reliable vitamin D assay 
available was used, in comparison to the previous studies. The results were also 
stratified by trimester of maternal 25(OH)D sample to explore the hypothesis that 
impairment to foetal skeletal development may be more vulnerable to nutritional 
deficits during certain trimesters of gestation. There was no association found, 
contrary to the belief that later periods of gestation may increase foetal 
vulnerability. Curiously, however, the results directly contradicted results 
published by the same group using the same cohort which suggested that maternal 
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UV-B exposure, as a proxy measure of vitamin D status, during pregnancy was 
predictive of offspring bone mass at the same age
111
. The group argued that in the 
initial analysis they did not account for children’s age at the time of DXA, given 
it was thought there would be no potential association with mothers UV-B 
exposure. It was suggested that due to an artefact in the dates, children who were 
born to mothers whose third trimester was in the summer months were likely 
older when they underwent DXA
110
. The authors of the Princess Anne Hospital 
study argued that substantial collinearity between the children’s age at DXA and 
maternal UV-B exposure was the reason this relationship was no longer 
observed
112
. They also concluded that substantial uncertainty remains as 
regression analysis was unable to differentiate between cause and confounder. 
Further questions were also raised regarding the potential treatment of infant 
vitamin D deficiency to have counteracted any potential effects
113
. 
Again, as with infant bone mass, the results of the observational evidence 
are mixed in childhood. Reasoning for this remains unclear. The sample size of 
the ALSPAC was much larger than that of the Princess Anne Cohort, potentially 
making their null findings stronger. Of concern is the lack of multivariate 
analyses presented in the Princess Anne Cohort. The authors however did confirm 
that they performed multivariate analyses, but however did not make mention of 
adjustment for any current childhood measures which may have confounded 
associations, such as anthropometric characteristics like weight nor lifestyle 
characteristics such as physical activity. Furthermore, interestingly, while the 
issue of temporality was highlighted in the infant measures the ALSPAC findings 
suggested there were null associations regardless of the trimester the 25(OH)D 
sample was measured. 
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2.4.4 Maternal vitamin D and bone health in early 
adulthood 
A recently published Australian study has disputed the findings of the 
ALSPAC study
114
.  The longitudinal prospective cohort study, the Raine study, 
measured maternal serum vitamin D levels at 19 weeks gestation (mean: 
57.2nmol/L ± 19.2). Maternal vitamin D deficiency was associated with a 2.7% 
lower total body BMC and 1.7% lower total body BMD at 20 years of age. Given 
the older age of the cohort, these findings suggest the effect maternal vitamin D is 
associated with a lower peak bone mass and thus a possible increase in fracture 
risk later in life. It is of note, however, that the time points at which vitamin D 
status was measured were substantially different between this and Javaid 
study.
107
. Whilst the Princess Anne Hospital group hypothesized  that it was in 
gestational vitamin D in later pregnancy was associated with offspring bone 
mass
107
 the Raine cohort showed effects at a much earlier stage of pregnancy
114
, 
thus, the temporality of the association remains obscure. Indeed, it is plausible 
that gestational vitamin D at either stage of pregnancy may be associated with 
offspring bone, Lawlor et al. did not find that one stage was more important than 
the other
110
. However, there have been no studies to date that have compared 
vitamin D status at different gestational periods within the same individual with 
offspring bone mass. VIP collected 25(OH)D at two time-points and showed a 
differential effect of gestational vitamin D in late vs early pregnancy with markers 
of impaired bone development in utero
79
. Therefore, using the VIP cohort will 
allow for the examination of the associations at two time points comparable to the 
previous studies reporting positive associations. Thus, it will allow the ability to 
discern whether one time point is more critical than the other. 
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2.4.5 Impact of poor bone health in childhood 
While gestational vitamin D status may result in a lower peak bone mass 
and accelerated progression to osteoporosis, it appears that there may not be an 
association between maternal 25(OH)D and an increased risk of childhood 
fracture
115, 116
. To the contrary, one study, which used predicted vitamin D levels, 
found an increased risk of childhood forearm fracture in girls born in winter, 
whose mothers took higher dose vitamin D supplements
115
. This was thought to 
be potentially confounded by concurrent excessive intakes of vitamins, such as 
vitamin A which have the potential to increase the risk of fracture in an adult 
population
117
. Also, the use of predicted and not actual 25(OH)D levels may have 
obscured associations as vitamin D levels were extrapolated from a relatively 
small subsample in comparison to the whole sample (1497/36977), thus may not 
be accurate. The other, however, reported a borderline significant negative 
association between gestational vitamin D and forearm fracture, when vitamin D 
was expressed a continuous scale rather than as a categorical exposure
116
. It is of 
note that in this study there was an association observed between season of blood 
sample and offspring fracture independent of maternal vitamin D status. This 
further highlights the potential seasonal confounding in associations with 
maternal vitamin D. This may be mediated by factors that may also be influenced 
by season such as maternal diet, physical activity and mental health. Further 
studies, employing larger sample sizes may help to further elucidate this 
relationship between maternal vitamin D, offspring fracture and season. A large 
prospective cohort study has shown that bone mass predicts childhood fracture
118
, 
thus one may expect that if gestational vitamin D status reduces childhood bone 
mass, this might translate to an increase in fracture incidence. 
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As mentioned in the introduction, peak bone mass, plays an integral role 
in the future risk and speed of progression to osteoporosis
8
. Given that bone mass 
has been shown to track in childhood and adolescence
119-122
, it could be concluded 
that children with lower bone mass in childhood are likely to have a lower peak 
bone mass. Thus, if gestational vitamin D effects bone mineral accrual in 
childhood, there may be increased risk of osteoporosis in the offspring in later 
life.  
2.4.6 Summary of maternal vitamin D status and offspring 
bone health 
From existing evidence, solid conclusions cannot be drawn on whether 
indeed an association does exist between maternal vitamin D and offspring gone 
mass and to what extent and life-stage these effects may persist until. There has 
been extensive discussion of potential reasons for null findings above, however a 
consistent consideration amongst all positive findings, is the potential that 
maternal vitamin D is merely a marker for other lifestyle factors such as maternal 
adiposity, diet, smoking status or physical activity, which cannot be discounted. 
The observational evidence to date is highly inconsistent and the only trial 
conducted suggested overall null findings at birth. An important factor which has 
been highlighted throughout the literature is the potential importance of the 
temporality of the associations.  As mentioned above, the initial findings from the 
VIP study collected maternal vitamin D levels at two time-points in pregnancy
79
, 
thus is in an ideal position to examine the temporality of such associations in 
childhood. Given the positive findings of the Australia-based Raine study 
suggests potential for the effects to persist into adulthood
114
, this is an important 
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association to examine, to determine the timing of and effects, if any, of maternal 
vitamin D on offspring bone mass. 
2.5 Lean mass and muscle development 
2.5.1 Vitamin D and muscle development in utero 
The effect of maternal vitamin D status on muscle development in utero is 
largely unknown. Early animal studies have demonstrated that in a rat model 
maternal vitamin D was the largest contributor to early neonatal vitamin D status 
and that it was primarily stored in foetal muscle tissue
123
. The effect of vitamin D 
deficiency on the development of skeletal muscle and myoblasts have been 
demonstrated in vitro
124
. Vitamin D was shown to stimulate the growth and 
proliferation of cultured chick myoblasts. The same group, again using a chick 
model demonstrated the promotion of myogenesis by vitamin D shown by 
increased expression of myosin and markers of muscle differentiation
125
. More 
recent studies in rat models have demonstrated maternal deficiency to adversely 
impact upon myogenesis and result in smaller muscle fibres
126
. Improved 
maternal vitamin D status has also shown enhanced foetal muscle development 
and myoblast activity in a porcine model 
127
. These animal studies all support the 
role of vitamin D in utero, and thus the importance of maternal status, in the 
embryonic development of skeletal muscle.  
The VIP study was the first known study to indirectly investigate the 
effect of maternal vitamin D status and muscle development in human neonates. It 
was seen that whilst there was a positive association between  calf and mid-arm 
circumferences and maternal vitamin D, the same difference was not observed in 
the accompanying skin-fold measurements
79
. Using this as a proxy measurement 
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of percentage of lean tissue mass it appeared that, in offspring born to deficient 
mothers, there was a decrease in lean tissue development. The authors suggested, 
however, that these findings would have to be confirmed with superior 
measurements of lean mass such as DXA. 
In the Princess Anne Hospital cohort at 9 years of age there was no 
statistically significant relationship observed between lean mass and maternal 
vitamin D status through use of DXA
128
. The authors did note, however, that there 
was a trend for lean mass to be lower in the children whose mothers were in the 
lowest quarter of vitamin D distribution. The values used were absolute, however, 
and thus may not be reflective of total percentage of lean muscle mass. Another 
cohort of children in the Southampton Women’s Survey (SWS) reported a 
positive linear relationship between gestational vitamin D, using both absolute 
and percentage offspring lean mass; however, this association was attenuated after 
further adjustment for confounding factors
129
.  The only other data to-date which 
examined this in children was derived from an Indian study by Krishnaveni et al., 
the Mysore Parthenon Study (MPS) (n=568)
130
. There was an increase in arm 
muscle area in infants born to mothers with higher vitamin D levels. These 
measurements were obtained using a similar proxy measurement to the VIP study, 
which took into account circumference and skinfold measurements. Once again, 
that measurement was only reflective of an absolute value and not total 
percentage. Furthermore, neither height nor weight was accounted for in the 
analysis, which may have further explained the associations.  
Two of these studies have further examined measures of muscle strength. 
Krishnaveni et al. were the first group to examine associations between 
gestational vitamin D and hand-grip measurements
130
 . At age 9.5 years there was 
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no differences observed in hand-grip measurements between children whose 
mothers were sufficient in vitamin D during pregnancy vs those who were not. It 
was thus concluded that it was possible that given there was an observed 
difference in amount of muscle tissue but not muscle strength that vitamin D in 
utero may affect muscle development but not strength. However, Harvey et al. 
concluded the opposite in the SWS cohort
129
. Whilst they found that the 
association with muscle mass was attenuated by confounding factors in offspring 
aged 6 years, the association with handgrip strength remained. The authors 
concluded that whilst gestational vitamin D may not increase the number of 
muscle fibres, the resultant fibres were stronger. Hence, the relationship with 
gestational vitamin D remains unclear.   
2.5.2 The role of vitamin D in skeletal muscle 
Alongside the classical roles of vitamin D on bone there is now an 
expanse evidence base which ties vitamin D status with muscle development and 
functionality. Initial studies reported that there were few or no VDRs present in 
skeletal muscle
131
. However, since then many studies have demonstrated that 
there VDRs are present in both the plasma membrane and nucleus of human 
skeletal muscles
132
. Observed associations between VDR polymorphisms and 
increased risk of decreased muscle strength and sarcopenia in adult populations 
tend to suggest that vitamin D plays an integral role in the development and 
functional capabilities of skeletal muscle
133-136
. 1,25(OH)2D appears to act 
through its actions on the VDRs to exert its effects of muscle tissue but the 
mechanisms are yet to be fully elucidated
137
. Moreover, vitamin D 
supplementation has been shown to have a modest effect on global muscle 
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strength in at risk populations, however not mass nor power
138
. Only one RCT has 
been conducted in a paediatric population
139
. In this population of school-aged 
girls, the opposite was reported to that of the adult findings, that is there was an 
effect on muscle mass but not strength
139
.  
2.5.3 Implications of decreased muscle mass and strength 
Decreased muscle mass and related strength is an intrinsic risk factor to 
falls in an adult population
140
, and the resulting injury in children include 
bruising, sprains, bone fractures and contusions
141
, however to date there is a lack 
of empirical evidence directly examining the association between muscle strength 
and falls in children. However, the cost of direct medical treatment is a huge 
financial burden to the public health system, with Australian data suggesting that 




Impaired muscle function in childhood may also persist into adulthood. 
Data are limited on childhood muscle strength tracking into adulthood however, 
one longitudinal study showed hand-grip strength in childhood to be a fair 
predictor of muscle strength at age 35 years
143
. Osteoporosis is commonly 
referred to as a ‘silent disease’ as the individual may not even realise they are 
effected a fragility occurs, defined as a fracture which occurs after minimal 
trauma
144
. In the elderly osteoporotic fractures are related to substantial morbidity 
and mortality
145-147
. A substantial contributing factor to osteoporotic fractures is 
an increased risk of falls amongst the elderly. In elderly populations, 
epidemiological studies have shown increased risk of falls in association with 
vitamin D deficiency
148
. Aside from causing a fracture, falls also can result in 
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damage to soft tissue, persisting pain, reduced quality of life and decreased 
mobility and thus a subsequent rise in healthcare costs
149
.  
2.5.4 Summary of maternal vitamin D status and muscle 
strength and function 
At present there is a scarcity of data using current gold standard methods 
such as DXA to quantify lean muscle mass and test to see if indeed associations 
exist between offspring lean mass and gestational 25(OH)D. 
Given the impact of falls across the lifespan, it is important to identify 
potential early life interventions to reduce the risk and thus the occurrence of 
falls.  
Initial findings in the VIP cohort at one year indicated that there was 
reduced lean tissue in infants born to mothers with low gestational vitamin D 
levels, thus there substantial reasoning to determine whether this effect is still 




2.6 Fat mass and adiposity 
2.6.1 Maternal Vitamin D and adiposity 
There is some evidence that BMI in adulthood varies as a function of 
season of birth
150, 151
. This gives rise to the hypothesis that seasonal variations in 
maternal vitamin D levels mediate this relationship
26
. However, as highlighted by 
Peterson et al.
116
 there are several other variables which may mediate this 
association. For example reduced maternal physical activity or poorer diet in 
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winter months may also play a role in such associations and thus should be 
eliminated as potential confounders. 
The first study to directly explore this hypothesis was a study conducted 
by Gale et al. in the Princess Anne Hospital cohort. Using serum levels of 
25(OH)D and calculating percentage body fat through use of DXA, it was 
reported that in the cohort at age 9 years (n=178, 30% of original cohort) there 
was no association between the gestational 25(OH)D and offspring fat mass
128
, 
contrary to the previous hypothesis. 
However, conflicting results were observed when the Indian MPS reported 
significant associations between maternal 25(OH)D and offspring fat mass
130
. 
When maternal levels were dichotomised into deficient (<50nmol/L) and 
sufficient there was an interaction with sex observed; males were more likely to 
have an increased percentage body fat, at 5 years but not 9.5 years, but 
interestingly this was not seen in females. It was proposed that this was perhaps 
the result of a more homogenous lifestyle of females in this population, namely 
less time spent outdoors. This suggestion is certainly supported by the high 
prevalence of vitamin D deficiency (67% <50nmol/L) evident in the mothers of 
the children studied. However, when maternal vitamin D was explored as a 
continuous variable, there were significant relationships observed for both sexes 
at 9.5 years. The reason for this discrepancy is unclear, however perhaps it 
50nmol/L was not a sensitive cut-point and the association may have been more 
apparent in those with lower 25(OH)D levels. Such a high prevalence of maternal 
vitamin D deficiency makes this study difficult to compare to others. It must also 
be noted that the method which they used to calculate body fat percentage, 
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bioimpedance, is not gold standard; however, has been shown to correlate well 
with more valid methods
152
. 
Supporting the findings of the Indian group but contradicting that of the 
Princess Anne Hospital study, Crozier et al. found significant associations at birth 
and at age 6 years in a different, larger cohort (n=977)
153
. The relationship 
observed between that at birth and that at age 6 was seen to reverse. At birth, 
those born to mothers of lower vitamin D status produced offspring with a lower 
percentage body fat. This was again measured at 4 years where there were no 
significant associations seen and again at 6 years where the relationship was 
opposite to that at birth. At age 6 years, offspring whose mothers had lower 
vitamin D had a higher body fat percentage. These findings tend to suggest that 
the children born to vitamin D deficient mothers, and thus lower body fat 
percentage, had overcompensated growth by age 6 years and had developed a 
greater percentage body fat in later childhood. This may also, however be 
attributable to the effect of other shared environmental factors coming into play at 
age 6, such as increased physical activity and outdoor play. 
 Reverse causality must also be explored when interpreting these results as 
vitamin D is a fat-soluble vitamin and mothers with greater adiposity may have 
lower bioavailability of vitamin D to transport to the growing foetus. Studies have 
shown that cord blood 25(OH)D levels in mothers with normal weight are higher 
than that of obese mothers
154
. Thus, this relationship may, at least in part, be 
driven by maternal influences on lifestyle choices, which have been previously 
associated with childhood obesity
155-157
. However, this did not appear to be the 
case in the larger SWS cohort as the 6 year fat mass was shown to be independent 
of maternal pre-pregnancy BMI
153
. Recent data derived from the Amsterdam 
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Born Children and their Development study reported that in children aged 5-6 
years echoed these findings of a positive association with fat mass with no 




Moreover, a recent systematic review showed that there was an 
association between high gestational fish intake and increased offspring 
adiposity
159
. It was highlighted that fatty fish is a rich dietary source of vitamin D 
thus may play a role in the associations seen with offspring adiposity, which may 
have been obscured by endocrine-disrupting environmental contaminants present 
in fish
160
. The authors of the systematic review highlighted that there was a null 
association with fatty fish and offspring adiposity
161
. There is the potential for 
vitamin D to have counteracted the effect of environmental contaminants. 
However, it was noted that there was a relatively low consumption of fatty fish 
across cohorts.  
Furthermore, the most recent randomised control evidence suggested that 
in winter-born babies, offspring of those mothers who were supplemented had a 
greater fat mass vs offspring of mothers who were in the placebo group
106
. 
However, in the Raine cohort, absolute body fat was examined as a secondary 
outcome and reported a null association with gestational vitamin D
114
. Thus, the 
longevity of this relationship remains obscure. Other environmental factors in 
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2.6.2. Vitamin D and its role in adiposity 
Evidence from familial studies tend to suggest that total body adiposity is 
largely a heritable phenotype
162
.  Heritability has been shown to be able to 
account for between 18-65% for BMI and approximately 37-81% of waist 
circumference measurements
163
; these data tend to suggest that there are both 
environmental and genetic contributors at play. The contributing environmental 
factors are well documented and include increased consumption of calorie-dense 
food, sedentary lifestyle, socioeconomic status and parental eating patterns and 
attitudes
162
. Predisposition to obesity both in childhood and later life appears to be 
mediated by several different genes
164
. Of particular interest, is that VDR 
polymorphisms are linked to adiposity phenotypes
163
. This supports the 
conclusion VDR variants may play a biological role in lipogenesis and adipocyte 
differentiation. 
There is an increasing recognition of the metabolic roles played by 
vitamin D. Vitamin D deficiency has been linked to both insulin resistance and 
impaired glucose tolerance and subsequent development of the metabolic 
syndrome in adult populations
165
. A considerable risk factor in the development 
of metabolic abnormalities is increased adiposity. 
In both adult and paediatric populations a causal relationship between 
vitamin D insufficiency and increased adiposity has been postulated
166-169
. This is 
further supported by aforementioned VDR polymorphisms being linked with 
adiposity phenotypes
163
.   
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2.6.3 The impact of adiposity and associated obesity 
The World Health Organisation has previously described the phenomenon 
of global obesity, referred to as ‘globesity’, as: 




In 1995 estimations suggested that there were 200 million adults obese 
worldwide which escalated by 50% over a five year period to 300 million in the 
year 2000
170
. Whilst obesity is more prevalent in adult populations, there is a 
worrying trend observed internationally which shows the rates of childhood 
obesity to be increasing
171
. Between the years of 1985-1999, rates of childhood 
obesity tripled
172
. However, contrary to popular media hype in Australia, 
epidemiological studies tend to suggest that  rates seem to be declining in more 
recent times
173
. This observed trend however may be due to the use of opt-in 
consent
174
 which may bias study results. Despite this reported decline, there 
remains an estimated 4-9% of school-aged children classified as obese and 
approximately a quarter of young children are classified as overweight or 
obese
173
.  In Australia alone the total direct cost of overweight and obese 
individuals was estimated to cost 21 billion dollars in 2005
175
. 





. Childhood obesity and the related increased adiposity may 
be associated with a number of not only physical conditions, but psychological 
stressed which may predispose individuals to serious adverse multisystem health 
outcomes in later life. These can include but are not limited to several 
complications such as shown in Table 2.1 on the following page: 
  Chapter 2: Literature review 
43 
 
















Asthma Steatohepatitis Forearm 
fracture 
Coagulopathy Type 2 
Diabetes 















Table 2.1: Complications of childhood obesity broken down by systems. Adapted 
from Ebbeling et al. 2002  
176
 
Obesity-induced comorbidities, such as hypertension and type-2 diabetes 
developed in childhood frequently persist into adulthood and are associated with 
an increased mortality risk
177, 178
. The Australian Government recognised the 
expanse nature of both the prevalence and subsequent adverse health outcomes of 
childhood obesity, and in 2003 the National Obesity Taskforce subsequently 




There is a continuing debate as to the protective or detrimental effect 
obesity has upon fracture risk. Arguments have been put forward for a 
paradoxical relationship that sees an increase in risk of childhood fracture 
associated with obesity, but a protective effect in adults mediated by a weight 
related increase in BMD
180
.  At a population level it seems that increased BMI 
may be protective in adults for fragility fractures at most skeletal sites, though not 
all 
181
. However, Australian recommendations suggest to avoid being above the 
normal weight range (BMI >25kg/m
2
), as obesity does not act as protection from 
fracture in all individuals
182, 183
.  It is also important to note that even if obesity 
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acts as protection from fracture in older populations, it does not counteract the 
effects of the plethora of obesity-induced diseases such as type 2 diabetes and 
cardiovascular disease. 
2.6.4 Summary of maternal vitamin D and adiposity in the 
offspring 
In order to establish whether maternal vitamin D impacts upon adiposity 
in children, further studies need to be conducted to either corroborate or disprove 
the positive findings. There remains a distinct paucity of data from an Australian 
population and thus the current findings may not be generalizable given different 
geographical location and populations which may impact upon vitamin D status. 
In the absence of longitudinal RCT data to fill this gap, the VIP study provides 
the opportunity to investigate these offspring outcomes during childhood in the 
Australian context. 
2.7 Other maternal dietary factors and offspring bone 
It would be misleading to infer that maternal vitamin D is the only maternal 
dietary constituent which may have impact on offspring bone. There are several 
other nutrients which are important to bone health which should be considered as 
having an impact on offspring bone health. Given the observational nature of 
much of the evidence surrounding gestational vitamin D and offspring bone, it is 
plausible that a suboptimal diet might confound the relationship. Evidence from 
animal models has shown that not only nutrient deficits, but also excess, in the 
case of protein and fat consumption, can have long-standing effects on offspring 
bone mass and geometry
184
. In humans, a study in female twins reported 
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associations between birthweight and offspring bone measures and concluded that 
foetal nutrition plays a key role in the development of the skeleton
185
. 
 2.7.1 Maternal diet and offspring bone mass  
Prospective mother-child birth cohorts have examined the association 
between individual nutrients and offspring bone measures.  
The first to describe this relationship between offspring bone mass 
childhood and maternal diet in pregnancy was an Australian group
186
. Jones et al. 
reported seeing positive associations with magnesium, phosphorus and potassium 
with spine BMD, and between magnesium, phosphorus and protein with total 
body BMD. Furthermore, at both sites, negative associations were reported with 
fat density. However, after further adjustment, the only associations that remained 
were at the spine with phosphorus and fat. However, these findings may not be 
representative of the wider population as they were originally recruited into the 
study on the basis of being at higher risk of sudden infant death syndrome. 
Indeed, the authors reported a high percentage of premature babies, teenage 
mothers, smoking during pregnancy and an over-representation of males. 
Constraints aside, these findings provided the initial evidence, and certainly 
support the notion, that maternal diet is associated with offspring bone mass.  
 The next to examine these associations was the ALSPAC group
187
. 
Maternal magnesium, potassium, and folate intakes were reported to be associated 
with varying measures of offspring bone mass. However, the relationship between 
maternal magnesium and potassium was attenuated after adjustments for offspring 
height. Further data from the Pune study suggested that in Indian population 
calcium and magnesium intake, assessed at varying stages of pregnancy, was 
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associated with offspring bone mass
188
. The most recent, and largest study 
(n=2,819) to report on these associations during childhood was the Generation R 
study from the Netherlands
189
. They found first trimester protein, calcium and 
phosphorus intakes to be associated with higher total body bone mass in 
offspring. Conversely, carbohydrate intake was negatively associated with 
offspring bone mass. In adjusted regression models including all investigated 
nutrients, phosphorus intake most strongly predicted offspring bone mass.  
The findings of Jones et al.
190
 were also re-examined offspring at age 16 
years
191
. Maternal calcium, magnesium and phosphorus density were positively, 
and fat density negatively, associated with offspring BMD
191
. When all dietary 
factors were considered in the one model, fat density was the strongest predictor 
at the spine, and remained significant at the femoral neck, and magnesium was 
also significant at the femoral neck. 
Most importantly, in the same cohort that first reported associations 
between gestational vitamin D and bone mass in childhood
107
, dietary patterns 
during pregnancy have been shown to be independent of gestational vitamin D 




2.8 Summary of findings and gaps in the literature 
 It is clear that there is conflicting evidence with regards to gestational 
vitamin D status and offspring health outcomes. Furthermore, there is 
considerable heterogeneity in the time points at which vitamin D has been 
assessed between studies. To-date, only one small study of infants in Gambia has 
examined these outcomes in the context of two defined time points during 
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gestation to aid with elucidating the temporality of associations with health 
outcomes, should associations exist. This thesis will address this gap in the 
literature by assessing the associations with offspring health outcomes and 
gestational vitamin D status at two time point during pregnancy. Additionally, 
further knowledge will be contributed to the growing body of evidence 
surrounding gestational vitamin D and health outcomes. 
 Moreover, there is evidence to suggest that maternal nutrient consumption 
during pregnancy may also impact on offspring bone mass in childhood and 
adolescence.  Therefore, we will identify whether our cohort has a high rate of 
deficiency of pertinent nutrients and attempt to address whether these nutritional 
factors are concurrently associated with or confounding associations with 
gestational vitamin D status. 
2.9 Research questions and aims 
The VIP study provides the unique opportunity to prospectively 
investigate musculoskeletal and body composition in the offspring with relation to 
maternal gestational vitamin D levels and dietary exposures within an Australian 
population at two time-points during pregnancy. 
Specifically, the thesis will examine: 
a) the prevalence of women during pregnancy not meeting national 
recommendations for nutrients important for bone health and compare 
them to that of their non-pregnant peers 
b) the association between gestational dietary intakes and offspring measures 
of linear growth and bone mass 
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c) the association between gestational vitamin D and calciotropic factors during 
pregnancy and offspring bone mass 
d) if the association between gestational vitamin D and offspring bone mass 
is mediated by maternal bone quality 
e) the association between gestational vitamin D and offspring vertebral 
microarchitecture 
f) the association between gestational vitamin D and offspring fat and lean 
tissue 
Each aim is presented is addressed in the following chapters as individual 
manuscripts. 
The overarching objective of this thesis is to inform evidence-based practice 
with regards to vitamin D during pregnancy.  
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3.1 Overview of methods 
The main study is the Vitamin D in Pregnancy (VIP) study. This study 
was established in 2002, whereby mothers were recruited before 16 weeks 
gestation from the Geelong Hospital antenatal clinic. The current 11 year follow-
up, which is the primary focus of the offspring musculoskeletal outcomes in this 
thesis commenced in 2013 and drew to a close in early 2016. The analyses in this 
thesis utilise data from: baseline recruitment, the 28-32 week gestation follow-up, 
offspring at birth, and the 11 year follow-up. Following this is overview is a more 
detailed description of the pertinent exposures, outcomes and confounders 
examined in this thesis. 
Manuscript II utilised data from the Geelong Osteoporosis Study (GOS). 
Women aged 20-40 years who participated in GOS at the 10 year follow-up 
formed a non-pregnant control group to compare pregnant mother’s diet with 
peers from the same geographical area. A brief description of the methodology of 
the GOS follows the VIP methods. 
Descriptions of statistical analyses are provided in each individual paper.  
After methods and ethical considerations are considered a cohort profile 
(manuscript I) of VIP is presented. This provides an overview of the 
measurements and methods of collection at each follow-up phase and the 
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3.2 Detailed methodology used in the VIP study 
 3.2.1 Recruitment for the 11-year follow-up 
  Recruitment commenced in August 2013. Mothers were sent 
letters to the most recent address on file inviting themselves and their child to 
attend the study centre at University Hospital Geelong. Letters were sent out in 
batches in order of date of birth of the child and followed up with a second letter 
or a phone call if no response. The final mother-child pair was assessed in January 
2016. As reported in the cohort paper, 209 of the 402 mother child pairs at birth 
responded at the 11-year follow-up. . Differences between responders’ vs non 
responders are as listed in Table 3.1 and are further described in each manuscript.
 Table 3.1: Characteristics and differences between responders and non-







Age at delivery (years) 30.2 (4.4) 29.2 (5.1) 0.02 
Height (cm) 166.0 (162.0-171.3) 152.0(162.0-172.5) 0.76 
Weight (kg) 69.5 (60.8-82.5) 68.2 (62.2-79.3) 0.43 
Smoked during pregnancy n (% 
yes) 
39 (18.9) 33 (17.3) 0.68 
Completed high school (% yes) 127 (61.4) 102 (53.4) 0.11 
Parity (% nulliparous) 76 (37.1) 81 (42.6) 0.26 
25(OH)D recruitment (nmol/l) 55.9 (42.1-73.0) 54.6 (39.5-67.3) 0.15 
25(OH)D 28-32 weeks (nmol/L) 55.9 (42.1-77.4) 55.6 (39.9-84.0) 0.97 
Calcium recruitment (mmol/L) 2.26 (2.18-2.35) 2.27 (2.18-2.34) 0.55 
Calcium 28-32 weeks (mmol/l) 2.20 (2.12-2.27) 2.18 (2.09-2.26) 0.13 
PTH recruitment (pmol/L) 1.7 (1.0-2.6) 1.6 (1.0-2.3) 0.09 
PTH 28-32 weeks (pmol/L) 1.4 (2.0-3.2) 1.1 (2.0-2.7) 0.13 
Offspring 
Birth weight (kg) 3.5 (0.5) 3.6 (0.5) 0.46 
Birth length (cm) 50.5 (48.9-52.0) 50.4 (48.7-52.0) 0.72 
Knee-heel length (mm) 122.0 (117.0-126.5) 120.8 (115.8-125.3) 0.12 
Gestation length (wks) 40 (38-42) 40 (39-42) 0.85 
Data presented as median (interquartile range) or mean (±standard deviation) 
Serum 25-hydroxyvitamin D (25(OH)D) presented in nmol/L, Parathyroid hormone (PTH) in 
pmol/L and calcium in mmol/L 
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3.2.2 Participant measures 
  3.2.2.1 Offspring measures 
3.2.2.1.1 DXA 
  Measurements of offspring total body, vertebral, proximal femur 
and forearm areal BMC, BMD and bone area were conducted on the same DXA 
(Lunar Prodigy Pro, Madison, WI, USA) at the University Hospital, Geelong. For 
the purpose of this thesis, the sites used were total body and lumbar spine, in 
accordance with the International Society for Clinical Densitometry. At the total 
body, the head was excluded from calculations of bone mass, as it contributes a 
large proportion of overall bone mass but is the least responsive to external 
stimulus. Children were instructed to remove all metallic objects, and were 
measured in hospital gowns or minimal clothing. When the lumbar spine was 
measured, the children were supine and centrally positioned on the scanning bed. 
The lower legs were raised and positioned on a cushioned block at a 90 degree 
angle, to separate the vertebral bodies and reduce spinal lordosis. Participants 
were then instructed to place their arms flat on either side of their body. The 
scanner then positioned the scanning arm at the approximate area at which L5 was 
located and instructed the participants to stay still. Once the scan was 
commenced, adjustments were made if the spine was not straight or if the starting 
position was incorrect.  
Similar to the lumbar spine, for the total body scan participants were instructed to 
lay supine, centrally on the scanning bed. Arms were places either side of the 
body with fingers outspread.  
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Analyses were conducted with the paediatric version of the manufacturer’s 
software (enCORE, v.13). For consistency, 95% of the scans were performed by 
the same operator.  Likewise, all scans were analysed by the same operator using 
standard landmarks for region of interests (NKH), as shown in figure 3.2 on the 
following page.  The machine was calibrated daily using an equipment specific 
phantom. 
 
Figure 3.1: Dual energy x-ray absorptiometry scan region of interest 
3.2.2.1.2 Body composition 
 Using the same region of interest as shown in figure 3.2, measures of lean, 
as a measure of all tissue not comprised of bone or fat, and fat mass were 
ascertained from total body scans. The coefficient of variation (using adults) on 
the machine was 0.07% and 1.4% for lean and fat mass, respectively.  
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   3.2.2.1.3 Trabecular bone score (TBS) 
From the spine scans obtained by DXA, trabecular bone score was 
retrospectively calculated (v. 2.2; Med-Imaps, France). Trabecular bone score is 
yet to be validated for use in children; however, the limited published studies that 




  3.2.2.2 Maternal measures 
   3.2.2.2.1 Maternal serum measures 
  Details of the assays performed to determine 25(OH)D, 
parathyroid hormone and serum calcium are as described in manuscripts IV-VII, 
where relevant. At birth there were 374 mothers (79% of those recruited) who 
provided a sample for analysed of 25(OH)D at 28-32 weeks gestation. 359 of 
these also provided a sample at recruitment. At the current follow-up 183 (51% of 
the original 359, with samples at both time points) mothers that returned provided 
a sample at both time points. 
   3.2.2.2.2 Anthropometric measures 
  Maternal anthropometric measures were collected at both study 
visits during gestation and at the 11-year follow-up. For the purpose of the 
analyses presented in this thesis, height from the current follow-up to the nearest 
0.1cm was used. Two mothers did not attend the study visit at 11 years, thus 
height recorded at recruitment was substituted in its place. At the current follow-
up mothers height was measured with shoes removed on a wall-mounted 
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stadiometer. Weight was taken (±0.1 kg) with minimal clothing on regularly 
calibrated electronic scales. 
    
3.2.2.2.3  Maternal sociodemographic characteristics 
  Sociodemographic characteristics such as age, sex and 
marital status were collected with questionnaires at recruitment. Maternal 
education was self-reported at recruitment. For the purposes of analyses, this was 
categorised as 0=not finished high school or 1=completed high school. Smoking 
status was reported at recruitment as number of cigarettes currently smoking per 
day. For the purpose of analyses those who reported smoking zero cigarettes were 
categorised as 0=non-smoker or one or more cigarettes as 1=smoker.  Area-based 
socioeconomic status was calculated from the participant’s residential address at 
the time of assessment, using the Socioeconomic Index For Areas (SEIFA) 
scores. For SEIFA used for analyses was the Index of Relative Socioeconomic 
Disadvantage (IRSD). The IRSD is a measure which incorporates variables which 
are characterised by low levels of vocational or occupational training, and low 
incomes and high levels of unskilled occupations. The indexes used in these 
analyses were derived from data collected at the Australian Bureau of Statistics 
2006 census. Based on their address, participants were assigned an individual 
IRSD score relevant to the Barwon Statistical Division. For analyses these scores 
were then categorized into quintiles ranging from 1 representing the most 
disadvantaged group, to 5 representing the least disadvantaged group.     
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3.2.2.2.4 Maternal diet 
 At both recruitment and 28-32 weeks gestation women completed 
the Cancer Council Food Frequency Questionnaire. This questionnaire is 
validated for use in assessing habitual food intakes in women of childbearing age. 
Participants were asked to recall their usual consumption of 74 food and six 
alcoholic beverages. Answers were provided on a 10-point Likert scale; the 
options were never, less than once a month, once per week, twice per week, three 
to four times per week, five to six times per week, once per day, twice per day or 
three or more times per day. To assist with quantifying serving sizes photographs 
were provided of standard serving sizes. Further questions were asked to ascertain 
fruit and vegetables, fat spreads, bread, dairy, egg and sugar consumption. From 
this information detailed information of individual nutrients were ascertained 
including, but not limited to carbohydrate, fat, protein, magnesium, phosphorus, 
potassium, calcium and zinc. Dietary intakes were calculated from the most recent 
national government food composition database of Australian foods at the time of 
completion of the FFQ (NUTTAB, 1995). Taking into account reported daily 
serving sizes estimated daily intakes of nutrients were calculated. Questionnaires 
were scanned and analysed by the Victorian Cancer Council. For analyses, given 
that the FFQ takes into account the previous 12 months, the data from the later 
visit at 28-32 weeks gestation was used. 
3.3 Geelong Osteoporosis Study (GOS) 
The GOS is a longitudinal cohort study which was established in 1993. Women 
between the ages of 20-94 years were recruited residing in the Barwon Statistical 
Division from the Commonwealth of Australia Electoral Rolls. Additionally, at 
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the 10-year follow-up, a new cohort of women aged 20-29 years was recruited as 
the sample had aged 10 years since inception. Details of recruitment, subject 
characteristics and retention are presented elsewhere
194
. Data in manuscript II, 
pertains to GOS women aged 20-40 years at the 10-year follow-up phase.  This 
phase was chosen, as the dates of assessment and ages of GOS women closely 
aligned with those of the VIP mothers.  
3.3.1. Measurements used from the GOS 
  3.3.1.1 Women’s diet 
 The same FFQ described above that was given to the women in the 
VIP study was also completed by the women in GOS and analysed with the same 
composition tables (NUTTAB, 1995). From this, nutrient intakes were 
ascertained to directly compare with the intakes reported by pregnant women in 
the VIP study 
  3.3.1.2 Anthropometric measures 
Height and weight were measured using a similar protocol to VIP. 
Participants were measured, with shoes removed, to the nearest 0.1cm with a 
wall-mounted stadiometer. Weight was measured to the nearest 0.01kg on 
electronic scales, where possible in a hospital gown, or wearing minimal clothing. 
3.3.1.3 Smoking status 
Smoking status was self-reported at the 10-year follow-up. Participants 
were coded as a non-smoker (0) if they reported currently smoking zero cigarettes 
per day or a smoker (1) if they reported smoking one or more cigarettes. 
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3.3.1.4 Alcohol intake 
 Alcohol consumption was calculated in grams per day from the 
FFQ. 
3.3.1.5 Socioeconomic status 
Area-based socioeconomic status was calculated from the participant’s 
residential address at the time of assessment, using the IRSD as described above. 
3.4 Data storage 
All hard copies of data are currently stored in locked archives at the 
Health and Education Research Building, Barwon Health. Access to this data is 
strictly limited to study personnel. These data are also stored electronically and 
for both studies has been entered into separate Access databases. These databases 
are password protected and backed up on a hospital network drive. Furthermore, 
all data collected are only identifiable in these databases by study protocol 
numbers, to ensure the anonymity of participant clinical data. 
3.5 Ethical considerations 
Both the VIP study and the GOS were approved by the human research 
ethics committee at Barwon Health (refer to appendices for notification of 
approval). This approval was corroborated by Deakin University. At each stage, 
participants provided informed written consent. In the case where a mother did 
not attend the study visit, consent was provided by the child’s guardian present at 
the visit. Additionally, at the 11-year VIP follow-up, children provided optional 
assent. The study procedures were all explained verbally, with potential 
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implications and risks noted. All participants were informed that they were able to 
opt out of some or all of the measurements or questionnaires, should they not 
wish to participate in them. 
3.6 Statistical analyses 
Descriptions of the individual analyses are as described in each respective 
manuscript. All data was tested for normality and appropriate parametric and non-
parametric tests were used for comparison between groups. Where linear 
regression was employed, all normality and homogeneity of residuals were 
inspected to ensure the assumptions for linear associations were met. All analyses 
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3.7 The Vitamin D in Pregnancy Study 
MANUSCRIPT I:  
COHORT PROFILE: THE 
VITAMIN D IN PREGNANCY 
STUDY





1.  Details of publication and executive author 
Title of Publication Publication details 
Cohort profile: The Vitamin D in Pregnancy Study   To be resubmitted at International 
Journal of Epidemiology  
Name of executive author School/Institute/Division if based 
at Deakin; Organisation and 
address if non-Deakin 
Email or phone 
Natalie Hyde School of Medicine nkhy@deakin.edu.au 
2.  Inclusion of publication in a thesis 
Is it intended to include this publication in a higher degree 
by research (HDR) thesis? 
Yes  
 
If Yes, please complete Section 3 
If No, go straight to Section 4. 
3.  HDR thesis author’s declaration 
Name of HDR thesis author if 
different from above. (If the same, 
write “as above”) 
School/Institute/Division if based at 
Deakin 
Thesis title 
As above School of Medicine Gestational Vitamin D and Offspring 
Development 
If there are multiple authors, give a full description of HDR thesis author’s contribution to the publication (for 
example, how much did you contribute to the conception of the project, the design of methodology or 
experimental protocol, data collection, analysis, drafting the manuscript, revising it critically for important 
intellectual content, etc.) 
I wrote the initial draft of the manuscript and sourced information about previous follow-ups from the relevant 
sources. I edited it accordingly according to critical feedback. All descriptive statistical were performed by myself. 
I declare that the above is an accurate description of 
my contribution to this paper, and the contributions of 




4.  Description of all author contributions 
Name and affiliation of author  Contribution(s) (for example,  conception of the project, design of 
methodology or experimental protocol, data collection, analysis, drafting 




 Provided initial edits to first and subsequent drafts and provided critical 




Was involved with the inception of the cohort and initiation of the 11 year 





Provided information about health literacy and provided critical feedback 
on intellectual content of the manuscript 
Pete Vuillermin 
 
 Provided information about previous follow-ups and provided critical 
feedback on the content and structure. 
Lana Williams Provided information about psychiatric measures and provided critical 
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feedback on the content and structure. 
Julie Pasco Was involved in the inception of the initial cohort and initiation of 11 year 
follow-up. Provided initial edits to first and subsequent drafts and provided 
critical feedback on the structure and content 
5.  Author Declarations 
I agree to be named as one of the authors of this work, and confirm:  
i. that I have met the authorship criteria set out in the Deakin University Research 
Conduct Policy, 
ii. that there are no other authors according to these criteria, 
iii. that the description in Section 4 of my contribution(s) to this publication is accurate,  
iv. that the data on which these findings are based are stored as set out in Section 7 
below. 
If this work is to form part of an HDR thesis as described in Sections 2 and 3, I further  
v. consent to the incorporation of the publication into the candidate’s HDR thesis 
submitted to Deakin University and, if the higher degree is awarded, the subsequent 
publication of the thesis by the university (subject to relevant Copyright provisions).   
 


























6.  Other contributor declarations 
I agree to be named as a non-author contributor to this work. 







* If an author or contributor is unavailable or otherwise unable to sign the statement of 
authorship, the Head of Academic Unit may sign on their behalf, noting the reason for their 
unavailability, provided there is no evidence to suggest that the person would object to being 
named as author 
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7.  Data storage 
The original data for this project are stored in the following locations. (The locations must be 
within an appropriate institutional setting. If the executive author is a Deakin staff member and 
data are stored outside Deakin University, permission for this must be given by the Head of 
Academic Unit within which the executive author is based.) 
Data format Storage Location Date lodged Name of custodian if other 
than the executive author 
Hard copies of participant files HERB Building 
Geelong Hospital 
 Julie Pasco 
Access database Computer network, 
Geelong Hospital 
 Julie Pasco 
This form must be retained by the executive author, within the school or institute in which 
they are based. 
If the publication is to be included as part of an HDR thesis, a copy of this form must be 
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Why was the study set up? 
There is substantial evidence supporting the Developmental Origins of Health and 
Disease hypothesis which ties early-life exposures to an increased risk of non-
communicable disease in adult life by means of “foetal programming” 
1
. Foetal 
programming represents the phenomenon by which nutritional, environmental and 
genetic influences in utero impact upon foetal growth and development which 
thus, in turn, may permanently alter disease risk trajectories
2
.  
Vitamin D status represents a modifiable and affordable target for nutritional 
intervention during pregnancy. At the time of inception of the Vitamin D in 
Pregnancy (VIP) study, and in more recent times, a significant number of 
Australian women, including those of child-bearing age, recorded low serum 
vitamin D levels
3, 4
. Maternal insufficiency of vitamin D during pregnancy is of 
concern not only for the mothers, but also because it exposes the developing 
foetus to insufficiency during critical phases of development, and  thus may 
predispose the offspring to an increased risk of disease, such as osteoporosis, in 
adulthood .  
The VIP study was originally designed to investigate the potential role of vitamin 
D during pregnancy on infant bone development and growth measures; however, 
based on a growing body of literature 
5, 6
, has since expanded to encompass 
longitudinal investigations of several aspects of offspring growth and 
development. Importantly, the VIP cohort was recruited at a time when vitamin D 
measurement and supplementation was relatively uncommon in Australia 
resulting in relatively high rates of maternal vitamin D insufficiency
7, 8
. The study 
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thus provides an important opportunity to investigate the relationship between 
low maternal vitamin D status and offspring outcomes. 
The aims of the study are to identify whether maternal vitamin D insufficiency 
during pregnancy is associated with the following outcomes in the offspring: 
1. Bone measures 
2. Muscle mass and strength 
3. Adiposity 
4. Atopic and respiratory symptoms 
5. Behaviour and psychological symptomology  
The study design of the VIP cohort will contribute information to the growing 
policy debate surrounding vitamin D supplementation and sun exposure during 
pregnancy to alleviate chronic disease burden in the offspring. 
Who is in the cohort? 
In total, 475 pregnant women were recruited prior to 16 weeks gestation from the 
antenatal clinic at the University Hospital Geelong (formerly known as the 
Geelong Hospital), in south-eastern Australia. At the time of recruitment, and 
currently, the University Hospital Geelong served as the sole public teaching 
hospital in the region. Recruitment took place over an 18 month period and was 
completed in 2004. During the recruitment period, the population in the Barwon 
Statistical Division was approximately 260,000 and there were an estimated 2,470 
women who registered for antenatal care at University Hospital during the study 
period. Inclusion and exclusion criterion are presented in Table 3.2.1. At birth, 
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400 mother-child pairs had data recorded, with a maternal vitamin D level 
measured at one or both time points.  
How often have they been followed up? 
Following recruitment before 16 weeks gestation, mothers were reassessed at 28-
32 weeks gestation. Mother-child pairs underwent follow-up appointments once 
the offspring were born, with subsequent clinical assessments at 12 months and 
11 years later (Figure 1).  
Table 3.2.1: Inclusion and exclusion criteria for recruitment of pregnant mothers 
into the study 
Inclusion criteria Exclusion criteria 
1. Singleton pregnancy 
2. Over the age of 18 
3. Gestation length of less than 16 
weeks 
4. Unlikely to leave the area within the 
foreseeable future 
1. Evidence of insulin-dependent 
diabetes, anticonvulsant therapy, 
renal disease 
2. Sarcoidosis, familial 
hypocalciuria, hypercalcemia 
3. Substance/abuse 
4. Maintenance systematic or high-
dose glucocorticoid therapy 
5. Significant maternal illness and/or 
disability 






































475 pregnant women 
recruited before 16 
weeks gestation: 
415 women provided 
a blood sample at 
recruitment 
378 provided a sample 
at 28-32 weeks  
402 women and 
eligible infants at birth 
(84.6%)  
13 aborted 
6 moved away 
26 withdrew before 
birth 
4 withdrew after 
delivery 
1 neonate transferred 
to tertiary hospital  
25 provided no blood 
sample at either time 
point in pregnancy 








2 withdrew  
12 moved away 
 4 uncontactable 
38 not interested 
 2 illness 
1 unable to cope with 
involvement 
16 “too busy” 
3 personal reasons 
18 repeated failure to 




Figure 3.2: Participation rates at clinical follow-ups  




Telephone interviews were conducted in women who had a vitamin D sample 
during late pregnancy when offspring were approximately 5 years of age n=342 
(92% of those eligible).  Additionally, after the telephone interviews, in a sub-
study (n=58), lung function was tested in a selection of children 5-years post-birth 
whose mothers were in the highest or lowest quartile of vitamin D at 28-32 weeks 
gestation. Participant characteristics at each follow-up are as listed in Table 3.2.2. 
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(±0.43) 




- - 83.2 
(±4.9) 
Paternal      
Height (cm) 178.6 
(±0.36) 
- - - - 
Weight (kg) 87.0 
(±0.77) 
- - - - 
Offspring      
























What has been measured? 
Throughout the study, a series of clinical and questionnaire data has been 
collected from maternal and paternal parents, and the offspring; these data are 
briefly described below, and Table 3.2.3 presents the schedule of data collection 
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at each time point. Where it was possible, self-reported health outcomes which 
would require hospital admission, were verified with medical records at the 
University Hospital Geelong.  
Table 3.2.3: Schedule of measurements collected at each follow-up appointment of the 
VIP study 
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and the comprehensive fracture register for the Barwon Statistical Division, 




Blood collection  
Maternal venous blood samples were taken at recruitment and 28 weeks gestation. 
Serum samples were centrifuged within 2 hours and stored at -70C. Samples were 
analysed for 25-hyroxyvitamin D (25(OH)D) by radioimmunoassay 
(Immunodiagnostic Systems, Tyne and Wear, UK), parathyroid hormone by 
chemiluminescent enzyme-labelled immunometric assay (Diagnostic Products 
Corporation, Los Angeles, CA) and total calcium and albumin using Vitros 250 
autoanalyzer (Ortho-Clinical Diagnostics, Rochester, NY).  
Anthropometry, other clinical measures and demographics 
Body weight (±0.1kg) was measured with electronic scales and height (±0.1cm) 
ascertained by use of a wall mounted stadiometer at recruitment, 28 weeks 
gestation and at 11 years post-birth. Clinical measures included head 
circumference at recruitment, and hip and waist circumferences at 11 years post-
birth of their offspring. Blood pressure during pregnancy was extracted from 
patient obstetric records. Area-based socioeconomic status (SES) was ascertained 
by matching the residential address of each participant at baseline recruitment, 
and of the mother at 11 years post-birth, to the corresponding Australian Bureau 
of Statistics (ABS) Census Collection District (an area that encompasses 
approximately 250 households). Using ABS software, Socio-Economic Indexes 
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for Areas (SEIFA) values were determined from the 2001 census for the 
addresses ascertained at baseline, and from the 2011 census for addresses at 11 
years post-birth 
10, 11
. The composite SEIFA indexes summarise the average 
characteristics of participants within an area: the Index of Relative 
Socioeconomic Disadvantage (IRSD) was employed to provide a single measure 
that was used to rank the (weighted) level of disadvantage at the area-level
10, 11
. A 
low score, as measured by the IRSD, represents a more disadvantaged area, while 
a high score represents the least disadvantaged area. After obtaining the IRSD 
values, the study population at baseline and at the 11 year post-birth follow-up 
was categorised into quintiles of SES based on the reference range data for the 
Barwon Statistical Division for 2001 and 2011, respectively. Information on 
educational attainment, employment status, occupation type, living arrangements 
(home ownership and how many occupants in the home), marital status and 
country of birth were ascertained by self-report (Table 3.2.3).  
Bone measures 
Quantitative heel ultrasound was performed at 11 years using a Lunar Achilles 
ultrasonometer (GE, Madison, USA) on the left foot, to obtain measures of 
broadband attenuation, speed of sound and stiffness index as measures of bone 
quality. 
Health behaviours 
Skin pigmentation on the back of hands, inner underarm and shoulder, was 
determined using a flash spectrophotometer at recruitment and at 28-32 weeks 
gestation. Maternal sun exposure was also recorded by self-reported, as time spent 
outdoors in the sun and sunbaking behaviours at these assessment phases.  
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Maternal and household self-reported smoking status was collected at 
recruitment, and at the 5 year and 11 year follow-up assessments. This was 
recorded as number of occupants smoking in their main residence and number of 
cigarettes smoked by each individual.  
Maternal dietary and alcohol intake was recorded at recruitment, 28-32 weeks 




Maternal health literacy was measured at 11 years using the Health Literacy 
Questionnaire (HLQ) 
13
. The HLQ is a multidimensional tool that measures nine 
specific domains: healthcare provider support, access to sufficient health 
information, ability to actively manage health, social support, level of critical 
appraisal, level of active engagement with healthcare providers, ability to 
navigate the healthcare system, ability to find quality health information, and 
comprehension of health information. 
Mental Health 
Maternal mental health status was assessed using semi-structured clinical 
interviews at 11 years.  The Structured Clinical Interview for Diagnostic and 
Statistical Manual of Mental Disorders (DSM) Axis I Disorders, non-patient 
edition (SCID-I/NP) was used to obtain diagnoses for current and past mood, 
anxiety, alcohol and non-alcohol substance misuse, and eating disorders
14
. 
Personality disorders were identified using the Structured Clinical Interview for 
DSM-IV Axis II personality disorders (SCID-II)
15
. The Perinatal Grief scale was 
also completed by the mothers at 11 years to determine factors that may be 
important with the relationship between mother and her living children
16
. 




Fathers self-reported their height (±cm), weight (±kg) and head circumference 
(±cm) at baseline recruitment. Socio-demographic information including living 
arrangements, employment status, occupation type and educational attainment 
was collected at recruitment and 11 years. Smoking status was recorded at 
recruitment and 11 years by the mothers on the fathers’ behalf. 
Offspring data 
Blood sample 
Deoxyribonucleic acid was extracted from the offspring’s blood spot on their 
Guthrie card sample to determine vitamin D receptor genotype using Chelex 
reagent (BioRad, Hercules, CA, USA). 
Anthropometry and other clinical measures 
At birth, weight was measured by obstetric staff on regularly calibrated scales 
(±1g), crown-heel length was measured using a length board (Ellard 
Instrumentation Ltd., Seattle, WA) and knee-heel length to the nearest millimetre 
using a handheld BK5 knemometer (Force Technology, Brondby, Denmark). At 
12 months and 11 years post-birth, offspring body weight (±0.1kg) was measured 
with electronic scales and height (±0.1cm) ascertained by use of a wall mounted 
stadiometer. Skinfold measurements were collected at various sites at birth, 12 
months and 11 years in the offspring, according to International Society for the 
Advancement of Kinanthropometry protocol using Holtain calipers (±0.1mm) 
(Holtain, Crymych, UK) 
17
. Mid-arm, calf and head circumferences were 
collected at birth, 12 months and 11 years, with the addition of hip and waist at 11 
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years. Triplicate blood pressure was measured at 12 months (Critikon Dinamap 
Pro 100 oscillometric device, GE Healthcare, UK) by a trained research nurse, 
and at 11 years using a digital meter (A&D Company). Muscle strength was 
measured at 11 years by use of a manual muscle tester (Nicholas, Model 01163), 
and grip strength using a hand-held dynamometer (JAMAR Plus Digit). Balance 
and explosive force were measured in a subset of participants (n=13) by use of a 
Ground Reaction Force Platform (Leonardo). Self-reported pubertal staging was 




Bone densitometry was performed for the children at age 11 years by dual energy 
x-ray absorptiometry (DXA) using a Lunar Prodigy densitometer (GE Lunar, 
Madison, WI, USA) at the lumbar spine (L1-4), forearm (ultradistal and distal 
33%), proximal femur and total body). From the total body scans, we ascertained 
total and regional fat and lean tissue mass. Quantitative heel ultrasound was also 
performed (Achilles Insight, GE Lunar, Madison, WI, USA). In a small subset of 
participants (n=13) bone density and geometry were measured by peripheral 
quantitative computed tomography at eleven years.  
Allergy, wheezing and asthma 
Asthma, wheezing and eczema in the offspring was self-reported by the mothers 
at 12 months. The International Study of Asthma and Allergies in Children 
(ISAAC) questionnaire was completed by the mothers at 5 and 11 years
20
. 
Spirometry was conducted in a sub-sample of offspring at age 5 years, and for all 








Information about sun exposure, skin type and sunburn history of the offspring 
was collected at 5 and 11 years. Additionally, a naevi count was performed at 11 




Physical activity was recorded at 5 years by recording how much time was spent 
on average partaking in sporting activities. At 11 years activity was recorded 
using an after-school diary 
24
. This diary recorded activity for a two-hour period, 
three days after school on a scale of resting/sleeping to intense activity. 
Breastfeeding status and age of introduction to solids were recorded at 12 months. 
At 5 years of age, intake of vitamin D rich food sources, such as oily fish, was 
recorded by questionnaire, and at 11 years dietary patterns were assessed using 
the Children’s Dietary Questionnaire 
25
.  
All health behaviour measures were maternally reported on behalf of the child. 
Mental Health 
Behaviour and mental health symptomology of the offspring were assessed at 11 
years. Self-reported psychological symptoms were identified using the Spence 
Children’s Anxiety Scale 
26
, psychotic life exposures, and the Short Mood and 
Feelings Questionnaire 
27
.  Mothers provided informant responses on the 
Strengths and Difficulties Questionnaire, which assessed  emotional, internalising 
and externalising symptoms and behaviours 
28
 and the Australian Scale for 
Asperger’s syndrome to identify behaviours and abilities that typify Asperger's 
Syndrome during childhood. 
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What has been found? Key findings and publications 
Data generated from the VIP cohort has been published in peer-reviewed journals, 
and presentations made at national and international scientific meetings. We have 
reported that mothers who had lower vitamin D levels were more likely to give 
birth to babies who had: 




 Reduced mid-upper arm and calf circumferences29 
 Shorter gestation length29 




We have also reported that infant vitamin D receptor genotype potentially plays a 
role in the association between low maternal vitamin D status and offspring birth 
measures
31
. Smoking has also been shown to be associated with reduced crown-
heel length in the offspring at birth. Maternal intake of magnesium, phosphorus 
and zinc was likewise shown to be positively associated with offspring size at 
birth. Data collection for the 11 year follow-up of VIP closed in early 2016. 
Preliminary data suggest an association between maternal vitamin D and 
offspring outcomes at age 11 such as bone and body composition measures. At 
the time of writing, several manuscripts are currently in preparation to 
disseminate these findings.  
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What are the main strengths and weaknesses? 
The major strengths of this project are that data were collected during two stages 
of pregnancy (prior to 16 weeks, and at 28-32 weeks gestation), and that at the 
time of recruitment, maternal vitamin D insufficiency was relatively common. 
Furthermore, the prospective study design enables us to discern temporal 
associations between exposures during both early and late stages of pregnancy 
and offspring outcomes ranging from birth to 11 years of age. The Barwon region, 
from which the study population was drawn, is comparable to the wider 
Australian population, thus enhancing the generalisability of findings at a national 
level 
32
. At the 2001 Australian Bureau of Statistics census, the Barwon region 
was similar to the wider Australian population in terms of age (0.7% difference), 
marital status (2.2%), weekly income (1.4%) and school leavers’ age (7.5%). Our 
sample, however, may be more relatively disadvantaged than mothers in the 
region who accessed prenatal care via private options and, given a relative lack of 
ethnic diversity within the region, and the exclusion of dark-skinned or veiled 
women, the majority of our sample are Caucasian. This may decrease the ability 
to extrapolate findings to the broader international community, but assists with 
internal validity. The ethnic homogeneity however has its advantages, in that it 
reduces a potentially major confounding factor.  In comparison to some of the 
larger birth cohorts such as the Hertfordshire Cohort Study 
33
, 400 mother-child 
pairs could be considered a relatively small number that may limit statistical 
power to test for associations in less prevalent outcomes. However, unlike larger 
studies, the VIP encompasses significantly detailed prospective information and 
blood samples, and thus does not rely on proxy measures or recalled information 
for exposures during pregnancy.  




Can I get hold of the data? Where can I find out more?  
Data are archived by the Epi-Centre for Healthy Ageing, Deakin University, 
located at University Hospital Geelong (Barwon Health). Information on the 




Collaborations are encouraged and data requests can be sent to the principle 
investigator Professor Julie Pasco (juliep@barwonhealth.org.au). Establishment 
of any collaborative projects will be overseen by the VIP research group and the 
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Abstract Objectives Maternal nutrition  during  preg- 
nancy plays an important role in predisposing offspring to 
the development of chronic disease in adulthood, includ- 
ing osteoporosis. Our aim was to investigate maternal 
dietary intakes during pregnancy, with a focus on nutri- 
ents important for skeletal development in the offspring. 
Methods In this case–control study, cases were pregnant 
women recruited for the Vitamin D in Pregnancy Study    
(n = 350, age 20–40 years) and controls were non-pregnant 
peers participating in  the  Geelong  Osteoporosis  Study  
(n = 305, age 20–40 years). Dietary intakes of nutrients 
were quantified using a validated food frequency question- 
naire. Results Compared to controls, cases consumed more 
energy [median (interquartile range): 7831  (6506–9461) 
vs. 7136 (6112–8785) kJ/day]; median intakes for cases 
were greater for carbohydrates [206.2 (172.5–249.9) vs. 
188.2 (147.7–217.5) g/day], fat [77.9 (60.3–96.6) vs.   72.1 
(53.3–87.4) g/day], potassium [2860 (2363–3442) vs. 2606 
(2166–3442) mg/day] and calcium [1022 (819–1264)     vs. 
918 (782–1264) mg/day] (all p ≤ 0.05). However, pregnant 
women were not consuming greater amounts of those nutri- 
ents which had an increased demand (protein,  magnesium, 
phosphorus and zinc). Similarly, this translated to the like- 
lihood of achieving national recommendations for corre- 
sponding nutrients. Conclusions  for  Practice  Compared 
to their non-pregnant peers, pregnant women were more 
likely to meet dietary recommendations for calcium and 
potassium; however, this was not the pattern observed for 
protein, magnesium and zinc. Future public health mes- 
sages should perhaps focus on increasing awareness of the 
importance of all these nutrients during  pregnancy. 
 






What is already known? Poor maternal diet may impact upon 
not only the individual’s bone health but also that of the off- 
spring. Despite this few studies have investigated maternal 
diet with relation to nutrients considered important for bone 
health and compared them to the general population. 
What this study adds? Women during pregnancy were 
consuming slightly higher amounts of nutrients required for 
   bone health than their non-pregnant counterparts; however, 
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they are not consuming more of those nutrients which have 
an increased demand. Public health messages should per- 





Maternal nutrition during pregnancy plays an instrumental role 
in predisposing offspring to the development of chronic dis- 
ease in adulthood (Barker 2012) with a well-established role 
in the development of osteoporosis (Dennison et al. 2010).   It 





has been suggested that the availability of nutrients in utero 
may directly impact foetal development, acting on biologically 
plastic processes during development, with potential long-term 
health outcomes (Barker 2012; Christian and Stewart 2010). 
Poor maternal dietary patterns during pregnancy have 
been shown to reduce childhood bone mass, with a subse- 
quent increase of fracture risk in offspring (Cole et al. 2009; 
Petersen et al. 2015; Tobias et al. 2005). Previously our 
group has reported that maternal vitamin D levels are asso- 
ciated with measures of long bone growth in utero (Morley 
et al. 2006). There are however several other nutrients, pri- 
marily obtained by diet, which may play a role in offspring 
bone development. Both macro- and micronutrients such as 
magnesium, phosphorus, potassium, calcium and zinc are 
all considered important for optimal bone health (Office of 
the Surgeon General (US) 2004). Calcium and phosphorus 
are integral components of bone and contribute to bone 
strength. Furthermore, potassium has been shown to reduce 
urinary calcium excretion, magnesium  potentially  plays  
an important role in growth of hydroxyapatite crystals, an 
important component in bone, and zinc plays a role in the 
function of enzymes and regulators involved in the mainte- 
nance of the bone matrix. Indeed, previous work has shown 
that maternal ingestion of nutrients such as magnesium and 
phosphorus impacts upon bone mass in offspring during 
childhood (Jones et al. 2000). Thus, pregnancy offers a pos- 
sible critical point of intervention for future osteoporosis 
prevention, however to date there is a lack of health promo- 
tion specifically targeted towards the pregnant population. 
Despite the recognition that maternal diet might be impor- 
tant in future onset of osteoporosis and prevention of sub- 
optimal bone development in offspring, few studies have 
specifically investigated maternal dietary intake during preg- 
nancy of macro- and micronutrients related to bone health. 
Although there is an increase in energy intake during preg- 
nancy changes in diet may not be adequate to meet national rec- 
ommendations, thus specific health promotion messages may 
be needed for this population. Dietary intake should increase 
during pregnancy, however, previous Australian research has 
suggested that pregnancy status does not influence diet quality 
(Hure et al. 2009), thus an increased energy intake may not be 
sufficient to ensure women are meeting national recommenda- 
tions. We therefore aimed to investigate if intakes of nutrients 
important for skeletal health are increased during pregnancy 







For this case-control study, cases and controls were   drawn 
from the same geographic region. Cases were defined as 
pregnant women enrolled in the Vitamin D in Pregnancy 
(VIP) Study. The VIP participants were recruited from the 
Geelong Hospital antenatal clinic  (2002–2004)  prior  to  
16 weeks gestation, and attended the study centre twice 
during pregnancy: at recruitment and 28–32 weeks gesta- 
tion. Data for this analysis pertain to the assessment at 28–
32 weeks. Details of study design and recruitment for the 
VIP study have been described elsewhere (Morley et al. 
2006). 
Controls were non-pregnant women who were partici- 
pants of the Geelong Osteoporosis Study (GOS). Women 
were recruited into the GOS using random selection from 
Commonwealth electoral rolls. Data for this analysis were 
collected at the 10-years follow up visit (2004–2008). 
Details of study design and recruitment for the GOS have 
been described elsewhere (Pasco et al. 2012). 
The age group was defined as <40 as there were sub- 
stantially fewer women in VIP aged over 40. In the interest 
of keeping the distribution of ages similar across cases and 
controls women aged 40 and over were excluded (6 cases, 
85 controls). 
 
Anthropometric and Demographic Measures 
 
For cases and controls, standing height (±0.01 cm) and 
weight (±0.1 kg) were measured with participants wearing 
no shoes and minimal clothing. At the 10 years follow-up 
study visit, current smoking status was self-reported by 
controls, and was coded as a yes for cases if they reported 
smoking at recruitment visit (before 16 weeks gestation). 
Area-based socioeconomic data were determined by match- 
ing the residential address for each participant to data col- 
lected in the Australian Bureau of Statistics (ABS) census 
data. ABS software was used to determine the Socio-Eco- 
nomic Indexes for Areas (SEIFA) scores that indicate the 
socioeconomic characteristics of individuals within  an  
area of ~250 households, thereby providing a single mea- 
sure to rank the level of disadvantage on a continuum of 
most to least disadvantaged. For these analyses we applied 
the index of relative socioeconomic disadvantage (IRSD), 
which incorporates variables that identify areas character- 
ized by low incomes and unskilled occupations, and little or 
no occupational/vocational training. SEIFA values were cat- 
egorized into quintiles for the study region, whereby quin- 
tile 1 of IRSD represents the most disadvantaged group and 




Dietary intake was assessed for both cases and controls 
using a 112-item food frequency questionnaire (FFQ) devel- 
oped by the Victorian Cancer Council (Australia) (Giles 





Australian women of child-bearing age (Hodge et al. 2000). 
From the FFQ, we  ascertained  the  self-reported  intakes 
of dietary macro and micronutrients (g/day and mg/day, 
respectively) and dietary energy intake in kilojoules per day 
(kJ/day). Using this tool, portion sizes were self-selected by 
participants referring to photographs of standard meal sizes 
as references. Dietary composition tables in NUTTAB95 
database were used to determine individual nutrient and 
overall energy intake. 
A total of 711 FFQs were completed (n = 366 cases, 345 
controls), 56 of which were excluded (16 cases, 40 con- 
trols) due to implausible total energy intake of <4500 or 
>20,000 kJ/day (Meltzer et al. 2008). Thus, 655 FFQs were 
included in analyses (n = 350 cases, 305 controls). Detailed 
information on supplementation and supplement composi- 
tion was not collected uniformly across studies thus was 
omitted from analyses. 
The National Health and Medical Research Council 
(NHMRC) 2006 Nutrient Reference Values (NRV) were 
used as reference standards for classifying the proportion 
of participants who had intakes at or above these values 
(NHMRC 2006). For the purpose of population-based anal- 
yses, we applied the estimated average requirement (EAR) 
or adequate intake (AI) for each micronutrient (Table 1). 
Written informed consent was obtained from all par- 
ticipants, and both projects were approved by the Barwon 




Differences in characteristics between the cases and controls 
were compared using the Mann–Whitney test for continu- 
ous and χ2 for categorical data. All nutrients and total energy 
intake were positively skewed thus natural log-transfor- 
mations were used to normalise the data, and multivariate 
linear regression modelling was used to identify differences 
in dietary intakes between cases and controls. Multivariate 
binary logistic modelling was used to identify differences in 
the proportions of cases and controls meeting their respective 
EAR and AI values. Energy intake and age, height, smoking 
status and SES were included as confounders in the models. 
Results are presented as standard beta co-efficient (β) and 
standard error (±SE), or as odds ratios (OR) and 95 % con- 
fidence intervals (95 % CI). Analyses were performed using 





The characteristics of cases and controls are  listed  in  
Table 2. There was no significant difference in age or height 
or smoking status. Cases were heavier, more likely to have 
a lower socioeconomic position and consumed less alcohol. 
Cases had a higher energy intake and a higher intake of car- 
bohydrates, fats, potassium and calcium (all p < 0.05). No 
further differences were observed between the groups. 
In multivariate analyses, the observed differences in 
dietary intake of fat, carbohydrates and calcium among the 
cases were sustained, however the association with potas- 
sium intake was attenuated (Table 3). Furthermore, intake of 
protein, magnesium and zinc was lower in cases than con- 
trols once adjusted. 
The NRVs for nutrient intakes for both the cases and 
controls and the proportion of cases and controls meeting 
EARs and AI of micronutrients are as presented in Table 4. 
Compared to controls, a greater proportion of cases met 
recommendations for potassium (51 % vs. 42 %, p = 0.02) 
and calcium (73 % vs. 61 %, p = 0.001) whereas a smaller 
proportion met recommendations for protein (98 %  vs.  
100 %, p = 0.003), zinc (74 % vs. 96 %, p < 0.001) and mag- 
nesium (42 % vs. 56 %, p < 0.001). The increased likeli- 
hood of meeting calcium and potassium  recommendations 
 
 
Table 1  2006 National Health 
and Medical Research council 
Nutrient reference values NHMRC recommendations  
dietary recommendations for  Cases (pregnant)  Controls (non-pregnant) 
the pregnant and non-pregnant     
population  19–30 years 31–50 years 19–30 years 31–50 years 
 EAR (/day)a    
 Protein (g) 49 49 37 37 
 Magnesium (mg) 290 300 255 265 
 Phosphorus (mg) 580 580 580 580 
 Calcium (mg) 840 840 840 840 
 Zinc (ug) 9 9 6.5 6.5 
 AI (mg/day)b    
Potassium 2800 2800 2800 2800 






Table 2 Characteristics and 
differences between the preg- 
nant (cases) and non-pregnant 
 
Characteristics and nutrients Cases 










controls    
 Age (years) 29.7 (26.1–32.7) 28.6 (24.8–33.2) 0.25 
Heighta 166.1 (0.39) 165.8 (0.38) 0.51 
Weight 76.4 (68.6–88.0) 68.6 (60.9–80.3) <0.001 
Smokers n (%) 
IRSD n (%)b 
62 (17.9) 58 (19) <0.001 
0.003 
Quintile 1 (most disadvantaged) 88 (25.3) 50 (16.4)  
Quintile 2 81 (23.3) 64 (21.0)  
Quintile 3 85 (24.4) 68 (22.3)  
Quintile 4 45 (12.9) 66 (21.6)  
Quintile 5 (least disadvantaged) 49 (14.1) 57 (18.6)  
Alcohol (g/day) 0.60 (0–2.6) 5.2 (1.1–14.6) <0.001 
Energy (kJ/day) 7831 (6507–9493) 7413 (5980–8843) 0.004 
Protein (g/day) 85 (70–103) 84 (68–104) 0.47 
Carbohydrate (g/day) 206 (172–250) 183 (148–228) <0.001 
Fat (g/day) 78 (60–97) 70 (54–88) <0.001 
Magnesium (mg/day) 277 (229–338) 270 (227–331) 0.41 
Phosphorus (mg/day) 1518 (1241–1831) 1457 (1214–1748) 0.14 
Potassium (mg/day) 2850 (2360–3439) 2659 (2242–3239) 0.02 
Calcium (mg/day) 1020 (819–1266) 906 (733–1120) <0.001 
 Zinc (mg/day) 11 (9–13) 11 (9–13) 0.46 
an = 16 missing data (3 cases, 13 controls) 
bIndex of relative socioeconomic disadvantage); n = 2 missing data (2 cases) 
 
remained significant after controlling for energy intake (OR 
2.52, 95 % CI 1.08–5.89, p = 0.03 and OR 0.03, 95 %    CI 
0.01–0.16, p < 0.001; respectively). All cases and controls 
met recommendations for phosphorus. There was no differ- 
ence in the proportion of cases and controls meeting all six 
measured EARs important for bone health (37 % vs. 37 %, 
p = 0.97), and almost two-thirds were not meeting recom- 





To our knowledge this is one of few studies to compare nutri- 
ent intake during pregnancy with non-pregnant peers. We 
report that pregnant women are not consuming more of most 
nutrients with increased demands compared to that of their 
non-pregnant counterparts. Similarly, pregnant women did 
not have an increased likelihood of meeting national recom- 
mendations in comparison to non-pregnant peers. Pregnant 
women were, however, more likely to meet recommenda- 
tions for calcium and potassium. For all nutrients with an 
increased requirement during pregnancy (protein, magne- 
sium and zinc) pregnant women were less likely to meet 
national recommendations. These findings highlight that an 
overall increase in energy intake during pregnancy may not 
be sufficient to meet the increased nutrient demands. 
The median levels of nutrient intakes in pregnant 
women were comparable to reported intakes for the Aus- 
tralia/New Zealand region in recent meta-analyses with 
the exception of calcium which was considerably higher 
in our sample (Blumfield et al. 2013). Comparative to 
international research from the United Kingdom, preg- 
nant women in our study consumed slightly higher lev- 
els of micronutrients measured in this study, than their 
non-pregnant peers (Rogers and Emmett 1998). In multi- 
variable models, however, the observed increased intake 
only remained for carbohydrate, fat and calcium intake. 
However, they were less likely to consume more protein, 
phosphorus magnesium and zinc which concurs with a 
previous Australian study that reported that women do 
not make more nutrient-dense food choices according to 
pregnancy status (Hure et al. 2009). It is perhaps unsur- 
prising that pregnant women were consuming more cal- 
cium as this is perhaps one of the more publicized and 
understood health promotion messages with regards to 
bone health. Of note is that for all the nutrients which 
had increased requirements during pregnancy, pregnant 
women were less likely to meet recommendations and 
despite increased energy intake did not have a higher 
consumption. Of particular concern is that previous 
research has shown that maternal magnesium consump- 





Table 3  Multivariate modelling for dietary intake 
Nutrient β-coefficient ±SE p 
factors required for calculating energy requirements; such 
factors include basal metabolic rate and level of daily physi- 
   cal activity. However, during the third trimester of preg- 
Protein (g/day) −0.04 0.01 <0.001 
Carbohydrate (g/day) 0.07 0.01 <0.001 
Fat (g/day) 0.02 0.01 0.01 
Magnesium (mg/day) −0.04 0.01 0.002 
Phosphorus (mg/day) −0.02 0.01 0.05 
Potassium (mg/day) 0.004 0.01 0.78 
Calcium (mg/day) 0.07 0.02 0.001 
Zinc (mg/day) −0.04 0.01 0.002 
Controlled for total energy intake (loge), age, height, socioeconomic 
and smoking status. In all regression models controls are held as ref- 
erent 
Table 4 National recommendations (NHMRC 2006) and percentage 
of cases and controls meeting estimated average requirements (EAR) 
or adequate intakes (AI) of nutrients 
nancy an additional 1900 kJ/day is recommended (NHMRC 
2006). Though there was greater energy intake, pregnant 
women in our study did not appear to meet these additional 
requirements. This is of importance, as caloric restriction 
during pregnancy has been linked to a reduction in bone 
mass in the offspring (Devlin and Bouxein 2012). Of fur- 
ther concern is that this difference may be attributable to  
an increase in fats. Previously, maternal fat intake has been 
shown to be negatively associated with offspring bone mass, 
potentially by reducing intestinal calcium absorption (Yin et 
al. 2010). Pregnant women were less likely to be meeting 
the increased protein demands and this deficit is important 
considering that protein accounts for approximately 50 % of 
bone volume and about one-third of its total mass. Increased 
energy requirements should be met by an increased protein 
   intake, rather than fat. Despite this the median level of pro- 
Nutrient reference values Meeting recommenda- χ2 
tions n (%) p 
tein intake was well above the EAR and caution must be 
made  as  excess  protein  intake  has  been  associated with 
EAR (/day) 
Cases 
n = 350 
Controls 
n = 305 
detrimental effects on bone through disruption of calcium 
balance. However, it is only extremely high protein diets 
without compensation for the calcium lost that are of con- 
cern (Dawson-Hughes 2003). 
The role of vitamin D during pregnancy and offspring 
bone health is also acknowledged and indeed an associa- 
tion between maternal serum 25OHD during pregnancy and 
infant knee-heel length, which is a proxy measure of long 
bone growth in utero, has been reported in this cohort previ- 
ously (Morley et al. 2006). However, in Australia, minimal 
amounts of vitamin D are obtained from diet, with the main 
source being endogenous synthesis after exposure to    sun- 
16, potentially through influencing calcium homeostasis 
and foetal calciotropic hormones (Yin et al. 2010). Given 
this, targeted health promotion messages for pregnant 
populations may be most wisely targeted at nutrients which 
have increased demands during pregnancy rather than 
those which remain unchanged such as calcium and 
potassium. With the exception of phosphorus, protein and 
zinc, a significant proportion of women were not meeting 
national recommendations. This is of concern, especially 
when taking into account the EAR is calcu- lated to ensure 
50 % of the population have adequate intakes. Given this, 
there may be a substantially greater proportion of women 
who do not have adequate intakes at an individual level. 
Unsurprisingly, our study also revealed that pregnant 
women to consume more energy than their non-pregnant 
counterparts, potentially from increased carbohydrate and 
fat intakes. We did not quantify individual energy require- 
ments according to the national guidelines, as consistent 
measures were not available for cases and controls on all 
light (Pasco et al. 2001). 
Given the growing evidence base suggesting that there 
are developmental origins of osteoporosis (Dennison et al. 
2010), it is imperative that public health campaigns target 
this particularly vulnerable population to optimize long- 
term offspring bone outcomes and reduce the growing 
burden of osteoporosis in later life. Recent public health 
initiatives, such as Osteoporosis Australia’s “Healthy Bones 
Australia” stress a whole of life preventative approach that 
highlights the importance of commencing preventative 
measures during pregnancy (Ebeling et al. 2013). Cam- 
paigns such as these however focus primarily on calcium 
and vitamin D and should perhaps consider extending  
these messages to be inclusive of other important nutri- 
ents. Whilst the message about calcium seems to be well 
received, public health policies should perhaps extend their 
focus to other important nutrients beyond calcium to opti- 
mise offspring bone health. Future studies could evaluate 
the effectiveness of extending these public health messages 
to  include  other  nutrients,  particularly  within  a pregnant 
Protein (g) 343 (98) 305 (100) 0.003 
Magnesium (mg) 147 (42) 172 (56) <0.001 
Phosphorus (mg) 350 (100) 305 (100) – 
Calcium (mg) 256 (73) 185 (61) 0.001 
Zinc (ug) 
AI (mg/day) 
258 (73) 292 (96) <0.001 






population. At both a policy and primary healthcare level, 
pregnant women should be encouraged to increase their 
energy intake with nutrient-dense food in order to attain 
national recommendations. 
A major strength of this study is that cases and con- 
trols were drawn from the same population at similar 
time periods. However, the cases were drawn from a con- 
venience sample and thus might not be representative of 
all pregnant women in the region at that time, whereas 
our controls were recruited as a  representative sample  
of the region at that time. We assessed nutrient intakes 
from the diet alone and have not accounted for the use of 
supplements. It is plausible that intakes might have been 
augmented by supplements, particularly during preg- 
nancy, and thus we cannot exclude the possibility that 
nutrient intakes have been under-estimated. It is possible 
that with supplementation, the proportion of participants 
meeting national recommendations might be greater, so 
these approximations should be interpreted with caution. 
Furthermore, although the FFQ has been validated for  
use in women of childbearing-age, by providing infor- 
mation regarding their “usual eating habits over the past 
12 months”, responses might have included time before 
conception. This could have influenced our results by 
including time when cases were not pregnant; however, 
previously it has been shown that participants are likely 
to report more recent dietary habits (Fowke et al. 2004). 
Given that our study included measures that were taken 
during late pregnancy, reported dietary intakes are likely 
to be more reflective of participant’s diet during preg- 
nancy. Measurement error is also of concern, when using 
a food frequency questionnaire to quantify dietary intake, 
though the same tool was used in both in both popula- 
tions thereby reducing error between groups. However, 
differential recall bias of dietary intake could influence 
participant responses, whereby varying considerations 
between cases and controls might influence responses 
such as social desirability to be seen to be consuming a 
healthier diet during pregnancy. 
Although the majority of pregnant women in this study 
met national recommendations for most micronutrients 
considered important for optimal bone development, 
two-thirds of this group failed to meet recommendations 
for all nutrients considered important for optimal bone 
development in the offspring. Public health approaches  
to improve bone health, such as “Healthy Bones Austra- 
lia”, should be extended to include other nutrients, and 
may aid in reducing this gap. A campaign focused partic- 
ularly on pregnant women with a primary focus on nutri- 
ents which have an increased demand during pregnancy 
may be beneficial. 
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Abstract Magnesium, phosphorus, zinc, calcium, potas- sium 
and protein all play integral roles in maintaining bone health 
in adults; however, less is known about the impor- tance of 
these minerals in utero. We aimed to determine associations 
between maternal dietary consumption of these nutrients 
during gestation and birth measures in off- spring. Of 475 
pregnant women recruited from a single antenatal clinic 
before 16-week gestation (2002–2003) as part of the vitamin 
D in pregnancy study, 346 with recor- ded maternal dietary 
intakes at 28- to 32-week gestation and offspring measures 
at birth were included. At birth, trained personnel measured 
the infant’s weight, knee-heel length, crown-heel length and 
head circumference. At age 11, returning offspring 
underwent assessment of bone mass 
by dual-energy X-ray absorptiometry (n = 171). Crown- 
heel length was positively and weakly correlated with 
maternal intakes of all measured nutrients except calcium, 
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associations with protein, phosphorus and potassium were 
not attenuated after adjustment for maternal and offspring 
characteristics. No sustained associations were seen with 
other birth measures. Further, associations with some 
nutrients persisted with offspring height at age 11 years. 
Offspring bone area was associated with maternal diet, but 
no other measure of bone mass at age 11. After adjustment 
for height, associations were not significant. These data 
highlight that whilst some nutritional factors during preg- 
nancy are associated with offspring linear growth in utero 
and childhood, this does not necessarily translate into an 
effect on offspring bone measures in  childhood. 
 
Keywords  Diet  · Maternal  · Nutrient  · Offspring · 
Osteoporosis · Pregnancy 
Introduction 
 
The in utero environment to which the developing foetus is 
exposed is now well documented as influencing the risk of 
developing many chronic diseases in adulthood. The phe- 
nomenon of developmental plasticity is thought to influ- 
ence adult bone mass and the development of osteoporosis 
and thus an increase in subsequent fracture risk [1]. 
Osteoporosis presents a high global burden of disease. As 
the population ages, and as long as jeopardy increases, this 
burden is continually rising [2]. Magnesium, zinc, phos- 
phorus, calcium and potassium are known to play integral 
roles in maintaining adult bone health [3]. However, less 
evidence exists to support their potential role in foetal bone 
development. Peak growth velocity of the foetus occurs in 
the second half of pregnancy and, as 80 % of foetal bone 
mineral accrual occurs during this period, maternal diet 
during  later  pregnancy  is  a  probable  target  to  optimise 
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foetal growth [4]. Gestational nutrient intakes have previ- 
ously been shown to be associated with offspring bone mass 
in childhood and adolescence; however, the evidence is 
inconsistent [5–9]. Previously, we have shown that a 
substantial percentage of pregnant women fail to meet 
national intake recommendations for these minerals 
important for bone [10]. This is of particular importance if 
we see that these nutrients impact upon the growth of the 
infants in utero and into childhood and   adolescence. 
We have also reported that lower maternal vitamin D status 
in later pregnancy is associated with detrimental effects on 
aspects of offspring birth measures [11]; how- ever, 
maternal diet has also been reported to be associated with 
offspring bone mass independent of vitamin D status [12]. 
Indeed, longitudinal evidence suggests that growth measures 
in early life are associated with reduced bone mass, not only 
in neonates, but also into adulthood [13]. We thus aimed to 
determine the associations between maternal nutrient intake 
during pregnancy and offspring measures of growth and 
bone at birth and 11 years in a prospective mother–child 
birth  cohort. 
 
 




The vitamin D in pregnancy (VIP) study is a longitudinal 
birth cohort study based in Geelong, Victoria, Australia, for 
which  women were  recruited from the  Geelong  Hospital 
antenatal  clinic  (2002–2004,  n = 475)  before 16-week 
gestation. Women were mostly Caucasian (five women 
reported South-East Asian descent; 1.1 %). Participants 
attended the study centre twice during pregnancy: at 
recruitment and at 28- to 32-week gestation. A trained nurse 
ascertained measurements of the infants at 12–72 h 
following birth. Details of the study design and measure- 
ments have been described elsewhere  [12]. 
 
Collection  of  Participant Measures 
 
Maternal height, date of birth, education, parity and smoking 
status were collected at recruitment. For this analysis, 
maternal age was calculated for the date when the dietary 
information was documented. Parity was coded as first child 
(yes/no) and education was recorded as com- pleted high 
school (yes/no). Paternal height was collected as reported by 
mothers. Dietary intakes of nutrients were ascertained using 
the 112-item Victorian Cancer Council Food Frequency 
questionnaire [14]. The questionnaire entails participants 
reporting their habitual food intake over the previous 12 
months and encompasses 80 food items  and alcoholic 
beverages, on a 10-point scale. Total   energy 
and individual nutrient intakes were computed from dietary 
composition tables in the NUTTAB 95 database [Food 
Standards Australia (FSANZ), Canberra, 1995]. This 
questionnaire has previously been validated in women    of 
child-bearing age [15]. Data for this analysis pertain to the 
28- to 32-week visit (n = 372). Maternal blood samples were 
collected at this visit, and the sera were analysed   for 
25-hydroxyvitamin D [25(OH)D] levels and parathyroid 
hormone (PTH) levels. Maternal serum 25(OH)D was 
ascertained by radioimmunoassay (Immunodiagnostic 
Systems, Tyne and Wear, UK) and PTH by chemilumi- 
nescent enzyme-labelled immunometric assay (Diagnostic 
Products Corporation, Los Angeles, CA). All assays were 
performed at the Royal Children’s Hospital, which partic- 
ipate in national and international quality assurance 
schemes. Birthweight of the infants was recorded by 
obstetric staff on regularly calibrated scales. A trained 
nurse measured crown-heel length using an Ellard newborn 
lengthboard (Ellard Instrumentation Ltd, Seattle, WA, 
USA), offspring knee-heel length using a knemometer 
(Force Technology, Brondby, Denmark) and head cir- 
cumference with a plastic encircling tape (Child Growth 
Foundation, London, UK). Gestation length at birth was 
calculated in weeks from the date of last menstrual period. 
Data for 16 women were excluded from analyses as their 
reported dietary intakes were implausible (total energy 
intake \4500 or [20000 kJ/day), and a further 10 infants 
were excluded for reasons of prematurity or intrauterine 
growth retardation; thus, 346 mother–infant pairs were 
included in analyses of birth measures. Of the 346, 171 
(49.4 %) offspring were reassessed 11 years later and 
underwent scans of the lumbar spine and total body (less 
head) (TBLH) using dual-energy X-ray absorptiometry 
(DXA; Lunar Prodigy Pro, GE, Madison, WI, USA). Two 
children were excluded from the current analyses as their 
bone measures were significant outliers. Estimated volu- 
metric bone mineral density (bone mineral apparent den- 
sity, BMAD) was calculated according to the methods of 
Katzman  et  al.  [16].  Offspring  height  (±0.1 cm)      was 
measured with shoes removed, using a wall-mounted sta- 
diometer, and weight (±0.1 kg) was measured on elec- tronic 
scales in minimal clothing. Pubertal stage was   self- 
reported as Tanner stages 1–5 and was coded as early (stages 




Descriptive data are presented as mean (±SD) if para- metric 
or median (interquartile range) if nonparametric. 
Comparisons between groups were made using a two- 
sample t test, or Mann–Whitney U test if data were non- 
parametric. Correlations were used to determine  univariate 
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associations. Multivariate linear regression modelling was 
used to investigate associations between offspring mea- 
sures and maternal nutrient intakes. The models were tested 
and adjusted for appropriate confounders. Relevant 
covariates included maternal height, age, parity, smoking 
status, total energy intake, gestation length and offspring 
age, pubertal stage, sex and height. VIF were inspected to 
assess for collinearity. All associations with offspring 
measures at birth and 11 years were checked for sex 
interactions with nutrient intakes. There were no significant 
interaction terms; thus, data were pooled for analyses. All 
analyses were performed using Minitab (version 17.0; 




Participant Characteristics and Offspring Sex Differences 
 
Participant characteristics at each follow-up are displayed in 
Table 1. There were no anthropometric differences in 
mothers who returned at 11 years versus non-responders. 
However,    non-responders    were    younger    (29.2      vs 
30.3 years, p = 0.03). Non-responders also had a  higher 
magnesium (290.9 vs 269.2 mg, p = 0.03) and potassium 
intake (2997.6 vs 2749.6, p = 0.006). No further differ- 
ences in dietary intakes nor in any of the offspring  birth 
 
Table 1  Maternal and 
 
 
Characteristics Non-responders (n = 177) Responders (n = 169) 
offspring characteristics of non-   
responders (and those excluded 
from current analyses) versus 
responders of the 11-year follow-
up 































BMC bone mineral content, BMD bone mineral density, TBLH total body less head 
a n = 3 missing information 
b n = 17 missing information 
c n = 1 missing information 
d n = 3 missing information 
Age (years) 29.7 (4.7) 30.3 (4.2) 
Height (cm)a 166.2 (7.2) 165.8 (7.0) 
Smoked during pregnancy n (%  yes) 60 (17.5) 32 (18.9) 
Completed high school n (%  yes) 204 (59.1) 106 (62.7) 
First child (% yes) 127 (37.0) 56 (33.3) 
Serum 25(OH)D (nmol/L)b 55.6 (41.3–78.8) 56.8 (44.90–72.60) 
Total energy intake (kJ/day) 7831 (6506–9327) 7657 (6171–9180) 
Maternal dietary nutrient intake   
Protein (g/day) 84.7 (69.7–102.3) 82.5 (67.8–100.0) 
Magnesium (mg/day) 278.2 (228.0–338.8) 269.2 (221.1–322.6) 
Phosphorus (mg/day) 1515.3 (1241.2–1823.6) 1490.4 (1223.3–1761.6) 
Zinc (mg/day) 10.9 (8.8–13.3) 10.4 (8.7–13.2) 
Calcium (mg/day) 1022.5 (816.6–1256.3) 1012.7 (810.9–1218.3) 
Potassium (mg/day) 2859.6 (2359.6–3436.7) 2749.6 (2247.7–3247.1) 
Offspring (birth)   
Gestation duration (weeks) 40 (39–41) 40 (39–41) 
Birthweight (kg)
c
 3.6 (0.48) 3.6 (0.5) 
Crown-heel (cm)c 50.4 (2.2) 50.3 (2.1) 
Knee-heel (mm)d 120.8 (7.50) 121.3 (7.08) 
Head circumference (cm)d 34.8 (1.40) 34.7 (1.3) 
Offspring (11-year follow-up)   
Age – 10.9 (10.8–11.4) 
Height – 147.20 (143.43–154.0) 
Spine BMC (g) – 24.41 (21.03–28.36) 
Spine BMD (g/cm2) – 0.821 (0.751–0.885) 
Spine bone area  (cm2) – 29.68 (27.45–32.69) 
TBLH BMC (g) – 1070.0 (941.0–1318.3) 
TBLH BMD (g/cm
2
) – 0.823 (0.780–0.875) 
TBLH bone area  (cm
2
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measures were observed. Of the 346 included in analyses, 
169 (48.84 %) were boys. Compared with girls, boys were 
heavier (3.6 ± 0.5 vs 3.5 ± 0.5 kg, p = 0.04), were longer 
(50.9 ± 2.2 vs 50.0 ± 2.1 cm, p \ 0.001), had a longer 
knee-heel length (121.74 ± 1.45 vs 119.86 ± 7.48 mm, 
p = 0.02) and had a greater head circumference (35.16 ± 
1.42 vs 34.39 ± 1.27 cm, p \ 0.001) at birth. At age 11, 83 
(49.1 %) of the 169 who had DXA measures were boys. 
There was no difference in height or most bone measures by 
DXA. Girls, however, had a higher spine BMD [0.851 
(0.783–908) vs 0.797 (0.715–854) g/cm
2
, p \ 0.001], which 
appeared to be driven  by  an  increase  in  spine  BMC  [24.88g 
(21.82–28.70) vs 23.63 g (20.24–28.02)], p = 0.05). 
 
Offspring Birth Measures 
 
Weak correlations were observed for crown-heel length of 
the offspring and maternal intake of all nutrients, except 
calcium and potassium (all p B 0.05, Table 2). There were 
no correlations observed between birthweight and any 
nutrient (p = 0.28–0.92). There were correlations  between 
knee-heel length and magnesium (r = 0.11, p = 0.05) and 
phosphorus (r = 0.11, p = 0.05) and between head cir- 
cumference and magnesium (r = 0.12, p = 0.03). 
In multivariable models adjusted for maternal height, age,   
parity,   smoking   status   and   total   energy  intake, 
gestation length and offspring sex, the associations with 
magnesium and phosphorus and head circumference and 
knee-heel length were no longer significant. However, a 
positive association persisted between offspring crown- heel 
length and intakes of protein, phosphorus and potas- sium, 
and a positive trend for magnesium and zinc, after 
adjustment for maternal height, age, parity, smoking status, 
total energy intake and offspring sex (Table 2). Further 
adjustment for maternal vitamin D and PTH status, and 
paternal height did not alter these   associations. 
 
Offspring Measures at 11 Years of Age 
 
Birth length, weight and head circumference correlated 
poorly with all DXA measures at 11 years at both sites (r 
= -0.10–0.13, p = 0.10–0.92). Conversely, knee-heel 
length was significantly associated with most DXA param- 
eters (r = 0.17–0.21, p = 0.006–0.03), with the exception 
of spine BMD (r = 0.09, p = 0.26); however, this did not 
remain significant after adjustment for height. 
At 11 years (n = 169), there was a significant correla- 
tion between offspring height and maternal protein, mag- 
nesium, phosphorus, zinc and potassium intake (Table 2). In 
multivariable models, the associations between offspring 
height and maternal intake of magnesium, phosphorus and 
potassium  remained,  whilst  the  association  with  protein 
 
 







Birth crown-heel length Correlation
b 
Height (11 years) 
regression modelling for         
 
















* p \ 0.05; ** p \ 0.01 
a 
Coefficient is per 100 g protein, per 100 mg for magnesium, phosphorus, calcium and potassium, and per 1 lg zinc 
b   Nutrient intake data and offspring current height are   log-transformed 
c Data adjusted maternal height, age, parity, smoking status and total energy intake, gestation length and offspring sex (plus current age and 
pubertal stage in models predicting height at 11 years) 
associations between maternal r p Adjusted modelc r p Adjusted modelc 
measures of linear growth    b (95 % CI) p   b (95 % CI) p 
 Protein 0.16 0.04 2.42 0.04 0.20 0.009 5.97 0.08 
    (0.13, 4.71)    (0.76, 12.70)  
 Magnesium 0.17 0.03 0.54 0.11 0.23 0.002 2.08 0.04 
    (-0.12, 1.20)    (0.14, 4.01)  
 Phosphorus 0.17 0.02 0.16 0.02 0.21 0.005 0.42 0.04 
    (0.03, 0.30)    (0.02, 0.57)  
 Zinc 0.15 0.046 0.14 0.06 0.20 0.008 0.35 0.12 
    (-0.02, 0.30)    (-0.09, 0.79)  
 Calcium 0.12 0.11 0.05 0.43 0.13 0.09 0.16 0.36 
    (-0.07, 0.16)    (-0.18, 0.50)  
 Potassium 0.16 0.04 0.08 0.03 0.19 0.01 0.26 0.03 
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and zinc showed a positive trend (p = 0.08 and p = 0.12, 
respectively). 
At both the lumbar spine and TBLH, several nutrients were 
correlated with BMC, BMD and bone area. After adjustment 
for maternal and offspring characteristics, none of these 
univariate associations with BMC and BMD per- sisted. 
Bone area was significantly associated with mater- nal 
dietary intakes of magnesium, phosphorus and potassium at 
the spine, whereas TBLH bone area was only associated 
with phosphorus (Table 3). However, after adjustment for 
current offspring height, all of these asso- ciations were no 
longer significant. Furthermore, there were no associations 
with projected volumetric BMD (BMAD) with any nutrient 
(data not  shown). 
There were no associations with birth or current off- spring 






The primary findings of this study were that greater maternal 
intakes of protein and the minerals magnesium, phosphorus 
and zinc during pregnancy was associated with longer 
crown-heel measures in the offspring and that the 
associations persisted after adjustment for potential con- 
founding factors. No associations were observed for 
maternal intakes with infant birthweight, knee-heel length or 
head circumference. Furthermore, at 11 years, the 
association persisted most strongly with magnesium and 
zinc and measures of linear growth. There was an observed 
association between these minerals and bone area; how- 
ever, these associations were completely explained by 
offspring current height. 
Greater consumption of these nutrients may optimise linear 
growth in utero and be positively associated with birth 
length and childhood height; however, these effects were not 
translated into an increased bone mass in child- hood at age 
11 years. Previously, it has been shown that crown-heel 
length and weight at birth are positively asso- ciated with 
BMD in Australian children aged 8 years [17], in contrast to 
our findings. However, it is noted that these associations 
were seen in BMD at the femoral neck; the association in the 
same study was not seen at the lumbar spine, in agreement 
with our results. If BMD is reduced in childhood, optimal 
peak bone mass may not be attained  and thus there is an 
increased risk of osteoporosis in later life. However, our 
results suggest that neither crown-heel length at birth nor 
maternal dietary intakes of measured nutrients were 
associated with measures of bone mass in children at age 11  
years. 
Studies investigating maternal diet and offspring bone mass 
have yielded conflicting results. Whilst some  studies 
 
have identified maternal magnesium intake as an important 
factor in childhood bone mass, others have reported a null 
association and one group reported a positive association at 
age 9 that was still present at age 16 [5–9]. In the case of 
protein and phosphorus, this group showed a positive 
association at  age  9  that  was  no  longer  present  aged  16 
years. Similarly, in these studies, calcium, potassium and to 
a lesser extent zinc have all shown varying associ- ations 
with childhood bone measures. Whilst we observed 
associations with bone area, this appeared to be entirely 
mediated by offspring linear growth. These relationships 
may be interpreted to mean that the observed effects on bone 
area are the result of longer, rather than wider, bones. 
Plausible reasons for this include heterogeneity of ages at 
which offspring were assessed and differences in the tools 
used to quantify maternal dietary intakes. In particular in this 
cohort, the inception of puberty and related sex hor- mones 
may obscure any potential associations. We adjus- ted for 
pubertal staging, and this did not alter the null association, 
but the possibility that associations might become evident 
after puberty cannot be excluded. To our knowledge, there 
are currently no detailed data on maternal diet in cohorts of 
offspring in adulthood for comparison to assess whether 
maternal nutrient intakes have long-stand- ing effects on 
offspring bone measures. Our results in childhood, however, 
suggest a null effect. Although our results suggest that intake 
of these nutrients during late pregnancy did not appear to be 
associated with offspring bone mass, this should be 
interpreted with caution. Dietary intakes during earlier 
stages of pregnancy, or indeed chil- dren’s intake during 
growth, may also play an important role, and this should be 
the focus of subsequent investigations. 
There are other strengths and limitations in our study. A 
major strength is the prospective study design that min- 
imises differential recall bias of dietary intakes in relation to 
offspring measures. However, as is the nature of prospective 
cohorts and long-term follow-up there was considerable 
attrition, and we may be limited by the sample size at the 11-
year follow-up. Whilst there is a potential for differential 
attrition bias to influence our results, compar- ison of 
demographic and anthropometric measures of responders 
versus non-responders was largely comparable. However, 
mothers who returned were likely to be con- suming less 
magnesium and potassium, though the mag- nitude of 
difference was small. Although we attempted to account for 
any potential sample differences, we cannot exclude the 
possibility for unrecognised differences between non-
responders and responders obscuring the associations. 
Indeed, birth cohorts examining DXA out- comes with a 
comparable number of participants but  greater attrition have 
demonstrated meaningful findings [18]. It should also be 









Table 3 Correlations and regression modelling for associations between maternal dietary nutrients and offspring bone measures by dual-energy X-ray absorptiometry at 11 years Nutrienta































* p \ 0.05; ** p \ 0.01 
a   
Coefficient is per 100 g protein, per 100 mg for magnesium, phosphorus, calcium and potassium, and per 1 lg zinc 
b   
Data adjusted maternal height, age, parity, smoking status and total energy intake, gestation length, current age and pubertal stage and offspring sex 
c   
Model 1 plus current offspring  height 
d   























rd Model 1b   Model 2c     Model 1b   Model 2c     Model 1b   Model 2c  
  b p b p  b p b p  b p b p 
Lumbar spine L2-L4               
Protein 0.16* 5.07 0.11 0.01 0.79 0.08 0.064 0.28 0.014 0.79 0.20** 3.33 0.10 0.83 (-1.91, 3.58) 0.55 
  (-1.09, 11.22)  (-0.09, 0.12)   (-0.052, 0.179)  (-0.086, 0.116)   (-0.61, 7.29)    
Magnesium 0.15* 1.28 0.16 -0.01 1.0 0.05 0.01 0.66 -0.010 0.49 0.21** 1.26 (0.13, 2.40) 0.03 0.39 (-0.40, 1.18) 0.33 
  (-0.49, 3.06)  (-1.32, 1.30)   (-0.03, 0.04)  (-0.040, 0.019)       
Phosphorus 0.16* 0.34 0.07 0.08 0.55 0.06 0.003 0.44 -0.001 0.79 0.21** 0.28 (0.05, 0.52) 0.02 0.11 (-0.05, 0.27) 0.19 
  (-0.03, 0.71)  (-0.19, 0.35)   (-0.004, 0.010)  (-0.007, 0.005)       
Zinc 0.16* 0.30 0.15 0.10 0.50 0.08 0.004 0.31 0.001 0.71 0.19* 0.18 0.16 0.05 (-0.13, 0.023) 0.58 
  (-0.11, 0.70)  (-0.19, 0.39)   (-0.004, 0.011)  (-0.005, 0.008)   (-0.07, 0.44)    
Calcium 0.09 0.15 0.34 0.06 0.61 0.02 0.009 0.75 0.000 0.90 0.14 0.13 (-0.07, 0.33) 0.19 0.07 (-0.07, 0.02) 0.32 
  (-0.16, 0.46)  (-0.17, 0.28)   (-0.005, 0.007)  (-0.005, 0.005)       
Potassium 0.14 0.15 0.11 -0.001 0.99 0.03 0.0003 0.85 -0.002 0.25 0.21* 0.17 0.006 0.06 (-0.02, 0.15) 0.13 
  (-0.034, 0.34)  (-0.140, 0.138)   (-0.003, 0.004)  (-0.005, 0.001)   (0.05, 0.28)    
Total body (less head) 
Protein 0.19* 248.00 0.11 74.6 0.42 0.19* 0.064 0.28 0.027 0.39 0.22** 190.0 0.08 45.8 0.49 
  (-21.0, 516.0)  (-107.6, 256.8)   (-0.051, 0.179)  (–0.035, 0.001)   (-20.0, 400.0)  (-85.1, 176.6)  
Magnesium 0.19* 43.3 0.27 -18.1 0.50 0.15 0.006 0.59 -0.007 0.51 0.20* 41.2 0.18 -9.7 0.61 
  (-34.6, 121.2)  (-70.9, 34.6)   (-0.016, 0.027)  (-0.025, 0.011)   (-19.6, 102.0)  (-47.6, 28.2)  
Phosphorus 0.21** 15.46 0.06 3.18 0.42 0.17** 0.002 0.18 0.000 0.82 0.22** 13.26 (0.79, 25.75) 0.04 3.18 0.42 
  (-0.05, 34.42)  (-4.64, 10.99)   (-0.001, 0.007)  (-0.003, 0.004)     (-4.64, 10.99)  
Zinc 0.20** 11.01 0.22 1.70 0.78 0.17* 0.003 0.29 0.006 0.77 0.20** 8.97 0.20 1.24 0.77 
  (-6.50, 28.51)  (-10.09, 13.50)   (-0.002, 0.007)  (-0.003, 0.005)   (-4.72, 22.67)  (-7.22, 9.71)  
Calcium 0.15 9.32 0.18 4.89 0.29 0.13 0.002 0.30 0.001 0.50 0.15 7.37 0.17 3.76 0.25 
  (-4.28, 22.73)  (-4.15, 13.93)   (-0.002, 0.006)  (-0.002, 0.004)   (-3.20, 17.94)  (-2.73, 10.25)  
Potassium 0.18* 5.50 0.19 -1.82 0.52 0.15 0.001 0.44 -0.001 0.48 0.18* 5.03 0.12 -1.04 0.61 
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was ascertained via self-report; thus, food intakes may have 
been over- or underestimated. To minimise this issue, we 
excluded mothers with exceedingly low or high energy 
intakes. Second, individual nutrient intakes using food 
frequency questionnaires are estimates only and may not 
accurately assess absolute values. Third, use of supple- 
ments has not been considered in our analyses and our 
nutrient data were derived from food intake alone. We 
cannot exclude the possibility that these intakes might have 
been augmented with supplement use. Objective measures 
of serum levels of individual nutrients in future studies may 
help to further clarify any potential associations. However, 
such measures are costly and are not always viable in large 
cohorts. There is also difficulty in measuring crown-heel 
length in infants which may obscure associations. There is 
an increased level of flexion in infants at birth, so it is 
possible that maternal serum levels of micronutrients might 
influence muscle tone and thus apparent crown-heel length 
measurements. For example, an increased probability of 
neonatal hypotonia has been shown to be associated with 
greater maternal magnesium serum levels [19]. However, 
given that the associations with linear growth were seen to 
persist into childhood, this seems unlikely. Lastly, our 
sample was essentially Caucasian. Whilst findings may not 
be generalizable to other ethnic groups, this homogeneity 
assists with internal validity of observed  associations. 
Maternal dietary intake of some minerals appears to 
favourably influence linear growth in utero and the effects 
appear to be sustained into childhood. However, we did not 
detect other associations with any other birth measure and 
the effects on linear growth do not appear to translate into an 
increased bone mass in offspring. Whilst these nutri- tional 
factors during pregnancy may be favourable for other 
offspring health outcomes, these findings suggest that they 
do not have an impact on offspring bone health in children 
aged 11 years. 
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Abstract 
Context: Previously we have demonstrated an association between maternal 
serum 25-hydroxyvitamin D (25(OH)D) during pregnancy and knee-heel length 
in offspring at birth. However, it is unknown if maternal serum 25-OHD is 
associated with bone mass in childhood. 
Objective: The objective of this study was to examine associations between 
25(OH)D at two stages of pregnancy and offspring bone measures at 11 years.  
Design: Observational, prospective mother-child cohort study 
Setting: Recruitment for the study was from a single hospital’s antenatal clinic 
Participants: Women, who were recruited before 16 weeks gestation, and their 
offspring at age 11 years. 
Intervention: No interventions were used. 
Main Outcome Measures: The primary outcome was offspring bone mineral 
content, density and area at the lumbar spine and total body (less head), as 
measured by dual-energy x-ray absorptiometry.  
Results: Maternal 25(OH)D at recruitment was positively associated with the 
children’s bone mineral content at both the spine and total body. This effect was 
observed in boys, but not girls. In boys, a 10nmol/L increase in maternal 
25(OH)D was associated with a mean 0.5g (95% CI 0.1,0.8) and 14.6g (95% CI 
4.6, 24.6) increase in bone mineral content in the spine and total body, 
respectively. No sustained significant differences were detected in girls.  
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Conclusions: At age 11 years, maternal 25(OH)D levels during early pregnancy 
were associated with a beneficial effect on bone measures in boys, but not girls. 
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Introduction 
It is increasingly accepted that there are developmental origins of chronic disease 
in adulthood [1]. Osteoporosis is no exception and indeed the risk of developing 
osteoporosis in later life and consequent fracture may be programmed by early 
life exposures [2, 3]. 
Vitamin D, measured as circulating level of 25(OH)D, is a key substrate for the 
production of 1,25 dihydroxyvitamin D, a secosteroid hormone which is essential 
for bone growth and mineralisation [4]. A substantial number of Australian 
women, including those of child-bearing age, have low serum vitamin D levels 
[5]. Maternal insufficiency is a cause for concern not only for the mothers, but 
also because it exposes offspring to insufficiency in potentially critical early 
phases of development [6].  Optimising vitamin D levels may thus be an 
affordable modifiable factor to target during pregnancy to enhance offspring bone 
development. 
Previously we have reported that maternal serum 25OHD level at 28-32 weeks 
gestation, but not at an earlier stage of gestation, was associated with a reduced 
knee-heel length, a proxy measure of long bone development in utero, in the 
offspring at birth [7]. Other prospective studies have explored associations 
between maternal 25(OH)D and offspring bone measures in early life [8]. In one 
study, 25(OH)D levels were associated with changes in foetal bone morphology 
as early as 19 weeks gestation [9]. Positive associations between maternal 
25(OH)D levels and offspring bone mineral content (BMC) in childhood [10] and 
young adulthood [11] have previously been described, although null associations 
in childhood have also been reported [12].  
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A critical difference in studies is the timing in the 25(OH)D measurements. To 
our knowledge, no study to-date has collected maternal vitamin D levels at two 
defined time points in each individual, and examined whether temporality of 
vitamin D status plays an important role in this association. We thus aimed to 
determine whether vitamin D status during early and later gestation was 
associated with bone measures in offspring aged approximately 11 years.    
Materials and methods 
Participants 
Mothers were recruited as part of a prospective longitudinal study based in 
Geelong, in south-eastern Australia. Mothers were recruited before 16 weeks 
gestation from the University Hospital Geelong (formerly the Geelong Hospital) 
between 2003 and 2004. From 475 women recruited, 402 infants were born to 
mothers who had at least one blood sample taken during pregnancy and provided 
some measurements at time of birth. Two hundred and eight mother-child pairs 
were assessed at follow-up during the period 2013 to 2016, when the children 
were aged ~11 years. The study approval was obtained from the Barwon Health 
Human Research Ethics Committee. Informed consent was obtained at each phase 
from the mothers and optional assent was provided by offspring at the current 
follow-up. 
Vitamin D, PTH and calcium assays 
Maternal serum samples were taken at recruitment and at 28-32 weeks. Venous 
samples were centrifuged within 2 hours and stored at -70 degrees Celsius until 
they were analysed.  Assays were undertaken in batches by radioimmunoassay 
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(Immunodiagnostic Systems, Tyne and Wear, UK): this assay reports a 75% cross 
reactivity with 25(OH)D2 and measures 100% of 25(OH)D3. At 30nmol/L the co-
efficient of variation (CV) was 10.2%, and similarly 10.1% at 100 nmol/L. 
Chemilumiscent enzyme-labelled immunometric 2000 autoanalyser (Diagnostic 
Products Corporation, Los Angeles, CA, USA). At 5.2 pmol/L the ‘between run’ 
precision was 7.8% and at 37.7 pmol/L, 8.0%. Calcium (mmol/L) and albumin 
(g/L) were measured with the Vitros 250 autoanalyzer (Ortho-Clinical 
Diagnostics, Rochester, New York, USA). Calcium was adjusted for albumin 
(adjusted calcium= calcium+0.01*(38-albumin)). All testing was performed at the 
Royal Children’s Hospital, Melbourne, which participates in both national and 
international quality assurance schemes.   
Offspring DXA measures 
At the 11 year follow-up, lumbar spine and whole body scans were performed for 
the offspring (GE Lunar Prodigy, Madison, USA); the scans were analysed using 
paediatric software (GE Encore v. 13) by the same operator (NKH). From scans, 
BMC, bone area, areal bone mineral density (BMD) and total lean and fat mass 
measures were ascertained. Further estimations of volumetric density, bone 
mineral apparent density (BMAD), were calculated using the methods of 
Katzman et al. [13]. In accordance with the International Society for Clinical 
Densitometry (ISCD) paediatric guidelines, the regions of interest included 
lumbar spine and total body less head (TBLH) [14]. Equipment-specific phantoms 
were used to perform daily calibration of the densitometer.  
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Other offspring measures 
Offspring were measured soon after birth (0-72hr) by trained personnel using 
standardised techniques to collect weight (±0.1g), and knee-heel length 
(±0.1mm). At the current follow-up children were weighed on electronic scales 
(±0.1kg) with minimal clothing and shoes removed. Height was measured using a 
stadiometer (±0.1cm; Harpenden). Children’s pubertal stage was collected by 
self-report and categorised as Tanner stage 1-5; groups were subsequently 
collapsed into a binary low/high variable (1-2=low and ≥3=high) [15, 16]. 
Maternal anthropometry and measurements 
Mothers were assessed when recruited and at the 11 year follow-up. Lifestyle and 
socio-demographic factors during pregnancy such as smoking status and 
education were completed by self-reported questionnaire at recruitment. Maternal 
height (±0.1cm) was measured at recruitment and at the 11 year follow-up. For 
these analyses we used maternal questionnaire data from recruitment and 
anthropometry from follow-up; however, if data were missing for the appropriate 
visit, the alternate values were used (height n=2, education and parity n=2). 
Statistical analysis 
Characteristics of responders were compared to those of non-responders. Mann-
Whitney U tests were used for non-parametric continuous variables across two 
groups or Kruskal-Wallis when there were three or more groups.  T-tests were 
used for continuous variables with a parametric distribution and chi-square tests 
used to compare categorical variables. Variables are presented as median 
(interquartile range) or mean (± standard deviation). Minimally-adjusted linear 
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regression models were developed and included adjustments for offspring height, 
weight, pubertal stage and sex. Model 2 was further adjusted for maternal 
education, parity, smoking status during pregnancy and height. Fully-adjusted 
models were further adjusted for gestation length and offspring birth knee-heel 
length. Residual plots were inspected to ensure that the assumptions of linear 
associations for maternal 25(OH)D were met.  Sex interactions were observed 
between vitamin D at recruitment and some bone outcomes, thus for the purpose 
of these analyses, data were stratified by sex. Maternal 25(OH)D was also 
examined as a binary variable, using a cut-off point of 28nmol/L which was used 
in the original analyses as used in previous results from this cohort at birth [7] 




Of the original 402 mother-child pairs, 208 (51.7%) participated in the 11 year 
follow-up. Of these, 195 had DXA measurements for both the spine and TBLH, 
and 183 had complete DXA measures and maternal vitamin D measurements at 
both recruitment (before 16 weeks) and 28-32 weeks gestation. A further two 
older children were excluded from analyses as their bone measures were outliers 
(+5.9 SD and +4.6 SD).   
Women who were included in final analyses had similar characteristics to non-
responders and those not included in the current analyses (Table 6.1); however, 
women included in the current analyses were older than those who did not return. 
There were no differences in any offspring birth measures. 
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Table 6.1: Characteristics and differences between the current sample (n=181) and those 
excluded and lost to follow-up since birth (n=221) 
Characteristics Included in 
analyses 




Age at delivery (years) 30.3 (4.2) 29.2 (5.1) 0.02 
Height (cm) 165.8 (6.7) 166.4 (7.4) 0.82 
Weight (kg) 73.6 (60.4-79.4) 71.4 (61.3-82.9) 0.56 
Smoked during pregnancy n (% 
yes) 
34 (19.0) 38 (17.5) 0.70 
















25(OH)D recruitment (nmol/L) 56.1 (42.2-73.2) 54.8 (39.7-67.2) 0.13 
25(OH)D 28-32 weeks (nmol/L) 56.8 (44.2-74.7) 55.9 (39.9-84.4) 0.85 
Offspring 
Birth weight (kg) 3.51 (0.6) 3.57 (0.5) 0.30 
Knee-heel length (mm) 121.1 (7.4) 120.3 (8.1) 0.33 
Gestation length (wks) 40.0 (39-41) 40.0 (39-40) 0.78 
 
In this analysis, mothers had a mean age of 30.3 years at time of delivery and a 
median serum vitamin D level of 56.1 (42.2-73.2) and 56.8 (44.2-74.7) nmol/L at 
recruitment and 28-32 weeks, respectively. Maternal 25(OH)D levels varied by 
season at both time points (p<0.001) (Table 6.2), with levels highest in summer 
and lowest in winter. The numbers of mothers with 25(OH)D <50nmol/L were 69 
(38.1%) at recruitment, 69 (38.1%) at 28-32 weeks; 80 (41.2%) had sufficient 
levels at both time points.  No associations were detected between 25(OH)D 
levels and maternal height, parity, smoking status or education at either time 
point. 
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Table 6.2: Maternal serum levels of vitamin D (25(OH)D), parathyroid hormone (PTH) and calcium (adjusted for albumin) by season of blood collection at 






Vitamin D 28-32 
weeks 












34 70.1 (57.6-80.2) 32 82.8 (62.5-98.7) 32 1.6 (0.9-2.3) 31 1.9 (1.3-1.9) 34 2.3 (2.3-2.4) 32 2.3 (2.2-2.3) 
 
Autumn 
66 62.4 (50.7-83.6) 28 60.9 (50.2-81.2) 64 1.7 (0.9-2.4) 26 1.8 (0.9-3.4) 65 2.3 (2.2-2.3) 28 2.3 (2.2-2.3) 
 
Winter 
57 44.0 (34.8-60.2) 55 51.2 (38-9-63.2) 54 1.5 (0.5-1.8) 53 2.1 (1.3-3.0) 57 2.3 (2.2-2.3) 55 2.2 (2.2-2.3) 
 
Spring 
24 47.9 (39.2-57.4) 66 51.4 (42.1-67.1) 24 2.5 (1.2-3.2) 65 2.2 (1.4-2.9) 24 2.3 (2.2-2.4) 65 2.3 (2.2-2.3) 
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Table 6.3 shows the characteristics of the offspring at current follow-up. There 
were 93 (51.4%) boys and 88 (48.6%) girls; no sex differences were observed in 
terms of age, height, weight or TBLH bone measures. However, girls had a 
greater median BMD and BMAD at the spine, which appeared to be driven by a 
tendency for a higher median BMC. No differences were detected in 25(OH)D 
levels for mothers of boys vs girls at either visit. There was a tendency for boys to 
be heavier at birth, and they had a longer knee-heel length.   
Table 6.3: Sex differences in offspring clinical measures 
Offspring Boys n=93 Girls n=88 p for 
difference 
Birthweight (kg) 3.6 (0.6) 3.4 (0.6) 0.06 
Birth knee-heel (mm) 123.6 (118.7-124.8) 119.4 (115.3-124.7) 0.005 
Age (years) 10.9 (10.7-11.5) 10.9 (10.7-11.3 0.32 
Gestation length (wks) 40 (38-41) 40 (38-42) 0.74 
Height (cm) 148.6 (7.9) 148.3 (6.6) 0.98 
Weight (kg) 39.6 (35.0-47.4) 40.0 (35.1-48.7) 0.83 
Tanner Stage n (% low) 80 (86.0) 75 (85.2) 0.88 
TBLH BMC (g) 1063.8 (937.0-1231.7) 1089.0 (931.0-1320.4) 0.63 
TBLH BMD (g/cm
2





) 1329.7 (1177.7-1456.4) 1328.8 (1208.5-1509.8) 0.55 
TBLH BMAD 0.092 (0.088-0.097) 0.091 (0.088-0.096) 0.16 
Spine BMC (g) 23.6 (19.9-27.3) 24.7 (21.8-28.5) 0.06 
Spine BMD (g/cm
2
) 0.794 (0.705-0.854) 0.851 (0.784-0.907) >0.001 
Spine area (cm
2
) 29.9 (27.6-32.8) 29.4 (27.1-32.1) 0.20 
Spine BMAD (g/cm
3
) 0.143 (0.133-0.154) 0.156 (0.147-0.166) >0.001 
Results presented as median (IQR) or mean (SD) 
BMC: bone mineral content BMD: bone mineral density BMAD: Bone mineral 
apparent density 
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Maternal 25(OH)D and offspring bone mass 
In minimally-adjusted models, maternal 25(OH)D at recruitment was positively 
associated with both BMC and BMD at the spine and BMC of the TBLH (Figure 
1). A sex interaction with maternal 25(OH)D in minimally adjusted models 
(Model 1) was observed, predicting bone outcomes, thus data were subsequently 
stratified by sex. 
The relationships between maternal 25(OH)D at recruitment and all bone 
outcomes were more apparent in boys than in girls. For boys, in fully-adjusted 
models for the spine, a 10 nmol/L increase in maternal 25(OH)D was associated 
with a mean 0.5g (95% CI 0.12,0.78) increase in BMC, 0.008 g/cm
2
 (95% CI 
0.0003,0.015) mean increase in BMD and 0.24cm
2
 (95% CI 0.05, 0.42) mean 
increase in bone area. For TBLH, a 10nmol/L increase was associated with a 14.6 
g (95% CI 4.6, 24.6) mean increase in BMC, 0.006 g/cm
2
 (95% CI 0.002, 0.010) 
in BMD and 7.1 cm
2
 (95% CI 0.6, 13.6) mean increase in bone area. There were 
no associations detected between maternal 25(OH)D at 28-32 weeks and bone 
outcomes in any model for boys. The addition of season of serum collection to all 
models did not alter the magnitude nor significance of any association between 
maternal 25(OH)D at recruitment or 28-32 weeks and offspring bone measures. 
Similarly, 25(OH)D at recruitment remained significant after further adjustment 
for 25(OH)D at 28-32 weeks.  
For girls, there were no associations observed between maternal 25(OH)D at 
recruitment, nor 28-32 weeks gestation and bone outcomes in all models. 
Associations remained unchanged after the addition of season of serum sample to 
all models. 
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Upon further inspection however, there was a 25(OH)D*maternal smoking 
interaction in girls, but not boys  in some models predicting bone outcomes. 
When further stratified by smoking status in offspring adjusted models there was 
an 0.012 g/cm
2
 (95% CI 0.006, 0.018) per 10nmol 25(OH)D at recruitment, 
however this was completely attenuated in fully adjusted models  (β 0.018 ,95% 
CI -0.070, 0.106).  
Maternal serum 25(OH)D and estimations of volumetric BMD 
There were no sex interactions for 25(OH)D in models predicting BMAD (p=0.3-
0.6). In fully adjusted models, 25(OH)D remained a significant predictor of spine 
BMAD whereby a 10nmol/L increase of maternal 25(OH)D was associated with a 
0.001 g/cm
3
 (95% CI 0.0001-0.002) mean increase. However the relationship 
with TBLH BMAD was not significant (β 0.0002, 95% CI -0.0001,0.0005). 
Maternal 25(OH)D as a binary exposure and offspring bone 
When 25(OH)D was examined with original cut point of 28nmol/L, in fully 
adjusted models there were significant associations in boys, but not girls (Table 
6.4). In mothers of boys who had a serum 25(OH)D level greater than 28nmol/L 
at recruitment mean spine and TBLH BMC and BMD and TBLH bone area was 
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Table 6.4: Expected differences in offspring of mothers with serum hydroxyvitamin D 
levels greater than 28nmol/L presented as beta co-efficient and 95% CI  






Spine BMC (g) 3.73 (0.52,6.93)* 1.47 (-1.98,4.91) 
Spine BMD (g/cm
2
) 0.074 (0.004,0.144)* 0.009 (-0.064,0.082) 
Spine area (cm
2
) 1.65 (-0.19,3.50) 1.45 (-0.71,3.61) 
TBLH BMC (g) 140.1 (43.4,236.9)** 14.4 (-85.2,114.0) 
TBLH BMD (g/cm
2
) 0.052 (0.013,0.091)** -0.009 (-0.048,0.031) 
TBLH area (cm
2
) 65.3 (2.4,128.1)* 27.1 (-44.8,99.0) 






Spine BMC (g) 0.68 (-2.74,4.11) 1.34 (-2.24,4.91) 
Spine BMD (g/cm
2
) 0.016 (-0.058,0.090) 0.046 (-0.029,0.121) 
Spine area (cm
2
) 0.22 (-1.72,2.17) -0.27 (-2.55,1.98) 
TBLH BMC (g) 44.7 (-60.1,149.6) 10.1 (-93.2,113.5) 
TBLH BMD (g/cm
2
) 0.024 (-0.030,0.020) 0.03 (-0.02,0.07) 
TBLH area (cm
2
) 6.5 (-60.3,73.2) -37.7 (-112.1,36.6) 
a
Models adjusted for child height, weight, tanner stage, maternal height, parity education, smoking 
status during pregnancy, gestation length and offspring birth knee-heel length 
BMC: bone mineral content BMD: bone mineral density  
Maternal serum measures and offspring height 
In models adjusted for age, pubertal stage, sex and maternal height, childhood 
height was not associated with maternal 25(OH)D.  
Sensitivity analyses 
When children who were in higher tanner stages were excluded from analyses, the 
pattern and magnitude of associations for those in Tanner stages 1-2 remained the 
same. Sex interactions remained in several models predicting bone outcomes, thus 
data were stratified by sex.  
For boys in the lower tanner stages, in fully-adjusted models at the spine, a 10 
nmol/L increase in maternal 25(OH)D was associated with a 0.5g (95% CI 
0.18,0.84) increase in BMC, 0.009 g/cm
2
 (95% CI 0.002,0.016) increase in BMD 
and 0.26cm
2
 (95% CI 0.06, 0.45) increase in bone area. For TBLH measures, a 
10nmol/L increase was associated with a 15.4 g (95% CI 3.43, 23.11) increase in 




 (95% CI 0.001, 0.009) in BMD and 8.5 cm
2
 (95% CI 1.66, 
15.4) increase in bone area. Addition of season of sample did not change the 
associations. There was no association with maternal 25(OH)D at 28-32 weeks 
and any bone measure. For girls, there was no association with maternal 25(OH)D 
at either recruitment or 28-32 weeks gestation and any offspring bone measure. 
Adjustment for season of serum sample did not alter any associations. 
 
Discussion 
To our knowledge, this study is the first to report differential relationships 
between maternal 25(OH)D and bone outcomes in offspring at two stages of 
pregnancy. Our results suggest that maternal 25(OH)D levels during earlier 
pregnancy have a greater effect on offspring bone mass at age 11 years. 
Furthermore, this association appeared to be more robust in boys than in girls. In 
boys, the differences represented a mean increase of ~2.0% in spine BMC and 
~1.5% in TBLH BMC per 10nmol/L increase in 25(OH)D. There have been no 
studies describing childhood bone mass directly and risk of osteoporotic fracture 
later in life; however, BMD has been shown to track in childhood [17] and thus 
will be a major determinant of peak bone mass [18]. Given that peak bone mass 
plays a substantial role in the risk of developing osteoporosis in later life [19], 
these findings are of potential clinical significance. 
The reported associations between maternal 25(OH)D and offspring bone 
measures concur with findings from other cohort studies. Princess Anne Hospital 
Cohort was the first to describe this relationship during childhood, in their 
seminal study published a decade ago [10]. The Raine cohort recently 
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demonstrated the longevity of this relationship in offspring aged 20 years [11]. 
However, it must be noted that findings from the Avon Longitudinal Study of 
Parents and Children (ALSPAC) study contradicted these, and found no 
association 25(OH)D at any stage of pregnancy and offspring bone mass at age 9 
years [12]. The reasons for the differences in these findings are unclear; however, 
heterogeneity in sample characteristics, study design and unaccounted 
confounding may explain some of the discrepancies. A notable difference 
between these studies was the timing at which the vitamin D levels were taken. 
Princess Anne Hospital and Raine cohorts had defined time points that differed 
substantially, at 34 and 18 weeks, respectfully, whereas ALSPAC had samples 
from varying stages of pregnancy and predicted third trimester values. The later 
time point in our current study somewhat aligns with that of the SWS whereas the 
first time point is closer, albeit somewhat earlier than that of the RAINE study.  
Our overall findings more strongly concur with that of the RAINE study, given 
that it was the first and not the second later time point that was most consistently 
associated with offspring measures. Given that both our study and the RAINE 
study are Australian, differences in seasonal variations of 25(OH)D levels 
corresponding to geographical differences may play a part in these discrepancies. 
However, the variation of season observed in the study by Javaid et al. showed a 
comparable variation of maternal 25(OH)D levels by season (~35 (winter) vs 36 
(spring) vs 76 (summer) vs 52 (autumn) nmol/L) [10].  
From a developmental perspective, it is biologically plausible that vitamin D may 
have effect on foetal development in both early and late pregnancy. Long bone 
growth accelerates in the second trimester, however, up to 80% of mineral accrual 
occurs during the third trimester [20]. Our early time point coincides with the end 
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of the first trimester, just before the commencement of the second. By week eight 
of pregnancy a cartilaginous scaffold is completely formed and in week eight to 
twelve of gestation, the primary ossification centres form both in the long bones 
and vertebrae [21]. Thus, early pregnancy may be an appropriate time to assess 
maternal 25(OH)D levels.  A recently published randomised control trial which 
investigated the influence on bone mass of the offspring due to vitamin D 
supplementation during pregnancy reported an overall null association. However, 
the authors also reported a seasonal interaction between treatment groups and 
season of birth [22]. Winter born babies were shown to have higher bone mass in 
the supplement group vs the control group. From this the authors concluded that 
preventing a nadir in vitamin D levels during late gestation resulted in increased 
neonate bone accrual, supporting the original findings from the SWS cohort.  
However, using this same logic it would be expected that an association would 
have also been seen in babies born in spring, which was not observed. This 
relationship may be further elucidated in the planned follow-up during childhood. 
The findings that maternal 25(OH)D in the earlier stages of pregnancy, but not the 
later, has an effect on offspring bone are in contrast with earlier findings from this 
cohort at birth [7].  Previous results revealed an association between 25(OH)D 
levels greater than 28nmol/L at 28-32 weeks, but not recruitment, were associated 
with a longer knee-heel length. However, this association was largely attenuated 
by gestation length and thus reduced overall growth as a result of shorter gestation 
may have explained this relationship rather than a reduced bone development per 
se. The current findings were completely independent of both offspring knee-heel 
length and gestation length. 
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The reasons for the distinct sex differences remain unclear. This sexually 
dimorphic phenomenon has been described in several foetal developmental 
outcomes [23]. It remains unclear in this cohort whether this is whether this effect 
will be sustained into adulthood, or if it is transient and an artefact of the 
children’s current developmental stages. One may assume the latter on the basis 
of previous literature. For example, the Raine study examined similar associations 
and found no sex interactions [11]. The ALSPAC study identified sex interactions 
[12], however, reported that they were completely attenuated after adjustments for 
offspring characteristics, unlike the observed interactions within this cohort. The 
velocity of bone accrual during late childhood and early adolescence remains 
similar in girls and boys until approximately age 11 years [24]. In the following 
year, velocity in girls increases whilst boys plateau until approximately age 13 
years. Given that the age range of our cohort was 10-12 years, this may explain 
some of the discrepancies between sexes. However, we did attempt to address this 
issue by conducting a sensitivity analyses which excluded children in higher 
developmental stages, but acknowledge that Tanner staging was assessed by self-
report, so it is likely that some residual confounding remained.  
There are limitations to these findings to this observational study. Although we 
have detailed data on both maternal and offspring characteristics, we cannot 
exclude the possibility of residual confounding. Several shared causal pathways 
such as genetics and lifestyle factors are possible that might influence both 
offspring bone measures and maternal vitamin D during pregnancy. However, our 
models were adjusted for potentially confounding factors to confirm that the 
association between maternal 25(OH)D and offspring bone measures were 
independent of these. Although we have long-term follow-up, attrition within the 
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cohort was high; although this may bias our results, few differences in 
characteristics were observed between those who did and did not return for the 11 
year follow up. Finally, there are some measurement issues with the use of DXA 
in children because of poorer precision in smaller subjects; however, DXA 
remains the ISCD preferred method for assessing paediatric BMC and areal BMD 
[14].  
Despite these caveats, our findings support several other studies which suggest a 
potential association between maternal 25(OH)D levels during pregnancy. Future 
RCT data in childhood will help further elucidate this association. Given that peak 
bone mass plays an important role in the risk of developing osteoporosis in later 
life, women should be aware of the importance of maintaining adequate levels of 
vitamin D from early pregnancy, in order to optimise offspring bone mass.  
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Abstract  
Objective: Trabecular Bone score (TBS), a novel tool derived from dual energy 
X-ray absorptiometry (DXA), reflects the microarchitecture of the vertebrae. It 
has been shown to predict fracture independent of standard DXA parameters in 
adult populations. Previously, we demonstrated that maternal serum 25-
hydroxyvitamin D (25(OH)D) during pregnancy is associated with offspring bone 
mineral content at age 11 years. However, associations between maternal 
25(OH)D and offspring TBS have not been explored. 
Methods: Data were collected from the Vitamin D in Pregnancy study. Venous 
blood samples were taken at recruitment and at 28-32 weeks gestation. Maternal 
25(OH)D was measured by radioimmunoassay. Offspring (n=195, n=181 with 
complete measures) underwent spine DXA (GE Lunar), at age 11yr (median: 10.9 
(IQR 10.9-11.4)). TBS was calculated using TBS iNsight software. 
Results: Offspring of mothers with sufficient 25(OH)D levels (≥50nmol/L) at 
recruitment had a higher TBS (1.363 vs 1.340, p=0.04). In multivariable linear 
regression models, after adjustment for child relative lean mass, sex, and pubertal 
stage, a 10nmol/L increase in maternal 25(OH)D was associated with a 0.005 
(95% CI 0.000, 0.010, p=0.04) increase in TBS. Adjustment for maternal factors 
and season of serum sample did not alter these associations. There were no 
associations with TBS and maternal 25(OH)D at 28-32 weeks. 
Conclusions: Maternal 25(OH)D in early pregnancy was associated with TBS  
which  may indicate impaired vertebral microarchitecture in offspring at age 11. 
These findings warrant confirmation with existing interventional and long term 
follow-up studies, as optimising 25(OH)D during early pregnancy may 
favourably influence offspring TBS.   
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Introduction 
Trabecular bone score (TBS) is a novel measure derived from dual energy X-ray 
absorptiometry (DXA), which correlates with vertebral microarchitecture. From 
the pixel grey-level variation in lumbar spine DXA scans, a texture parameter is 
calculated [1]. In doing so, it provides complementary information about the 
skeleton that standard DXA parameters do not capture. Previous evidence has 
shown that TBS in adulthood is able to discern between those who have 
previously fractured and non-fractured controls, independent of other well-
recognised clinical risk factors [2-4]. Differences of approximately 0.03-0.04 in 
TBS between cases and controls have been reported in men and women [3,4]. In 
adult populations, it is postulated that a TBS greater than 1.350 is normal, 
between 1.200 and 1.350 represents partial degradation of the vertebral 
microarchitecture and less than 1.200 represents a degraded vertebral 
microarchitecture [1]. 
It is clear that this emerging technique may have high value in clinical practice in 
distinguishing fracture risk-profiles in those who have not been identified as high-
risk by current routinely used methods [5]. Most studies examining TBS have 
been conducted in adult populations; however, emerging evidence is highlighting 
factors which are associated with TBS in paediatric populations such as 
anthropometric measures, age, pubertal stage, and standard DXA parameters [6, 
7]. 
Associations between TBS and vitamin D status, measured as serum 25-
hydroxyvitamin D (25(OH)D), has been examined in several studies; however, 
the reported associations in adults have been conflicting, and evidence in a 
paediatric population is sparse. Some observational evidence, suggests that there 
  Chapter 7: Manuscript V  
144  
may be an association between maternal 25(OH)D and offspring bone measures 
in childhood and adulthood, though a recent clinical trial reported an overall null 
association at birth[8-10]. However there is yet to be trial data to examine 
outcomes beyond birth. However, to our knowledge, the association between 
maternal 25(OH)D during pregnancy and offspring TBS remains unexplored. 
Previously we have demonstrated that maternal 25(OH)D in early pregnancy is 
associated with proxy measures of bone [11] and birth and measures of bone mass 
in the offspring at age 11 years [12]. We thus aimed to determine if there was an 
association between maternal 25(OH)D during pregnancy and offspring bone 
TBS in childhood.     
Methods 
Study participants 
Women were recruited as part of the Vitamin D in Pregnancy (VIP) study from 
the University Hospital Geelong (formerly the Geelong Hospital) antenatal clinic 
(2002-04). Women were recruited before 16 weeks gestation and were assessed at 
two time points during pregnancy: both at recruitment and at a further study 
assessment at 28-32 weeks gestation. Approximately 11 years later (2013-16), 
mother-child pairs were recalled for reassessment. 
Anthropometric and demographic measures 
At the 11 year follow-up, offspring and maternal heights were measured 
(±0.01cm), without shoes, using a wall mounted stadiometer (Hardepen, UK). 
Two mothers were missing height measurements, thus height measured at 
recruitment was used for these individuals. Current offspring weight was recorded 
using electronic scales (±0.1kg) wearing minimal clothing. Maternal smoking 
status, education and parity were documented by self-report at recruitment. Four 
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mothers were missing data on education and parity, thus these data were obtained 
at the 11 year follow-up. Offspring pubertal stage was determined by self-
reported Tanner staging, whereby offspring in Tanner stages 1-2 were considered 
to be in early puberty, whereas those in stages 3-4 were considered late; no child 
reported as being in stage 5. 
Maternal vitamin D, parathyroid hormone (PTH) and calcium measures 
Mothers provided a blood sample at recruitment and 28-32 weeks gestation. 
Within 2 hours, venous samples were centrifuged and then stored at -70 degrees 
Celsius until they were analysed. Serum 25(OH)D levels were determined by 
radioimmunoassay (Immunodiagnostic Systems, Tyne and Wear, United 
Kingdom). The assay reports a 100% cross reactivity with 25(OH)D3 and 75% 
cross reactivity with 25(OH)D2. The coefficient of variation at 100nmol/L was 
10.1% and at 30nmol/L was 10.2%. Calcium and albumin were measured with the 
Vitros 250 autoanalyzer (Ortho-Clinical Diagnostics, New York, USA). Adjusted 
calcium was calculated according the formula adjusted 
calcium=calcium+0.01*(38-albumin). PTH was measured using 
chemiluminescent enzyme labelled immunometric 2000 autoanalyzer (Diagnostic 
Products Corporation, Los Angeles, CA, USA). The between run precision was 
8% at 5.2pmol/L and 7.8% at 37.7pmol/L. All assays were performed at the Royal 
Children’s Hospital, which participate in national and international quality 
assurance schemes. 
Offspring DXA and TBS measures 
At 11 years offspring underwent lumbar spine and total body DXA scans (GE 
Lunar Prodigy, Madison, WI, USA). Estimations of bone area, bone mineral 
density (BMD), bone mineral content (BMC), and lean and fat mass were 
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ascertained from these scans. Relative body composition variables were further 
adjusted for height (kg/cm
2
). All scans were analysed by the same operator 
(NKH), using paediatric software from the DXA manufacturer (GE enCORE, 
v.13). Daily calibration was performed using equipment specific phantoms. TBS 
was calculated retrospectively from lumbar spine scans using iNsight software (v. 
2.2; Med-Imaps, France), with the same region of interest used to calculate BMD. 
Statistical analyses 
All descriptive data are presented as mean (±SD) if parametric, or median 
(interquartile range, IQR) if non-parametric. Two-sample t-tests or Mann-
Whitney U tests were used to compare measures between groups. Univariate 
linear associations were assessed with Spearman’s rho correlation analyses. 
Multivariate linear modelling was used to evaluate the association between 
25(OH)D and TBS, both on a continuous scale. Models were adjusted for 
confounders with the highest magnitude of univariate association. All residuals 
plots were inspected to ensure that assumptions of a linear association between 
exposure and outcome were not violated. Collinearity was assessed by inspecting 
the variation inflation factor (VIF). A VIF of greater than 10 was considered 
substantial collinearity.  Further comparisons were also made grouping offspring 
by maternal 25(OH)D sufficiency (≥50nmol/L) and the original cut point 
(≥28nmol/L). Given the effect of puberty on bone development, a sensitivity 
analysis was conducted whereby offspring who reported higher Tanner stages 
were excluded. All analyses were conducted using Minitab (version17.0, Minitab, 
State College, PA).  
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Ethical considerations 
This study was approved by the Barwon Health Human Research Ethics 
Committee. All participants provided informed written consent; mothers provided 
consent on their own behalf, and that of their children. Additionally, children 
provided optional assent. 
Results    
In total, 181 mother-child pairs with maternal 25(OH)D serum measures at both 
recruitment and 28-32 weeks, and offspring DXA measures at 11 years, were 
included in these analyses. The numbers of mothers with vitamin D sufficiency 
(25(OH)D ≥50nmol/L) were 112 (61.9%) at recruitment, 112 (61.9%) at 28-32 
weeks and 80 (44.2%) at both time points.   
Maternal characteristics are listed in Table 7.1. There were no differences in 
maternal anthropometric characteristics between mothers who were and were not 
sufficient in 25(OH)D during pregnancy at either time point. Women who had 
completed high school were more likely to be sufficient in 25(OH)D at 
recruitment, and there was a trend for the same association at 28-32 weeks 
gestation.  At recruitment, mothers who had sufficient 25(OH)D levels had lower 
PTH levels, but this difference was not observed at 28-32 weeks.  
Offspring characteristics are presented in Table 7.2. There was an even 
representation of each sex with 93 (51.4%) of the sample being boys.  There was 
no difference in self-reported pubertal status in the offspring, with 13 boys 
(14.8%) and 13 girls (14.0%) reporting higher Tanner stages (stages 3 and 4) (p 
for difference=0.88).  
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Predictors of TBS 
Overall, boys had a higher median TBS than girls (1.374 (1.139-1.436) IQRs vs 
1.343 (1.287-1.383), p=0.002). Girls in higher pubertal stages had higher median 
TBS than those in lower stages (1.368 (1.335-1.401 vs 1.339 (1.127-1.339, 
p=0.04), but this difference was not observed in boys (1.369 (1.326-1.417) vs 
1.377 (1.316-1.439), p=0.9). There were several univariate correlations between 
anthropometric and demographic variables as presented in Table 7.3; the 
correlations were stronger in girls than boys. No associations were detected 
between offspring TBS and birthweight, birth length or knee-heel length. All 
measures by DXA at both sites correlated moderately with TBS. Furthermore, 
offspring TBS was not related to maternal education, parity, height, age at 
delivery or smoking status during pregnancy, nor maternal serum levels of 
calcium or PTH at either time point.  
Maternal 25(OH)D and offspring TBS 
In linear regression models, unadjusted maternal 25(OH)D at recruitment was 
associated with offspring TBS (Table 7.4).  
After adjustment for offspring relative lean mass, tanner staging and sex, this 
relationship persisted, whereby a 10nmol/L increase in maternal 25(OH)D was 
associated with a mean increase in offspring TBS of 0.005 (95% CI 0.0002, 
0.010). This association was apparent in boys but not girls, however a sex 
interaction term was not significant (p=0.16). Adjustment for maternal factors 
(height, parity, smoking status and education) did not alter the associations. 
Further adjustment for offspring spine BMC explained this association in the total 
sample (β 0.003 95%CI -0.002, 0.007), and this pattern persisted in models 
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Table 7.1: Maternal characteristics stratified by vitamin D sufficiency at recruitment and 28-32 weeks gestation  
  Recruitment 28-32 weeks gestation 
















Age at delivery (yrs) 30.3 (4.3) 30.7 (4.5) 30.1 (4.2) 0.44 30.2 (4.3) 30.5 (4.3) 0.64 
Height (cm) 165.1 (5.9)  165.6 (5.7) 164.8 (6.0) 0.41 165.3 (6.5) 165.3 (5.6) 0.67 
Smoked during 
pregnancy n (% yes)
a
 
34 (19.0) 16 (23.5) 18 (16.2) 0.23 17 (25.0) 17 (15.3) 0.11 
Completed high school 
n (% yes) 
112 (61.9) 36 (52.1) 76 (61.9) 0.04 37 (53.6) 75 (67.0) 0.07 
Nulliparous n (%) yes  67 (37.0) 24 (34.8) 43 (38.4) 0.63 23 (33.3) 44 (39.3) 0.42 


















PTH recruitment 1.8 (1.1-2.6) 2.3 (1.6-3.1) 1.6 (1.0-2.4) 0.003 1.7 (1.1-2.6) 1.8 (1.1-2.8) 0.76 
PTH 28-32 weeks 1.9 (1.3-2.8) 1.9 (1.2-2.6) 2.0 (1.4-3.0) 0.60 2.1 (1.4-2.8) 1.9 (1.3-2.9) 0.42 



















Data presented as median (interquartile range) 
Serum 25-hydroxyvitamin D (25(OH)D) presented in nmol/L, Parathyroid hormone (PTH) in pmol/L and calcium in mmol/L  
a 2 missing information 
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Age (years) 10.9 (10.7-11.4) 
Height (cm) 147.5 (143.4-154.1) 
Weight (kg) 39.7 (35.0-47.4) 
BMI (kg/m
2
) 18.2 (16.7-20.6) 
TBS 1.354 (1.298-1.554) 
TBLH BMC (g) 1075.2 (933.1-1280.2) 
TBLH BMD (g/cm
2
) 0.822 (0.778-0.870) 
TBLH area (cm
2
) 1329.4 (1183.1-1471.0) 
Spine BMC (g) 24.17 (20.90-27.82) 
Spine BMD (g/cm
2
) 0.820 (0.746-0.821) 
Spine area (cm
2
) 29.63 (27.31-32.51) 
Fat mass (kg) 9.71 (6.92-16.06) 
Lean mass (kg) 28.23 (25269-31335) 
Relative lean mass (kg/m
2
) 12.88 (12.25-13.71) 
Tanner staging n (% low) 155 (85.6) 
BMI: Body mass index; TBS: Trabecular bone score; BMC: Bone mineral 
content; BMD: Bone mineral density; TBLH: Total body less head   
Table 7.3: Spearman’s rho correlations between TBS and anthropometric and 
bone measures 
 Total Boys n=93 Girls n=88 
Height (cm) 0.16* 0.10 0.23* 
Weight (kg) 0.23** 0.17 0.31* 
Age 0.08 0.04 0.08 
BMI 0.22** 0.18 0.28** 
Lean mass 0.30** 0.16 0.40** 
Fat mass 0.10 0.15 0.13 
Relative lean mass 0.35** 0.18 0.48** 
Relative fat mass 0.07 0.12 0.10 
Spine BMC 0.37** 0.35** 0.46** 
Spine BMD 0.37** 0.44** 0.32** 
Spine area 0.26** 0.17 0.32** 
TBLH BMC 0.32** 0.28** 0.39** 
TBLH BMD 0.39** 0.36** 0.43** 
TBLH area 0.26** 0.23* 0.33** 
Maternal PTH recruitment -0.07 -0.17 -0.01 
Maternal PTH 28-32 
weeks 
0.05 0.09 0.10 
Maternal calcium 
recruitment 
0.08 0.05 0.04 
Maternal calcium 28-32 
weeks 
-0.10 -0.06 -0.16 
BMC: Bone mineral content; BMD: Bone mineral density; TBLH: Total body 
less head; BMI: Body mass index; PTH: Parathyroid hormone 
Significant differences indicated as: *<0.05 **<0.01 
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Table 7.4: Expected difference in trabecular bone score per 10nmol/L of maternal 
25(OH)D 
25(OH)D recruitment 
 n Unadjusted p Adjusted p 
Total 181 0.005 (0.000,0.010) 0.049 0.005 (0.000,0.010) 0.04 
Boys 93 0.008 (0.0003,0.015) 0.04 0.008 (0.001,0.016) 0.03 
Girls 88 0.002 (-0.005,0.008) 0.65 0.001 (-0.005,0.008) 0.63 
25(OH)D 28-32weeks 
 n Unadjusted p Adjusted p 
Total 181 0.000 (-0.005,0.005) 0.98 0.000 (-0.005,0.005) 0.98 
Boys 93 0.002 (-0.010,0.006) 0.63 -0.003 (-0.012,0.006) 0.48 
Girls 88 0.002 (-0.004,0.008) 0.46 0.002 (-0.003,0.008) 0.42 
Model adjusted for relative lean mass, pubertal stage and sex 
Results presented at beta co-efficient and 95% confidence intervals 
stratified by sex: boys (β 0.005 95%CI -0.003, 0.012) and girls (β 0.001 95%CI -
0.005, 0.007). All significant associations remained independent of season of 
serum sample. There was no association with maternal 25(OH)D at 28-32 weeks 
and offspring TBS in unadjusted or adjusted models (Table 3). 
Maternal 25(OH)D sufficiency and offspring TBS 
Offspring of mothers who had sufficient 25(OH)D (≥50nmol/L) in early 
pregnancy had higher median TBS at 11 years (1.363 (IQR 1.316-1.414) vs 1.340 
( IQR 1.282-1.391), p=0.04). After adjustment for offspring factors (relative lean 
mass, tanner staging and sex) this association was no longer significant; however, 
a positive trend remained (β 0.023 95%CI -0.002, 0.047, p=0.08). There was no 
difference detected in median TBS values for offspring of mothers who had 
sufficient 25(OH)D at 28-32 weeks (1.364 (1.306-1.413) vs 1.348 (1.284-1.400), 
p=0.17) and this was further attenuated after adjustment for offspring 
characteristics (β 0.015 95%CI -0.010,0.040, p=0.24).  There was a trend for 
association using the original cut-off point of 28nol/L (1.356 ( IQR 1.302-1.410) 
vs 1.327 (IQR 1.254-1.381), p=0.09), however significance was further attenuated 
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after adjustment for offspring characteristics (β 0.038 95%CI -0.011, 0.087, 
p=0.13). There was no association with maternal vitamin D at 28-32 weeks using 
this cut point. 
Sensitivity analyses 
When the data were restricted to pubertal stages one and two only (n=26 excluded 
in pubertal stages 3-4), the magnitude and pattern of association persisted. The 
association between 25(OH)D and offspring TBS was significant in boys 
(adjusted model: β 0.010 95%CI 0.002,0.018) but not in girls (adjusted model: β -
0.000 95%CI -0.008,0.007).  In this group the sex interaction term was closer to 
significance (p=0.07).  
 
Discussion 
To our knowledge, this is the first study to demonstrate an association between 
maternal 25(OH)D during early pregnancy and offspring vertebral 
microarchitecture in childhood, as indicated by TBS. This positive association 
was apparent in boys, particularly in those in lower pubertal stages, but not in 
girls. 
Given that TBS is a relatively novel measure, there have been few studies 
designed to evaluate the association between 25(OH)D status and TBS, most of 
those which have been conducted have been in adult and specific-patient 
populations. In studies of adults, the preservation of bone microarchitecture has 
been reported in conjunction with combined calcium and vitamin D treatment 
[13], however treatment of vitamin D insufficiency in postmenopausal women 
showed no effect [14]. Another study, involving patients with primary 
hyperparathyroidism, reported that TBS did not differ by 25(OH)D status [15]. 
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Contrary to this, in a further study involving healthy volunteers, borderline 
correlation of TBS with serum 25(OH)D levels observed [16]. Given the paucity 
of data to date, it is difficult to draw definitive conclusions on the effect of 
25(OH)D on TBS in adult populations. 
It has been suggested that vitamin D supplementation in deficient paediatric 
populations could result in clinically significant improvements in measures of 
bone mass, however, the relationship between 25(OH)D and TBS is less 
characterised. One study, in anorexia patients, showed no correlation with 
25(OH)D and TBS [17], whilst another study of healthy school aged children 
reported no benefit of vitamin D supplementation [6]. There are no studies to date 
which have examined vitamin D status during pregnancy, nor any other early-life 
exposure, and offspring TBS. Given that there is a paucity of data in paediatric 
populations it also difficult to comment on the clinical significance of the 
observed associations. However, differences of 0.032 between those who have 
fractured and non-fracture controls in adult male populations have been reported. 
Thus, given that a 0.008 difference was observed per 10nmol/L of maternal 
vitamin D, these findings could be of potential clinical significance. However, it 
must be noted that there have been no studies to discern fracture risk in a 
paediatric population, so the clinical significance of the differences remains 
speculative.  
There is evidence to suggest that origins of osteoporotic fracture may begin in 
utero [18] and whilst results have been conflicting, maternal vitamin D status has 
been shown within this cohort, and others, to impact on offspring bone mass [19]. 
We have reported that maternal vitamin D at recruitment was associated with 
spine BMC, BMD and area [12]. Comparable to the observations with TBS, these 
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associations were more robust in boys and not observed for maternal 25(OH)D 
levels measured at 28-32 weeks gestation.  Unsurprisingly, our current data 
suggest that measures of offspring bone mass were all moderately correlated with 
TBS. This seems pertinent given that trabecular microarchitecture is a composite 
measure of the quantity, porosity and connectivity of the trabeculae. Indeed, we 
observed that the association between maternal 25(OH)D and offspring TBS was 
explained by measures of offspring bone mass. Unlike conventional bone mass 
measures by DXA which is a combination of cortical and trabecular bone, TBS is 
thought to be more reflective of  trabecular bone, thus perhaps previous 
associations observed in this cohort are driven by a change in trabecular, rather 
than cortical bone.  Furthermore, in accordance with the previous associations 
observed with measures of offspring bone mass by DXA, we detected no 
association between maternal 25OHD at 28-32 weeks gestation and offspring 
TBS. Previous research has reported that foetal lumbar mineralisation begins at 
approximately during the eleventh week of gestation [20], a time corresponding to 
the measurement of 25(OH)D levels at recruitment. Further research has 
suggested that by late pregnancy mineralisation occurs at a linear rate, leading 
authors to conclude, based on predicted intercepts, that initial mineralisation 
might occur at a faster rate than that during late pregnancy [21]. These findings 
suggest that a disruption to mineralisation in early pregnancy might have greater 
effects on the trajectory of future bone mass, and thus trabecular 
microarchitecture, in the spine. 
It is unclear why these effects where present in boys, but not girls. Whilst there 
has been research to suggest differential sex effects of exposures in utero, it is 
perhaps an artefact the differential effects of puberty at this age. However, 
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contrary to this theory, the sex interaction came closer to significance once those 
in higher pubertal stages were removed in the sensitivity analyses. The sensitivity 
analyses showed sustained patterns of associations between maternal 25OHD and 
offspring TBS, suggesting that the associations were not confounded by pubertal 
stages. Furthermore, when describing correlations between TBS and 
anthropometric measures, as opposed to 25(OH)D, Shawwa et al [6] described 
stronger associations in girls as opposed to boys, similar to what we found in the 
current study. The findings by Shawwa et al. may have been confounded by a 
greater proportion of girls in higher tanner stages driving the association. In the 
current study, few participants reported higher Tanner stages, thereby limiting our 
ability to examine differential effects relating to pubertal stage.  It must also be 
noted that pubertal status was recorded by self-report, thus there may be 
differential recall bias between boys and girls. 
There are currently no studies that have investigated TBS as a risk factor for 
fracture in a paediatric population. Thus, we are unable to comment on the 
clinical significance of the magnitude to which maternal 25(OH)D is associated 
with offspring TBS. Similarly, there are no studies which show if TBS tracks 
correspondingly to bone mass during childhood and into adulthood. We therefore 
cannot speculate on the trajectory of TBS through childhood into adulthood. 
However, similar to conventional measures of bone mass, a decline in TBS has 
been associated with increasing age after peaking in early adulthood, in 
population based studies [22-24]. Should TBS also track in childhood like BMC 
and BMD, we can assume that those individuals with lower TBS in childhood 
will be more likely to have lower TBS in adulthood. However, future studies are 
needed to confirm these hypotheses. 
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There are limitations to these findings. First, there are no studies to validate use of 
TBS in a paediatric population. However, TBS correlated with relevant 
anthropometric and bone measures in this and other studies, suggesting that it 
may be clinically useful [6,7]. It must be noted, however, that the correlations 
between TBS and anthropometric measures were not as strong as those in the only 
published study of TBS in healthy children [6]. Given that the age range was up 
to 17 years in this study, it is plausible that TBS is more relevant in an older 
paediatric population. Indeed, the authors of the aforementioned study note that 
the correlations were largely driven by those in later pubertal stages. However, 
this could also be reflective of the software used, given that current versions are 
designed for use in adult populations. Future software editions may allow for 
paediatric specific analyses, such as those used in paediatric DXA analyses.  
Given these constraints, our results suggest that maternal 25(OH)D in early 
pregnancy, but not late, was associated with impaired vertebral microarchitecture 
in offspring at age 11 years. While the clinical implications of lower TBS in 
childhood cannot be commented on, future population-based studies in children 
are needed in order to investigate the prognostic ability for fracture. The current 
findings warrant confirmation in existing interventional and long term follow-up 
studies, as optimising 25(OH)D during early pregnancy may favourably influence 
offspring TBS by means of increasing offspring bone mass.  
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Aims: Growing evidence suggests an association between maternal vitamin D 
during pregnancy and offspring bone measures. Shared genetics and 
environmental factors might confound this association thus we aimed to 
determine if the association is mediated by maternal bone quality.  
Methods: Pregnant women recruited from the University Hospital Geelong 
(2002-03) and had serum samples collected at recruitment (before 16 weeks 
gestation) and 28-32 weeks gestation. Vitamin D was assessed by 
radioimmunoassay (Immunodiagnostic Systems). Two hundred and eight mother-
child pairs were re-assessed when offspring were aged approximately 11 years. 
Maternal and offspring bone quality was assessed for 168 pairs at the calcaneus 
using quantitative ultrasound (QUS, Lunar Achilles) in terms of speed of sound 
(SOS), broadband ultrasound attenuation (BUA) and stiffness index (SI). 
Results: Maternal 25(OH)D at recruitment was associated with offspring SOS (β 
1.6 95% CI 0.2,3.1) and, in boys only, with SI (β 1.0 95% CI 0.1, 1.8). These 
relationships remained independent of maternal QUS parameters (β 1.7 95% CI 
0.3, 3.1) and (β 0.9 95% CI 0.1, 1.6), respectively. No associations were detected 
for BUA or with maternal 25(OH)D at 28-32 weeks. 
Conclusions: These prospective data support prior evidence of a relationship 
between maternal 25(OH)D levels during early pregnancy and measures of bone 
health in offspring. Importantly, these associations were independent of maternal 
QUS parameters, suggesting that the relationship between gestational vitamin D 
status and offspring bone health is independent of maternal bone phenotype. 
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Introduction 
There is mounting evidence to suggest a probable relationship between maternal 
vitamin D status during pregnancy and offspring bone mass in childhood and 
young adulthood.
1-3
 Modifiable lifestyle characteristics such as diet and physical 
activity play an important role in determining peak bone mass;
4
 however, twin 
and familial studies have shown that bone mineral density (BMD) is highly 




Previous observational studies reporting an association between maternal vitamin 
D and offspring bone mass have attempted to control for potential shared familial 
characteristics which may mediate the relationship, such as socioeconomic status 
and maternal anthropometric measures and lifestyle. However, no studies have 
controlled for measures of maternal bone health. In order to account for heritable 
characteristics in this relationship, parental bone measures should be considered.  
We and others have previously reported a positive association between maternal 
25(OH)D and offspring bone phenotype assessed by dual energy X-ray 
absorptiometry (DXA), but in these reports, no adjustments had been made for 
maternal DXA measures. However, in this study collected measures of both 
maternal and offspring bone using calcaneus quantitative ultrasound QUS.  We 
thus aimed to determine whether associations between gestational vitamin D and 
measures of offspring bone were still evident with QUS parameters, and if they 
were in part, or fully explained by equivalent maternal parameters. 
 




Pregnant women were recruited before 16 weeks gestation from the University 
Hospital, Geelong (formerly the Geelong Hospital) (2002-04). At birth, 402 
mother-child pairs had a blood sample from at least one time point during 
pregnancy and some offspring birth measures. Details of the methods have been 
described elsewhere.
6
 Mothers and their children were invited to attend a follow-
up visit approximately 11 years after birth (2013-16). All follow-up assessments 
were approved by the Barwon Health Research Ethics Committee. Mothers 
provided informed written consent on behalf of themselves and their child. 
Additionally, at the 11 year follow-up, offspring provided optional assent. 
Vitamin D measures 
Mothers provided a blood sample both at recruitment and 28-32 weeks gestation. 
Aliquots were stored at -70◦C until analyses. Samples were analysed soon after 
offspring were born by radioimmunoassay (Immunodiagnostic Systems, Tyne and 
Wear, UK). There is a reported cross-reactivity of 100% with 25(OH)D2 and 75% 
of 25(OH)D3. The co-efficient of variation was 10.2% at 30nmol/L and 10.1% at 
100nmol/L.  
Bone measures  
Trained operators performed duplicate calcaneus QUS measures (Lunar Achilles 
InSight ultrasonometer) on the left heel of both mothers and their offspring. 
Parameters obtained from these scans were Broadband Ultrasound Attenuation 
(BUA; db/MHz), Speed of Sound (SOS; m/sec), and Stiffness Index (SI), which is 
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a calculation using both BUA and SOS. The average of the two measurements 
was used in analyses. Four mothers, and a further one child one had one 
measurement of QUS, thus this measurement was used. Additionally offspring 
had dual energy X-Ray absorptiometry (DXA) scans at the spine and total body. 
Maternal and offspring anthropometric and sociodemographic data 
Maternal height (0.01cm) and weight (0.01kg) were measured at the 11 year 
follow-up with shoes removed and in minimal clothing. Pubertal staging was self-
reported by offspring as Tanner stages 1-5
7, 8
, which was further collapsed into a 
binary variable (low≤2, high≥3). At recruitment, mothers provided details on 
current smoking status, number of previous children and education. 
Statistical analyses  
Descriptive data are presented as mean (±standard deviation) if parametric or 
median (interquartile range) if non-parametric. Three multivariable linear 
regression models describing the relationship between maternal 25(OH)D and 
offspring measures of BUA, SOS and SI were developed: in model 1 included 
adjusted for offspring factors (height, weight, tanner stage and sex), model 2 
included maternal factors (height, age, smoking status during pregnancy, parity 
and education) and  in model 3, for corresponding maternal QUS measures. 
Residual plots were inspected for normality. All analyses were performed using 
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Results 
Of the 209 mother-child pairs which were assessed at follow-up, 168 (80.4%) had 
complete measures of maternal 25(OH)D and heel ultrasound measures. Mothers 
who returned were slightly older (30.4 vs 29.1 years, p=0.001) but there were no 
other differences. The characteristics of the sample are as presented in Table 8.1.  
Table 8.1: Characteristics of mother-child pairs 
Characteristics  n=168 
Maternal  
Age at delivery (yrs) 30.4 (4.3) 
Age at 11 year follow-up (yrs) 41.5 (4.3) 
Height (cm) 165.0 (5.9) 
Weight
a 
(kg) 73.0 (63.7-90.2) 
Smoked during pregnancy n (% yes)
b
 31 (18.7%) 
Completed high school (% yes) 106 (63.1) 
Parity n (% nulliparious) 104 (61.9) 
25(OH)D recruitment (nmol/L) 55.4 (41.8-73.1) 
25(OH)D 28-32 weeks (nmol/L) 57.0 (45.0-76.4) 
BUA ( db/MHz) 1577.3 (30.9) 
SOS (m/sec) 114.8 (16.2) 
SI 97.9 (17.0) 
Offspring  
Sex n (% boys) 88 (52.3) 
Age (years) 10.9 (10.7-11.4) 
Height (cm) 147.5 (143.4-153.8) 
Weight (kg) 39.6 (34.8-47.2) 
Tanner n(% low) 145 (86.3) 
BUA( db/MHz) 89.9 (83.3-97.6) 
SOS (m/sec) 1569.2 (22.0) 
SI 78.3 (71.1-86.5) 
Spine BMC (g) 24.2 (20.7-27.8) 
Spine BMD (g/cm
2
) 0.819 (0.741-0.885) 
Spine area (cm
2
) 29.6 (27.3-32.7) 
TBLH BMC (g) 1065.4 (930.4-1290.4) 
TBLH BMD (g/cm
2
) 0.817 (0.777-0.870) 
TBLH area (cm
2
) 1328.0 (1120.1-1471.9) 
a 
1 missing data 
b 
2 missing data 
BUA= Broadband Ultrasound attenuation; SOS= Speed of Sound; SI=Stiffness 
Index 
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There was significant correlations between all maternal and offspring QUS 
measures (BUA r=0.22, p=0.004; SOS r=0.23, p=0.003 and SI r=0.35, p<0.001). 
Likewise there was a significant correlation between most offspring bone mass 
measures from DXA and all offspring QUS measures as presented in Table 8.2.  
 
Maternal 25(OH)D and QUS parameters 
In the total sample, maternal 25(OH)D levels at recruitment were associated with 
offspring SOS, whereby a 10nmol/L increase in 25(OH)D corresponded with a 
1.6 m/sec (95% CI 0.2,3.1) increase in offspring and maternal factors adjusted 
models (model 2). This was not attenuated after further adjustment for maternal 
SOS (β 1.7, 95% CI 0.3, 3.1; model 3).  
A sex*25(OH)D interaction term (p=0.08) suggested some sex differences in the 
association between maternal 25(OH)D and SI. In boys, but not girls there was 
also a significant association between maternal 25(OH)D at recruitment and 
offspring SI, whereby a 10nmol/L increase in maternal 25(OH)D was associated 
with a 1.0 (95% CI 0.1-1.8) increase in SI in model 2, adjusting for offspring and 
maternal factors. The associations also remained independent after further 
adjustment for maternal SI (β 0.9 95% CI 0.1, 1.6).  
There was no association between maternal 25(OH)D at recruitment and offspring 
BUA in any models or either sex. Furthermore, there was no association between 
maternal 25(OH)D  at 28-32 weeks and any offspring QUS parameter (data not 
shown). 
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Table 8.2: Correlations between measures by dual energy X-ray absorptiometry and quantitative heel ultrasound 
 Spine BMC Spine BMD Spine area Spine BMAD TBLH BMC TBLH BMD TBLH area TBLH 
BMAD 
 r p r p r p r p r p r p r p r p 
BUA 0.57 <0.001 0.54 <0.001 0.48 <0.001 0.30 0.008 0.59 <0.001 0.58 <0.001 0.55 <0.001 -0.13 0.25 
SOS 0.33 <0.001 0.45 <0.001 0.13 0.10 0.45 <0.001 0.21 0.007 0.34 <0.001 0.12 0.11 0.21 0.06 
SI 0.53 <0.001 0.59 <0.001 0.34 <0.001 0.42 <0.001 0.48 0.00 0.55 <0.001 0.41 <0.001 -0.01 0.90 
BMC: Bone mineral content BMD: Bone mineral density BMAD: Bone mineral apparent density  
BUA: Broadband Ultrasound Attenuation SOS: Speed of Sound SI: Stiffness Index 
BUA is presented as (db/MHz), SOS (m/sec), BMC (g), BMD (g/cm
2























































   















































































  Model 1 Model 2 Model 3 
Figure 8.1: Differences in quantitative ultrasound measurements per 10nmol/L 
maternal 25(OH)D at recruitment (presented as beta co-efficient and 95% 
confidence intervals) n=168 (88 boys, 80 girls) 
a Broadband Ultrasound Attenuation (BUA; dB/MHz) b Speed of Sound (SOS; m/sec) 
c Stiffness Index (SI) 
    Total sample       boys       girls 
Model one (offspring adjusted model);adjusted for offspring height, weight, pubertal 
stage(and sex for total sample).Model 2: model one plus maternal factors; maternal 
height ,parity, education, smoking status during pregnancy and age. Model 3: Model 
2 plus corresponding maternal ultrasound measure 
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Comments 
In this longitudinal birth cohort, we have demonstrated that maternal 25(OH)D in 
early pregnancy but not at 28-32 weeks gestation is associated with offspring 
SOS, but not BUA in boys. Most importantly, these associations remained 
independent of maternal QUS measures. To our knowledge, this is the first study 
to demonstrate an association with maternal vitamin D and offspring bone in 
childhood that is independent of maternal bone measures. 
Associations between maternal 25(OH)D and offspring bone DXA measures in 
childhood and young adulthood have previously been demonstrated within this 
cohort and by others
1-3
. To our knowledge, no one has examined this relationship 
using QUS in place of DXA measures. The associations reported here mimic 
those observed for maternal 25(OH)D and bone phenotype as measured by DXA.  
Like the associations described with QUS, we have described maternal 25(OH)D 
status at recruitment but not 28-32 weeks was associated with offspring BMC and 
BMD, where the associations also appeared to be more robust in boys.  
There is sparse evidence describing the association between QUS parameters and 
clinical outcomes in healthy paediatric populations. Thus, it is difficult to draw 
definitive conclusions as to whether the expected differences observed are 
translatable to clinical significance. In a study of children who had fractured and 
healthy controls a 0.7% difference in SOS represented a significant difference 
between groups.
9
 Therefore given our results are equivalent to approximately a 
0.1% change per 10nmol/L, the reported expected differences potentially may be 
of clinical significance, however we cannot definitively draw this conclusion. It is 
also of note that this study was conducted in the phalanges, therefore may not be 
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comparable to the calcaneus measurements in our study. It must also be noted that 
there was no association detected between maternal 25(OH)D and offspring BUA. 
This may be reflective of the different properties of bone each parameter is 
measuring. In vitro studies have reported significant correlations between indices 
of microarchitecture, such as trabecular number, thickness and separation, so 
perhaps SOS is more reflective of trabecular bone.
10
 Certainly, a previous study in 
rodents, showed a differential effect of vitamin D on trabecular and cortical 
bone.
11
  It is also unclear why there is an apparent sex difference, whereby the 
association was seen in boys, but not girls. This is similar to the previously 
reported associations with maternal vitamin D and offspring measures by DXA in 
this cohort. It is perhaps reflective of the different pubertal stage in girls vs boys 
at this age that obscures the association in girls. However, we did adjust for 
pubertal status, and this did not appear to impact the association. 
Weak-moderate correlations were observed between offspring and mother’s QUS 
parameters. Indeed, familial resemblance for bone phenotypes has been 
demonstrated in pre-pubertal children. Correlations between maternal and 
daughter lumbar spine and femoral neck DXA parameters in have been shown to 
a similar magnitude (r=0.24-36) as the associations we observed with mother and 
child QUS measures. 
These findings are not without limitations. First, information about mother’s 
menopausal status was not collected. Thus, given the age range, a proportion of 
mothers may have been menopausal, which would have confounded the 
association between maternal and offspring measures. However adjustment for 
maternal age did not alter this association and we still had comparable 
correlations to those seen with DXA measures. Moreover, we did not have 
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paternal QUS measures thus were unable to control for paternal heritable 
phenotypes. Additionally, these findings will need to be replicated in larger 
studies, using current gold standard measures such as DXA. The potential for 
other offspring characteristics and lifestyle behaviours to be confounding this 
association can also not be discounted. It is plausible that those mothers with a 
higher vitamin D status may have offspring who engage in more physical activity 
or have a better diet, than those mothers with a lower level. 
While we cannot extrapolate these findings to associations seen with maternal 
25(OH)D and bone measures by DXA, these findings act as initial proof of 
principle, that the association between 25(OH)D and offspring could be 




















1. Hyde NK. Brennan-Olsen SL, Wark JD., Hosking SM., Bennett, K., 
Morse, AG., Pasco, JA. Gestational Vitamin D Status and Offspring Bone 
Mineral Measures in Childhhod: A preliminary analysis. World Congress on 
Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 
2016).  Osteoporos Int.  2016  p. 79-548. 
2. Javaid MK, Crozier SR, Harvey NC, Gale CR, Dennison EM, Boucher BJ, 
et al. Maternal vitamin D status during pregnancy and childhood bone mass at age 
9 years: a longitudinal study. Lancet. 2006; 367:36-43. 
3. Zhu K, Whitehouse AJ, Hart PH, Kusel M, Mountain J, Lye S, et al. 
Maternal vitamin D status during pregnancy and bone mass in offspring at 20 
years of age: a prospective cohort study. J Bone Miner Res. 2014; 29:1088-1095. 
4. Heaney RP, Abrams S, Dawson-Hughes B, Looker A, Marcus R, 
Matkovic V, et al. Peak bone mass. Osteoporos Int. 2000; 11:985-1009. 
5. Kemp JP, Medina-Gomez C, Tobias JH, Rivadeneira F, Evans DM. The 
case for genome-wide association studies of bone acquisition in paediatric and 
adolescent populations. BoneKEy Rep. 2016; 5. 
6. Morley R, Carlin JB, Pasco JA, Wark JD. Maternal 25-hydroxyvitamin D 
and parathyroid hormone concentrations and offspring birth size. J Clin 
Endocrinol Metab. 2006; 91:906-912. 
7. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in 
girls. Arch Dis Child.1969; 44:291. 
8. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in 
boys. Arch Dis Child.1970; 45:13-23. 
  Chapter 8: Manuscript VI  
179  
9. Schalamon J, Singer G, Schwantzer G, Nietosvaara Y. Quantitative 
ultrasound assessment in children with fractures. Journal of Bone and Mineral 
Research. 2004; 19:1276-1279. 
10. Chin KY, Ima-Nirwana S. Calcaneal Quantitative Ultrasound as a 
Determinant of Bone Health Status: What Properties of Bone Does It Reflect? Int 
J Med Sci. 2013;10(12):1778-1783.  
11. Lee, Alice MC, et al. Discordant effects of vitamin D deficiency in 
trabecular and cortical bone architecture and strength in growing rodents.  J 

















  Chapter 9: Manuscript VII  
180  
CHAPTER 9 
MANUSCRIPT VII: Vitamin D 
during pregnancy and offspring 
body composition 
 
  Chapter 9: Manuscript VII  
181  
AUTHORSHIP STATEMENT 
1.  Details of publication and executive author 
Title of Publication Publication details 
Vitamin D during pregnancy and offspring body composition To be submitted to European Journal 
of Clinical Nutrition 
Name of executive author School/Institute/Division if based 
at Deakin; Organisation and 
address if non-Deakin 
Email or phone 
Natalie Hyde School of Medicine nkhy@deakin.edu.au 
2.  Inclusion of publication in a thesis 
Is it intended to include this publication in a higher degree 
by research (HDR) thesis? 
Yes  
 
If Yes, please complete Section 3 
If No, go straight to Section 4. 
3.  HDR thesis author’s declaration 
Name of HDR thesis author if 
different from above. (If the same, 
write “as above”) 
School/Institute/Division if based at 
Deakin 
Thesis title 
As above School of Medicine Gestational Vitamin D and Offspring 
Development 
If there are multiple authors, give a full description of HDR thesis author’s contribution to the publication (for 
example, how much did you contribute to the conception of the project, the design of methodology or 
experimental protocol, data collection, analysis, drafting the manuscript, revising it critically for important 
intellectual content, etc.) 
I helped conceive the initial research question and analyses for the current study. I wrote the initial draft of the 
manuscript and edited it accordingly according to critical feedback. All statistical analyses were performed by 
myself with guidance Julie Pasco. I also substantially contributed to the data collection and performed 95% of the 
dual energy X-ray absorptiometry scans for the study.  
 
I declare that the above is an accurate description of 
my contribution to this paper, and the contributions of 




4.  Description of all author contributions 
Name and affiliation of author  Contribution(s) (for example,  conception of the project, design of 
methodology or experimental protocol, data collection, analysis, drafting 




Assisted with formulation of research question. Provided critical feedback 




Was involved in the initial inception of the cohort and initiation of the 11 





Assisted with data collection and provided critical feedback on intellectual 




Was involved in the establishment of the initial cohort and initiation of the 
11 year follow-up .Provided guidance for statistical analyses and 
formulation of research question. Provided critical feedback on intellectual 
  Chapter 9: Manuscript VII  
182  
content of the manuscript 
5.  Author Declarations 
I agree to be named as one of the authors of this work, and confirm:  
xxxi. that I have met the authorship criteria set out in the Deakin University Research 
Conduct Policy, 
xxxii. that there are no other authors according to these criteria, 
xxxiii. that the description in Section 4 of my contribution(s) to this publication is 
accurate,  
xxxiv. that the data on which these findings are based are stored as set out in Section 7 
below. 
If this work is to form part of an HDR thesis as described in Sections 2 and 3, I further  
xxxv. consent to the incorporation of the publication into the candidate’s HDR thesis 
submitted to Deakin University and, if the higher degree is awarded, the subsequent 
publication of the thesis by the university (subject to relevant Copyright provisions).   
 




















6.  Other contributor declarations 
I agree to be named as a non-author contributor to this work. 







* If an author or contributor is unavailable or otherwise unable to sign the statement of 
authorship, the Head of Academic Unit may sign on their behalf, noting the reason for their 
unavailability, provided there is no evidence to suggest that the person would object to being 
named as author 
7.  Data storage 
The original data for this project are stored in the following locations. (The locations must be 
within an appropriate institutional setting. If the executive author is a Deakin staff member and 
  Chapter 9: Manuscript VII  
183  
data are stored outside Deakin University, permission for this must be given by the Head of 
Academic Unit within which the executive author is based.) 
Data format Storage Location Date lodged Name of custodian if other 
than the executive author 
Hard copies of participant files HERB Building 
Geelong Hospital 
 Julie Pasco 
Access database Computer network, 
Geelong Hospital 
 Julie Pasco 
This form must be retained by the executive author, within the school or institute in which 
they are based. 
If the publication is to be included as part of an HDR thesis, a copy of this form must be 














  Chapter 9: Manuscript VII  
184  





, Sharon L Brennan-Olsen
1,2,3
, John D Wark
4
, Sarah M 
Hosking
1




Deakin University, Geelong, Victoria, Australia  
2
Australian Institute for Musculoskeletal Sciences, C/- The University of 
Melbourne, St Albans, Victoria, Australia 
3
Institute for Health and Ageing, Australian Catholic University, Melbourne, 
Victoria, Australia 
4
 Bone and Mineral Medicine, Department of Medicine, The University of 
Melbourne, Parkville, Victoria, Australia 
5
 Melbourne Medical School-Western Campus, The University of Melbourne, St 





Epi-Centre for Healthy Ageing, IMPACT SRC, School of Medicine, Deakin 
University (Barwon Health), PO Box 281 
Geelong, Victoria, Australia, 3220 
Phone: +61 (3) 4215 3306 Fax: +61 (3) 4215 3491  
Email: nhyde@barwonhealth.org.au 
 
Reference count: 33 







  Chapter 9: Manuscript VII  
185  
Abstract  
Aims: Conflicting evidence exists regarding the association between maternal 
vitamin D status during pregnancy and body composition during childhood. Thus, 
we aimed to determine the association between maternal vitamin D and offspring 
lean and fat mass. 
Methods: Participants were mother-child pairs recruited from an Australian based 
cohort study, the Vitamin D in Pregnancy Study. Mothers were recruited before 
16 weeks gestation and provided a blood sample at both recruitment and at 28-32 
weeks gestation. Vitamin D (25(OH)D) was measured by radioimmunoassay 
(Tyne and Wear, UK) At 11 years of age lean and fat mass was quantified using 
dual energy x-ray absorptiometry (GE Lunar Prodigy, Madison, WI, USA).  
Results: Fat mass percentage was greater (26.7% vs 22.6%, p=0.01) and lean 
mass lower (69.0% vs 73.3%, p=0.006) in girls, than boys. There was an 
interaction between maternal smoking and maternal vitamin D status at 
recruitment, thus data was stratified by smoking status. In smokers, serum 
25(OH)D status at recruitment was negatively associated with fat mass percentage 
and positively associated with lean mass both (p<0.05). There was no association 
with 25(OH)D status at 28-32 weeks gestation. 
Conclusions: Maternal vitamin D in early pregnancy, but not at a later stage of 
gestation, is associated with body composition in offspring, in those who smoke 
during pregnancy. Mothers, who smoke during pregnancy, should be encouraged 
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Introduction 
The most recent nationwide study in Australia showed that a quarter of Australian 
women of child-bearing age were vitamin D deficient (<50nmol/L)
1
. Whilst there 
are some dietary sources, such as fatty fish and fortified margarines, the majority 
of vitamin D is obtained from the endogenous synthesis in the skin after exposure 
to ultraviolet radiation from the sun
2, 3
. However, sunlight exposure and 
absorption varies by latitude, skin pigmentation, time of day, season, amount of 
clothing covering skin and sun-avoidance behaviours
3, 4
. Thus, internationally 
vitamin D deficiency is recognised as a substantial public health issue
5, 6
. 
Deficiency during pregnancy is of concern, not only for maternal health, but also 
that of her unborn offspring. 
It is increasingly recognised that vitamin D plays an important role in skeletal 
muscle. Vitamin D receptors (VDR) have been found in the plasma membrane 
and nucleus of human skeletal muscle cells
7
.  In animal models, maternal vitamin 
D has been shown to impact upon myogenesis and myoblast activity
8, 9
. 
Furthermore, VDR polymorphisms have been linked to adiposity phenotype, 
which supports the hypothesis that VDR may play a biological role in lipogenesis 
and adipocyte differentiation
10
.  There have been several studies to-date which 
have examined associations with maternal serum 25-hydroxyvitamin D 
(25(OH)D) status in human cohorts and offspring body composition during 
childhood; however, these studies have provided conflicting results
11-15
. Whilst 
some have showed a favourable effect on fat and lean mass
11,14,15
, another has 
reported null association
12
. Moreover, to-date, none of these studies has examined 
maternal 25(OH)D status at two defined time-points to determine if the 
temporality of the association is an important factor. 
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Previously we have reported a reduced mid-upper arm circumference and leg 
circumference with no associated changes in skinfold measures in the offspring of 
mothers with lower vitamin D levels
16
, suggestive that infants had a higher 
proportion of lean tissue mass. Given the paucity of data and conflicting results, 
we aimed to examine the associations between maternal vitamin D status at two 
defined time points in pregnancy and measures of offspring fat and lean tissue as 
components of offspring body composition. 
Methods 
Participants 
Mothers were recruited from University Hospital, Geelong, Australia (formerly 
Geelong Hospital), before 16 weeks gestation (n=475). There were 402 mother-
child pairs at birth that provided both at least one measure of maternal vitamin D 
and some birth measures. All mother-child pairs were invited back to participate 
in the 11 year follow up. Of the original mother-child sample 209 (51.9%) 
participated in the most recent follow-up. 
Maternal vitamin D measures 
Maternal serum samples were collected both at recruitment and 28-32 weeks. 
Samples were analysed in batches by radioimmunoassay (Immunodiagnostic 
Systems, Tyne and Wear, UK). There is a reported cross-reactivity of 100% with 
25(OH)D3 75% with 25(OH)D2. The co-efficent of variation at 100nmol/L was 
10.1% and 10.2% at 30nmol/L  
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Offspring muscle measures 
Lean and fat mass was measured by dual-energy X-ray absorptiometry (DXA) 
(Lunar Prodigy Pro, GE, Madison, WI, USA) and analysed using paediatric 
specific software (eNCORE, v.14.1). Percent lean and fat mass was calculated as 
a fraction of total weight. Lean mass incorporates all remaining tissue mass after 
subtracting bone and fat tissue such as connective tissue, the lean component of 
adipose tissue, skin and muscle. All scans were performed by trained operators. 
For internal validity all the scans were analysed by the same operator (NKH). 
Other maternal and offspring measures 
Maternal smoking status was self-reported at recruitment. Mothers were 
considered smokers if they reported currently smoking one or more cigarettes per 
day. Number of previous children were also self-reported at recruitment and 
mothers were considered nulliparous if they reported having no previous children.  
Offspring were measured at birth and the 11 year follow-up. Shortly following 
birth, offspring mid-upper arm circumference was measured with a plastic 
encircling tape (Child Growth Foundation, London, UK). Triceps skinfold 
measure was taken using Holtain calipers (Holtain, Crymych, UK). 
At 11 year follow-up, height (±0.01cm) was measured with shoes removed on a 
wall mounted stadiometer (Harpenden) and weight (±0.1kg) was measured in 
minimal clothing on electronic scales. Offspring self-reported their pubertal stage 
(1-5) referring to pictures of breast and pubic hair development according to the 
definitions of Tanner et al. Pubertal status was collapsed into a binary variable 
because of lower numbers in the higher stages, therefore stages 1 and 2 were 
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considered earlier development and stages 3 and 4 were considered later. Mid-
arm circumference was measured using a non-stretch tape on the right arm 
(±0.01cm) and triceps skinfold was measured using Holtain callipers. Two 
measures of circumference and skinfolds were taken and the average of the two 
measures used for analyses. 
Statistical analyses 
Characteristics are presented as mean (± standard deviation, SD) or median 
(interquartile range, IQR) depending on the distributions.  Mann-Whitney U tests 
were used to compare characteristics between boys and girls. The association 
between maternal 25(OH)D and offspring body composition outcomes were 
explored using multivariable linear regression techniques. The best models were 
achieved using higher order polynomial terms for vitamin D, thereby optimising 
high R
2
 and low Mallows’ Cp values.  The higher order polynomial terms were 
centred around the mean to reduce collinearity. Potential confounders and effect 
modifiers in the models that were tested but not included in the final model 
included maternal education, maternal and child age and maternal height. The 
multivariable model included the higher order polynomial vitamin D terms, child 
height, sex, maternal parity and smoking status at recruitment.  However, 
maternal smoking modified the association between maternal vitamin D at 
recruitment and offspring body composition, hence data for this time-point were 
stratified by maternal smoking status. All models were tested with and without 
season of serum sample to determine if this altered associations. Season was 
entered into the model as a sinusoidal function of the day of sample collection 
using the equation, sin((day of year of serum collection+87)*0.017453)
17
. All 
analyses were performed using Minitab version 17. 
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Results 
Of the 209 (87.6%) mother-child pairs who returned for the 11-year follow-up, 
189 provided both a maternal measure of 25(OH)D at recruitment and 28-32 
weeks gestation and had an offspring whole-body DXA scan at 11 years. Mothers 
who returned at the 11 year follow-up and had complete measures were slightly 
older (30.1 vs 29.2 years, p=0.02), but there were no other differences. There 
were 16 (36.6%) mothers who reported being nulliparous at recruitment and 35 
(19.3%; two missing information) who reported currently smoking at recruitment. 
Maternal and offspring characteristics are presented in Table 9.1. There were 93 
(50.8%) boys and 90 (49.2%) girls. Significant sex differences were observed 
between measures of body composition. Although there was no sex difference 
detected for mean weight, boys had greater median percentage lean mass, whereas 
girls had greater median percentage body fat.  




















(cm) 164.7 (5.7) 165.2 (6.1) 0.36 
Weight
a,b
 (kg) 71.6 (65.7-89.9) 77.1 (61.6-90.4) 0.15 
25(OH)D recruitment 
(nmol/L) 
59.0 (42.7-74.2) 53.6 (41.7-73.0) 0.40 
25(OH)D 28-32 wk 
(nmol/L) 
57.1 (45.0-68.8) 55.5 (41.6-83.7) 0.90 
Offspring    
Age (ys) 10.9 (10.7-11.5) 10.9 (10.7-11.3) 0.48 
Height (cm) 147.5 (143.2-154.8) 147.8 (144.3-153.4) 0.82 
Weight (kg) 39.6 (35.0-47.4) 40.4 (35.1-49.5) 0.82 
Pubertal stage n(% low) 80 (86.0) 75 (83.3)  
%lean mass 73.3 (64.1-79.2) 69.0 (61.3-74.1) 0.006 
%fat mass 22.6  (16.6-32.4) 26.7 (21.1-34.1) 0.01 
a
 measured at 11-year follow-up 
b
 3 missing information. 25(OH)D= serum 25-
hydroxyvitamin D 
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Maternal 25(OH)D at recruitment 
Results of stratified models are as presented in table 9.2. In smokers there was a 
mean increase in lean mass percentage and decrease in fat percentage with an 
increase in maternal 25(OH)D levels at recruitment. Mean lean and fat mass 
estimated from regression models for a range of 25OHD values (28, 50, 75nM) 
are presented in table 9.3. For offspring whose mothers smoked, the most marked 
body composition differences were observed between 28 and 50nmol/L, with 
approximately a 10% increase in both lean mass percentage and fat mass 
percentage for both sexes; smaller differences were observed at higher 25OHD. 
The pattern was similar for non-smokers, however, the differences were not to the 
same magnitude, nor significant. 
Maternal 25(OH)D at 28-32 weeks 
There were no smoking*vitamin D interactions observed in models for 25(OH)D 
at 28-32 weeks, thus data were not stratified by maternal smoking status for 
analyses. There were no associations observed between 25(OH)D and body 
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Fat % Lean % 
β (±SE) p β (±SE) p 
(25(OH)D-mean
a
) -0.21 (-0.32,-0.09) <0.05* 
 





 0.01 (0.003,0.01) -0.01 (-0.01,-0.002) 
Child height (cm) 0.36 (0.02,0.70) 0.04 -0.36 (-0.69,-0.02) 0.04 
Child sex 2.40 (-3.02,7.82) 0.37 -1.87 (-7.24,3.50) 0.48 




Fat % Lean % 
Β (±SE) p β (±SE) p 
(25(OH)D-mean
a





 0.0002 (-0.002,0.001) -0.0002 (-0.001,0.001) 
Child height 0.32 (0.15,0.50) <0.001 -0.28 (-0.45,-0.11) 0.001 
Child sex -5.07 (-7.72,-2.42) <0.001 5.06 (2.47,7.65) <0.001 
Parity 1.96 (-0.79,4.70) 0.16 -1.99 (-4.47,0.69) 0.15 
25(OH)D 28-32 weeks 
 
Predictor 
Smokers and non-smokers pooled 
Fat % Lean % 
β (±SE) p β (±SE) p 
(25(OH)D-mean
b





 0.001 (0.00,0.001) -0.001 (-0.002,0.001) 
Child height (cm) 0.37 (0.20,0.53) <0.001 -0.32 (-0.48,-1.66) <0.001 
Maternal smoking 3.13 (-0.07,6.32) 0.06 -2.72 (-5.83,0.39) 0.09 
Child sex -4.09 (-6.59,-1.59) 0.001 4.17 (1.73,6.61) 0.001 
Parity 2.85 (-0.32,0.06) 0.03 -2.77 (-5.32,-0.23) 0.03 
a
Mean serum 25-hydroxyvitamin D 25(OHD)=60.15 nmol/L 
b
Mean serum 25-hydroxyvitamin D 
25(OHD)=60.84 nmol/L 
NB: Non-smokers (maternal smoking), girls (child sex), and first child (parity) are held referent in 
the models 
*p considered less than 0.05 when F>Fc at α 0.05 
 
Table 9.3: Lean and fat mass of boys and girls predicted from regression equations for 
maternal 25(OH)D levels at recruitment of 28, 50 and 75nmol/L  
  Smokers 
25(OH)D 
nmol/L 
% Fat mass % Lean mass 
Boys Girls Boys  Girls 
28 36.5 (3.2) 34.1 (3.0) 60.3 (3.3) 62.2 (3.0) 
50 26.3 (2.0) 23.9 (2.4) 70.0 (2.0) 71.9 (2.4) 




% Fat % Lean 
Boys Girls Boys  Girls 
28 24.5 (1.6) 29.6 (1.6) 71.5 (1.6) 66.4 (1.5) 
50 23.1 (1.0) 28.2 (1.0) 72.8 (1.0) 67.8 (0.9) 
75 21.7 (1.2) 26.8 (1.2) 74.2 (1.2) 69.1 (1.1) 
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Discussion 
In this study we report an association between maternal 25(OH)D and measures 
of offspring body composition. To our knowledge these are the first findings to 
report a differential effect of maternal 25(OH)D status on offspring body 
composition, by maternal smoking status during pregnancy. Furthermore, these 
findings are the first to demonstrate that the association only appears to be with 
maternal 25(OH)D in early pregnancy and not at a later stage of gestation.  
Previous studies of maternal 25(OH)D and offspring adiposity have shown 
conflicting results. Our results concur with the two largest studies that report 
negative associations with measures of fat mass
11, 14
 in primarily Caucasian 
populations and a further study in an Indian population
15
. However, a further 
study has previously reported that at age 9 years there were no associations 
seen
12
. The magnitude of the association reported by this study appears to be 
greater than those who had previously reported negative associations with fat 
mass. Though our findings are not directly comparable to those of Crozier et al. as 
they reported on absolute measures of fat mass as opposed to percentages, they 
found that there was a 0.16 standard deviation decrease in fat mass per 1 standard 
deviation increase in maternal 25(OH)D levels. However, the time-point at which 
25(OH)D was assessed was 34 weeks gestation, whereas at a comparable time-
point of 28-32 weeks gestation, we detected no association. Hrudey et al. 
demonstrated approximately a 4% absolute change in fat percentage. A notable 
difference in the two aforementioned studies, is that the children were aged 
approximately 6 years. Therefore, it is plausible that the trajectory of the 
magnitude of association may increase as the children age. Certainly, Crozier et 
al. demonstrated that there was an increased fat mass associated with maternal 
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25(OH)D at birth, a null association at 4 years of age, and a decreased fat mass in 
children aged 6. We cannot exclude the possibility that comparable differences 
with our study might be observed if the children are assessed at similar age 11 
years. 
Similar to our findings with fat mass, Gale et al.
12
 detected no association 
between lean mass and maternal 25(OH)D in late pregnancy. However, it was 
noted that lean mass tended to be lower in those in the lowest quarter of the 
25(OH)D distribution (p=0.09). A larger cohort from the same study 
demonstrated associations between percentage lean mass in the offspring and 
maternal 25(OH)D during late pregnancy in unadjusted models 
13
, however the 
associations were explained after accounting for relevant confounders. The only 
study to report a positive association with lean mass was Krishaveni et al. in their 
study of Indian children
15
. However, lean mass was measured as arm muscle area, 
taking into account arm circumference and skinfold measurement. Thus, robust 
findings have not been previously reported with objective measures of lean mass 
as measured by DXA. 
An important difference in previous studies that have examined the associations 
between maternal 25(OH)D in pregnancy and offspring body composition is the 
timing of the 25(OH)D measurement. Biologically, it is plausible that 25(OH)D 
may have differential effects depending on the stage of development in utero. In 
animal models, maternal nutritional deficiency during early-mid gestation reduces 
the number of muscle fibres and muscle mass in the offspring; however, 
restriction in later gestation has been shown to reduce muscle fibre size
18
. 
Moreover, offspring adiposity has been associated more strongly with maternal 
nutritional restriction in early-mid gestation, rather than late
19
. A clear 
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epidemiological example of this is the Dutch famine cohort. Maternal dietary 
restriction during early pregnancy was shown to have a marked association with 
offspring obesity in women aged 50, than that of restriction in late pregnancy
20
. In 
line with this, our data suggest that early gestation is a critical time point for the 
programming of offspring lean and fat mass. 
Furthermore, with the exception of the study in Indian children
15
, the studies 
reporting a negative association with fat mass had adjusted for maternal smoking 
status during pregnancy
11, 14
, yet it is unclear if they had identified smoking as an 
effect modifier in the models. In adult populations, there is evidence to suggest 
that smoking influences vitamin D status
21
; however, one small study in Iran 
reported no significant effect of smoking on vitamin D status in pregnant 
women
22
. In our study, we detected no difference in 25(OH)D levels between 
smokers and non-smokers. However, similar interactions have been described 
between maternal 25(OH)D status and gestational diabetes
23, 24
. The authors of 
these studies postulated that proposed role for the anti-inflammatory
25
 and 
antioxidant effects of vitamin D
26
 that might mediate the association between 
25(OH)D and gestational diabetes. Given that smokers have a higher level of 
systemic inflammation and oxidative stress
27
, perhaps this is why a differential 
effect is seen between smokers and non-smokers. This same conceptual 
framework may also apply to measures of offspring body composition. In the case 
of adiposity, maternal low-grade systemic inflammation during pregnancy has 
been associated with childhood measures of obesity at age 8 years
28
. Given the 
relatively low numbers of smokers in our cohort, however, these findings need to 
be replicated in larger cohorts. 
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There are important implications to these findings, as body composition is an 
intrinsic risk factor for a wealth of other health conditions and accidents. 
Decreased muscle mass increases the risk of childhood falls, which can result in 
bruising, sprains, fractures and contusions
29
. Injuries, arising from accidental 
childhood falls are costly
30
 and present significant burden to the healthcare 
system. Childhood adiposity is associated with a number of physical and 
psychosocial health outcomes
31
. Furthermore, obesity-induced comorbidities that 
arise in childhood, such as hypertension and type 2 diabetes, frequently persist 
into adulthood and are associated with increased mortality
32, 33
.  
There are several strengths and limitations to our study. A major strength is the 
prospective cohort study design, using objective measures of 25(OH)D and 
offspring body composition. However, we did not collect pre-pregnancy weight 
and thus were unable to account for pre-pregnancy maternal adiposity. Low 
25(OH)D status has been described in both underweight and obese pregnant 
women. It has therefore been hypothesised that there may be an interaction 
between pre-pregnancy BMI and 25(OH)D in cardio-metabolic outcomes in the 
offspring
14
. However, while interactions with measures of insulin resistance have 
been shown in associations between 25(OH)D and measures of insulin, the same 
is not true in models predicting offspring adiposity. However, in our analyses, we 
found that the association with 25(OH)D in early pregnancy was not explained by 
maternal BMI as measured at recruitment (data not shown), suggesting that the 
observed associations are independent of maternal adiposity. We also did not 
collect maternal smoking status information at the 28-32 week visit. Thus, it is 
plausible that some women who were smokers during early pregnancy 
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discontinued during late pregnancy and thus the interaction with smoking may 
have been obscured at 28-32 weeks gestation.  
Though we cannot draw causal conclusions due to the observational nature of this 
study, these findings suggest that there is an association between maternal 
25(OH)D in early pregnancy and body composition in offspring of mothers who 
smoke during pregnancy. These findings warrant confirmation in larger cohorts. 
Mothers who smoke during pregnancy, should be encouraged to quit smoking, 
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The overarching aim of this thesis was to investigate the potential 
associations between maternal vitamin D status during pregnancy and measures 
of offspring musculoskeletal outcomes during childhood, and assess whether 
temporality played a role in this association. Secondarily, this work also aimed to 
establish the prevalence of vitamin D deficiency during pregnancy and other 
important nutritional factors in bone health.  These research questions and aims 
were each addressed in individual studies, as presented in manuscripts II-VII 
(chapters 4-9). These manuscripts have provided a comprehensive discussion of 
individual findings, thus the individual findings will not be discussed again in 
great detail. Rather, the purpose of this final discussion is to provide a brief 
summary of the findings presented in this thesis in context of one another, the 
advancement they provide to the current evidence base, and further discuss 
pertinent methodological considerations consistent across the studies, and provide 
suggestions for potential future avenues of investigation.  
10.1 Aim 1 and 2: Prevalence of dietary deficiencies and changes in 
dietary behaviours during pregnancy and the associations with offspring 
measures (Manuscript II and III) 
In manuscript II, a high prevalence of deficiencies of several pertinent 
nutrients was observed during late pregnancy. Furthermore, whilst pregnant 
women were consuming a higher amount of some nutrients, intakes remained the 
same of those with actual increased demands during pregnancy (protein, 
magnesium, phosphorus, and zinc). This is of potential concern, given that the 
growing foetus is reliant on maternal nutrient supply for development: thus, we 
further investigated whether these nutrient intakes were associated with offspring 
measures. While there was no association between any nutrients and most 
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offspring birth measures, an association was observed between several nutrients 
and offspring crown-heel length. These observed effects, seemed to persist into 
measures of offspring current height at age 11 years, indicating potential long-
term implications for linear growth. However, unlike previous reports
188-191, 195, 196
 
a robust effect of maternal dietary intakes on any measure of offspring bone was 
not observed. It cannot be discounted that dietary intake of these nutrients during 
pregnancy may have other long-term effects aside from bone in offspring, for 
instance mental health
197
. Thus, whilst these results would suggest no association 
between maternal intake of key nutrients in late pregnancy and offspring bone 
development, it would be premature to suggest that there is no other important 
role, and thus the significant proportion of pregnant women who were not 
meeting recommendations is still of public health concern.  
 A further important consideration from these findings, is that that 
25(OH)D during the later stage of pregnancy had the most marked effect on 
offspring birth measures
79
, thus we hypothesised diet in late pregnancy would be 
most relevant, and therefore used dietary measures collected at the 28-32 week 
gestation study visit. However, as manuscripts IV-VII reported, in the offspring 
aged 11 years, 25(OH)D at recruitment was associated with measures of offspring 
bone and body composition, and not at the later stage of gestation. Thus, if indeed 
early pregnancy is the critical developmental period, it is plausible that if the 
analyses were repeated with the dietary information collected at recruitment that 
we may see associations with offspring bone. However, this presents with its own 
methodological limitations. As highlighted in the discussion of manuscripts II and 
III, the dietary tool used to calculate maternal dietary intakes asked women to 
recall their dietary intake from the past 12 months at time of completion. Thus 
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given that the women in the VIP study were at 16 weeks or less gestation, the 
preceding 12 months would have included a substantial period of time were 
women were not pregnant, nor aware they were pregnant. Whilst the association 
between diet during the peri-conceptual period has been shown to be associated 
with several offspring outcomes, we are unable to confidently discern temporality 
of dietary intakes using this tool, thus it is beyond our capabilities to examine this. 
The most direct way to elucidate these associations would likely be with serum 
measurements of the nutritional constituents. This may be a future avenue of 
investigation for participants involved in the VIP study. Furthermore, we may 
have been underpowered to detect any meaningful associations. 
10.2 Aims 3-6: Maternal 25(OH)D and offspring outcomes 
(Manuscripts IV-VII) 
Maternal 25(OH)D was associated with all measured outcomes in 
manuscripts IV-VII. Furthermore, it was 25(OH)D in early pregnancy, but not 
late, which was consistently displayed associations with all reported offspring 
outcomes. This tends to suggest that early gestation is a critical phase in foetal 
development for measures of offspring bone and body composition.  
Manuscript IV reported that maternal 25(OH)D in early pregnancy was 
positively associated with measures of offspring BMC, BMD and bone area. 
Given that bone mass has previously been shown to track over time
119, 121, 122
, it 
could be concluded that peak bone mass may be potentially be reduced in 
offspring of mothers with lower 25(OH)D in early pregnancy. Thus, given the 
critical role in peak bone mass in the risk of osteoporosis, these offspring may 
have an accelerated progression to osteoporosis
8
. However, BMD is only one 
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measure that may predict an increased risk of fragility fractures associated with 
osteoporosis. Previous research has indicated that a substantial proportion of the 
fracture burden occurs in those in the normal or osteopenic range of BMD
198
. 
Thus, there remains an inability for standard measures such as BMD to entirely 
differentiate fracture risk profiles. Fracture risk prediction has been shown to 
improve with the use of TBS in adult populations
199
. Thus, given its potential 
importance in future fracture risk, manuscript V further looked at the associations 
between maternal 25(OH)D and TBS. As reported, the associations mirrored that 
of those seen in manuscript IV, that is a positive association, which appeared to 
be more robust in boys, with gestational 25(OH)D in early but not late pregnancy. 
Moreover, these associations were attenuated after adjustment for standard DXA 
parameters, thus it appears that the effect of maternal 25(OH)D on indications of 
lumbar spine microarchitecture appear to be mediated by the associations 
observed in manuscript IV. That is the decrease in offspring BMC and BMD 
associated with a reduction in gestational 25(OH)D levels, leads to a suboptimal 
lumbar spine microarchitecture. 
A further important factor to consider is the potential confounding 
attributable to genetics. BMD is a highly heritable phenotype, with estimates of 
heritability ranging between 50-80%
200
. Maternal DXA measures were not 
collected at the 11 year follow-up, thus were unable to account for maternal 
measures in manuscript IV, we did collect maternal QUS measures (manuscript 
VI). The findings in manuscript VI were again consistent with those seen in 
manuscript IV and V. Importantly, these associations remained independent of the 
relevant maternal QUS parameter, suggesting that the effect on offspring bone 
may be in part independent of maternal genetics. Limitations of these findings are 
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as discussed in manuscript VI, however these finding act as proof of principle that 
the associations observed with maternal 25(OH)D and offspring bone are 
independent of heritable characteristics. Though it is difficult to extrapolate these 
findings to the measures of bone reported in manuscript IV and V and this would 
need to be confirmed using the respective comparable measures to draw more 
solid conclusions.  
The final manuscript (manuscript VII) reported associations between 
gestational 25(OH)D, again in early pregnancy but not late, with measures of 
offspring body composition. However, unlike in the previous reported findings in 
bone (manuscripts IV-VI), the observed effect was consistent across both boys 
and girls. However, there was a marked interaction between maternal smoking 
and offspring body composition. Similarly, in girls, but not boys there an 
interaction between smoking and 25(OH)D was seen in some bone outcomes as 
measured by DXA. It is plausible that similar inflammatory processes during 
pregnancy govern bone mineralisation, myogenesis and adipogenesis in utero. 
Certainly given heightened inflammatory stress
201
 caused by smoking, this would 
explain why these associations, particular with body composition, were seen more 
strongly in women who reported smoking in pregnancy. Several biological 
mechanisms have been postulated for a role of inflammation regulating foetal 
myo- and adipogensis
202
 and gestational inflammation has been shown to play a 
role in offspring childhood adiposity
203
. However, the role, which inflammation 
plays in foetal bone mineralisation is less well characterised. Certainly in adult 
populations several inflammatory diseases, such as inflammatory bowel 
disease
204
,  are associated with a reduction in bone mineral density, and increased 
levels of inflammatory markers have been shown to be associated with increased 




. Taken in context, this infers that there is a link between 
systemic inflammation and bone. Furthermore, it has been suggested a potential 
candidate endocrine system effected by maternal 25(OH)D during pregnancy is 
the modulation of a basal set-point for the growth hormone/insulin-like growth 
factor-I (GH/IGF-I) axis
208
. Studies have shown that there are interactions 
between inflammatory cytokines, the GH/IGF-I axis and regulation of bone 
growth
209
. Thus it is plausible that proposed anti-inflammatory effects of vitamin 
D may be involved with the observed effects on offspring bone. However, with 
the data presented in this thesis we cannot elucidate whether inflammatory 
processes entirely mediate this relationship, or if this is an additive effect exerted 
on top of independent effects of maternal 25(OH)D on bone. Although, we did 
not see any interactions with maternal smoking status and maternal 25(OH)D on 
TBS (manuscript V), thus this would indicate that the associations with bone 
microarchitecture may be independent of a heightened maternal inflammatory 
state arising from gestational smoking.  
 The reason for the persistent sex differences observed in all measured 
bone outcomes (manuscripts IV-VI) is unclear, although some speculation is 
warranted, given that in all associations with bone, the association appeared to be 
more robust in boys. The role of GH/IGF-1 axis in skeletal sexual dimorphism is 
not yet fully elucidated
210
, however should a sexual dimorphism exist and if 
maternal 25(OH)D incites dysregulation of the GH/IGF-1 axis, this may explain 
some of the sex differences. However, if there was a dysregulation of the 
GH/IGF-1 axis we would have expected to see an effect on childhood height, 
which we did not (manuscript IV). More likely, as discussed in manuscript IV it is 
probably the inception of puberty and sex hormones obscuring these relationships. 
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This is certainly supported by Zhu et al.
114
, who reported no sex differences in the 
associations with maternal 25(OH)D, BMC and BMD in a cohort of young adults. 
In order to confirm this, however, this hypothesis would need to be tested in a 
further follow-up post-puberty within our cohort. 
   
10.3 Methodological considerations 
These findings are not withstanding some methodological limitations, 
some of which have been discussed above, and within manuscripts I-IV. 
However, there are a few pertinent limitations which are consistent across many 
manuscripts, thus the findings presented must be considered within the context of 
these constraints; these limitations are discussed below. 
 
10.3.1 Vitamin D assay 
Measurement of 25(OH)D can present challenges; there are several factors 
which contribute to analytical issues. First, 25(OH)D is a hydrophobic molecule, 
thus is unstable in water
211
. Furthermore, its lipophilic tendencies ensures that it 
strongly associates with vitamin D binding protein, which affects binding and 
chromatographic separation
211
. Vitamin D assays have been criticised for 
inaccuracy, and the increasing accepted gold standard assay is Liquid 
Chromatography–Tandem Mass Spectrometry  (LC-MS/MC)
212
. The VIP study 
used a radioimmunoassay to assess 25(OH)D levels. This assay  
(Immunodiagnostic Systems, Tyne and Wear, UK) reports a 75% cross reactivity 
with 25(OH)D2. Current practice in Australia deems that it is acceptable to 
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measure total patient 25(OH)D status
213
, however, use of this assay may have 
underestimated 25(OH)D2 concentration. The extent to which it would have 
underestimated vitamin D concentrations is presumed to be small, given that 
25(OH)D2 is only derived from a small number of plant-based food sources. 
However, given the possibility that mothers may have been taking 25(OH)D2 
based supplements, this issue must be taken into consideration when interpreting 
these findings. 
All our vitamin D samples were analysed within the same laboratory, 
which partakes in quality assurance programs, using the same assay. Thus, despite 
the limitations of the assays, including any potential error in the assay, it was 
likely systematic. Furthermore, it is unlikely a spurious association would arise, 
given the consistency of associations across all measures of offspring bone and 
body composition. In order to best combat these vitamin D-related limitations, 
future studies should assess 25(OH)D status using current gold standard methods. 
 
10.3.2 DXA 
In a paediatric population, DXA is the most widely used modality for 
measuring bone density, as it is precise, extensively available and has a 
comparably low radiation dose to other medical scans
214
.  While the most recent 
ISCD guidelines state that DXA measures remain the gold standard for assessing 
paediatric BMC and BMD, there are a unique set of technical limitations in this 
population.  
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DXA relies on the differential absorption of x-rays at two different energy 
levels to enable distinguishable differences between tissues at different 
radiographic densities
215
. At low energy, bone attenuation is more than soft tissue 
and at higher energies bone attenuation is similar to that of soft tissue. In this 
study the ISCD recommended sites of spine and total body were chosen for use, 
due to the high reproducibility, as opposed to sites such as the proximal femur, 
given the significant variability in skeletal development. However despite high 
reproducibility at the spine and total body, unlike other density measures, the 
measurement provided by DXA is two-dimensional and thus provides areal BMD 
(aBMD), rather than a true measure of volumetric BMD (vBMD). Depth cannot 
be measured, as it is in the same direction as the x-ray beam
214
. An artefact of 
these measurements, is that smaller bones will be reported to have a lower aBMD 
than larger bones, even if vBMD is equal
216
.  This is of particular relevance in a 
paediatric population, given the relative short stature as compared to adults, and 
the high variability of stature during growth.  It has been previously shown, that 
in age-matched, children of shorter stature will have a lower BMC, than that of 
their taller counterparts, even if their bones are otherwise completely normal as 
measured by pQCT
217
. Certainly pQCT eliminates the issue of bone size as it is 
able to measure bone density in three dimensions, unlike DXA, thus eliminates 
the issue of bone size. It was hoped as part of this thesis, that complementary data 
would be available from pQCT to eliminate the potential confounding effect of 
bone size in our models. However, we were limited by accessibility to the 
equipment. However, since close of recruitment for the 11 year follow-up of the 
VIP study, the study site has since acquired a pQCT, thus this line of investigation 
will be addressed in future follow-ups. The current findings were adjusted for, 
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and remained independent of, stature. Furthermore, using suggested calculations 
for projected vBMD, the associations remained significant in the spine. In 
addition, it is acknowledged that these findings should be corroborated with 
objective measures of vBMD. It must also be noted that algorithms used to 
calculate adult BMD, can significantly overestimate paediatric BMD, as they 
exclude the lower density pixels
218, 219
. However, in all analyses using DXA 
within this thesis, all DXA scans were analysed using specific paediatric software. 
Furthermore, DXA measures were also used in Manuscript VII to calculate 
offspring body composition. On the same make of DXA used in this study (GE 
Lunar Prodigy), measurements of whole body bone and body composition have 
been shown to be reproducible in paediatric populations
220
. Thus given we used 
the same machine for all participants to reduce potential intra-machine 
variation
221
, it could be concluded that we have reliable internal validity in these 
measures. 
A further advantage of pQCT is the ability for it to be able to distinguish 
between cortical and trabecular bone. This can give important information about 
bone microarchitecture and geometry that is not available from conventional 
DXA scans. However, there is now an emerging technique, TBS, as reported on 
in Manuscript V. In lieu of pQCT data, the findings suggested that maternal 
25(OH)D in early pregnancy was associated with TBS, suggesting that 25(OH)D 
has an effect on trabecular bone. However, without the use of pQCT we are 
limited to draw any potential effects of maternal 25(OH)D during pregnancy and 
offspring cortical bone.  This question will have to be addressed in future avenues 
of investigation. 
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10.3.3 Confounding and establishing causation 
Inferring causal associations in observational studies is problematic as it is 
difficult to disentangle true associations and account for all potential confounding 
and bias
222
. Randomised control trials (RCT) are currently considered the gold 
standard of clinical evidence. However an RCT study design can be problematic 
when examining associations with nutritional exposures
223
. Unlike in 
pharmaceutical studies, in both the placebo and treatment group the nutritional 
exposure of interest, in this case 25(OH)D, is potentially at adequate levels before 
study supplementation. Ideally to see an effect of vitamin D supplementation, as 
suggested by Reid
224
 we should be conducting trials in those with much lower 
levels of vitamin D. Although, as already indicated, this raises several ethical 
dilemmas if we knowingly avoid treatment of those with severe vitamin D 
deficiencies. Thus, in the case of nutritional trials, where severe deficiencies have 
well established health risks we cannot rely solely on evidence generated from 
RCTs. Perhaps, some focus needs to shift to well-designed observational studies. 
As the VIP study is an observational study, causation cannot be inferred, 
however, the plausibility of causal associations can be examined; in 1964, Hill 
established 9 criteria for determining causality in associations
225
. 
1. Strength; the magnitude of the association. This was demonstrated in 
manuscripts IV and VII in the measures of bone and body 
composition. In manuscript IV we reported a 2.1% and 1.4% mean 
increase in spine and TBLH BMD per 10nmol/L of 25(OH)D; 
respectively. Given that a 10% increase in peak bone mass potentially 
reduces the risk of hip fracture by 30%, this association is of clinical 
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relevant magnitude. Furthermore, in manuscript VII, there were 
reported differences of approximately 15% which represented about 
50% of absolute fat mass percentages and 20% of absolute lean mass 
percentage. 
2. Consistency; asking the question has this been repeatedly observed in 
different settings? There was internal consistency within this thesis 
showing similar associations with all examined bone outcomes 
(manuscripts IV-VI). Furthermore, this was consistently observed with 
25(OH)D at the same time-point in early pregnancy. Together, with 
other studies during childhood and young adulthood discussed in 
Chapter 2, there is a weighting towards a positive association, 
however, as in the case of the ALSPAC cohort, not all data supports 
this. Furthermore, across studies different time-points were used for 
maternal 25(OH)D assessment. 
3. Specificity; is this limited to a specific population/site/type of disease. 
Associations with 25(OH)D have been examined in several 
populations, age-groups and disease types, thus we cannot say the 
associations observed in this thesis met this criteria. However, Hill 
stressed that this characteristic should not be over-emphasised as some 
exposures may lead to multiple outcomes and similarly outcomes may 
have more than one cause.  
4. Temporality; the direction of the association; In this longitudinal 
study, it is easily discerned that maternal suboptimal 25(OH)D levels 
came before offspring childhood bone mass and body composition 
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5. Biological gradient; the existence of a dose response. In manuscripts 
IV-VII, a dose response was observed, that is there were greater 
changes in the outcome in response to a greater change in maternal 
25(OH)D 
6. Plausibility; is there plausible biological mechanisms?; As discussed 
in chapter 2 and in the relevant manuscript discussions there are 
plausible biological mechanisms to which 25(OH)D may exert an 
effect on offspring outcomes 
7. Coherence; does this conflict with generally accepted facts about the 
natural course and biology of disease. As discussed in Chapter 2, 
25(OH)D has a well-recognised role in bone metabolism. Furthermore, 
although less well-established there is growing experimental data 
which suggests a role in non-classical regulatory roles of muscle and 
adipose tissue. Thus, these findings are coherent with current literature 
8. Experiment; For example, taking preventative action and observing if 
it is indeed preventative. The work in this thesis did not conduct any 
experimental studies, by way of a RCT. To date the only RCT to 
examine these associations have reported positive associations of 
vitamin D supplementation, albeit in a sub analyses of winter-born 
babies. Whether these effects will be seen in childhood remains 
unknown. However as discussed in this section above, RCTs present 
with their own methodological limitations when examining nutritional 
exposures. To see robust results the hypothesis would likely need to be 
tested with low vitamin D levels. Given the growing body of evidence 
suggesting both maternal and offspring adverse events associated with 
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suboptimal gestational 25(OH)D status, there are several ethical 
implications in testing this hypothesis    
9. Analogy; The comparison of observed effects to accepted facts. 
Probably the best condition to draw parallels with is rickets. It is well 
established that maternal 25(OH)D deficiency leads to rickets in 
infants. Thus if this is generally accepted, it is not beyond the realms 
of possibility that less severe maternal deficiency may impact upon 
offspring bone in less immediately apparent clinical manifestations.  
Thus the findings presented in this thesis, building upon the paucity of 
data in this field, certainly suggest plausibility for a causative effect. 
However, this must be considered in the context that there may be 
unrecognised residual confounding from measures which were either not 
collected or reported incorrectly. For example, although we tried to 
address the potential confounding effects by genetics in manuscript VI, it 
is possible that there is still residual confounding. Another example is 
physical activity levels. Higher 25(OH)D level have been shown to be 
associated with higher physical activity levels
226
, thus it is plausible 
mothers who had higher 25(OH)D levels. In turn, their offspring may be 
more active
227
, and given that physical activity also exerts favourable 
effects on bone
228
, the observed associations between maternal 25(OH)D 
and bone and offspring body composition may be an artefact of this 
relationship. However, physical activity levels were not recorded for a 
large proportion of the children, thus this was unable to be adjusted for.  
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10.3.3 Multiple comparisons 
A further consideration is an increased risk of Type I errors in statistical 
reporting due to the multiple outcomes that were measured. Purists believe that if 
there are multiple outcomes measured in a study that the p-value should be 
stringently adjusted to reduce the chance of Type I error, or ‘false positives’. 
However, others disagree with this methodology, as it can have considerable 
effects on power, and may lead to erroneously rejecting beneficial associations. 
The analyses presented in these theses have not made adjustment for multiple 
comparisons as this would be at the expense of increased risk of Type II error, 
thus results should be interpreted within these constraints. Reasoning for this 
decision includes a comparatively small sample size which may have been 
underpowered to withstand p-value adjustment. It should be noted, however that 
the patterns of associations were consistent across all bone outcomes, which 
suggests that it was not likely spurious associations arising from Type I error.  
 10.4 Directions for future research 
 Throughout the course of the final discussion, I have touched upon some 
potential avenues for future investigations. There are several lines of 
investigations that this field could benefit from. 
At present, extant literature exists on long-term follow-up examining the 
effects of maternal 25(OH)D and offspring bone and body composition. To date, 
only one study has studied this in adults aged 20 years
114
. The field would benefit 
from confirmational studies examining if the effects are on offspring outcomes 
are long-standing, as there is limited clinical significance if the effects are 
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transient. This could be addressed in future follow-ups of the VIP cohort, the 
SWS and MAVIDOS RCT four year follow-up. 
Furthermore, as previously discussed measures such as pQCT will help to 
elucidate the effect on vBMD and reduce potential measurement error by DXA. 
As with long-term follow-up, this could also be addressed in existing cohorts. 
The current findings are the only report on maternal 25(OH)D at two time-
points during pregnancy, within the one individual. Future studies would benefit 
from assessing critical exposures at various time points in pregnancy. The 
importance of the temporality of the relationship has been shown in associations 
such as maternal folic acid and neural tube defects
229
, that is effects take place in 
early pregnancy before women are likely to know they are pregnant, thus 
supplementation is now advised pre-conception. Furthermore, mandatory 
fortification policies formulated on the basis of such work resulted in marked 
decreases in neural tube defects
230
.   Confirmatory studies of the importance of 
timing would assist with formulating relevant health policies for the timing of 
supplementation in deficient pregnant women and/or a more wide-spread 
fortification policy. 
Whilst this thesis examined anatomical outcomes using data collected at 
the current follow-up, associations between functional outcomes such as muscle 
strength will be elucidated in further work. Moreover, there is extant data 
examining the interactions between muscle, muscle strength and bone 
interactions, which will be explored in future work within this cohort.  
Finally, as highlighted by Hill
225
, causation is likely not exclusively driven 
by a single factor; there are undoubtedly multiple factors in utero which play a 
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role both in offspring bone development and body composition. And as 
highlighted by the work in this thesis, there is potentially an interaction between 
multiple exposures. The field would certainly benefit from a detailed exploration 
of maternal exposures beyond vitamin D and diet. Extending from this work, a 
detailed analysis of maternal inflammatory markers during pregnancy may assist 





















  Chapter 11: Final Conclusion 
222  
In closing, this thesis has provided evidence that maternal 25(OH)D status 
during pregnancy may be an important consideration in offspring development. 
The findings provide empirical evidence that implies that the critical period of 
development may be during early gestation, as opposed to later, which suggests 
that pregnant women should be optimising their 25(OH)D  levels in early 
pregnancy. Moreover, these data indicate that optimising 25(OH)D may be 
particularly important in women who smoke during pregnancy, specifically for 
male offspring, although smoking as a potential effect modifier requires further 
investigation to fully elucidate causal pathways. Indeed, smoking and 25(OH)D 
status during pregnancy may prove to be an affordable modifiable risk factors for 
future offspring bone and body composition outcomes. In addition to the benefit 
of ensuring 25(OH)D sufficiency during pregnancy to enhance offspring 
development, this thesis presented evidence suggesting that there is a high 
prevalence of pregnant women who do not meet national recommendations for 
the intake of pertinent nutrients;  particularly those nutrients for which there is an 
increased demand during pregnancy. Although intakes of these nutrients during 
late pregnancy were not associated with offspring bone health, associations were 
observed with measures of offspring linear growth. Thus, health promotion 
messages to pregnant women should therefore not just be targeted toward 
improving 25(OH)D status, but also toward the intake of other nutrients, 
particularly those with increased targets during pregnancy. 
This series of studies adds new insights to the pre-existing evidence base 
regarding vitamin D status during pregnancy, and provides foundational evidence 
for new avenues of enquiries in the field; in particular, the interplay between 
maternal 25(OH)D, smoking status during pregnancy, its effect on offspring 
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development and the causal pathways which mediate these associations. These 
findings complement and build upon the existing literature and will assist in 
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Participant Information and Consent Form 
 
Full Project Title: 01/43_E2 Maternal vitamin D in pregnancy and 
childhood growth 
 
Principal Investigators: Prof Julie A Pasco and Prof John D Wark 
Associate Investigators: Dr Sharon L Brennan, Dr Peter Vuillermin, and 
Dr Lana Williams 
 
1. Introduction 
You and your child are invited to take part in this research project, 
which is an extension of the Vitamin D in Pregnancy Study, for which 
you have previously consented. 
This Participant Information and Consent Form contain detailed 
information about this research project. Its purpose is to explain to 
you as openly and clearly as possible all the procedures involved in 
this project before you decide whether or not you and your child will 
take part in it. 
Please read this Participant Information and Consent Form carefully. 
Feel free to ask questions about any information in this form. 
Once you understand what the project is about and if you agree to 
take part in it, you will be asked to sign the Consent Form. By signing 
the Consent Form you indicate that you understand the information 
and that you give your consent to you and your child participating in 
the research project. You will be given a copy of the Participant 
Information and Consent Form to keep as a record. 
2. What is the purpose of this research project? 
This study is designed to provide information about maternal vitamin 
D levels during pregnancy and growth and wellbeing in the offspring at 
ages between 9 and 11 years. In this study we will determine the 
following in the mother-child pairs: 
 bone and muscle development 
 body shape, size and composition 
 wheeze and lung function (child only) 
 behavior 
 physical and psychological symptoms/illnesses. 
 
MATERNAL VITAMIN D IN PREGNANCY 
AND CHILDHOOD GROWTH STUDY 
Epi-UMMD 
School of Medicine, Deakin University 
PO BOX 281, GEELONG, VIC 3220 
TELEPHONE  (+61 3) 421 53333/3331 
FACSIMILE: (+61 3) 421 53491 
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Approximately 400 child-mother pairs will participate in this phase of 
the project. 
3. What does participation in this research project involve? 
The child-mother participation in this project will involve completion of 
questionnaires and clinical measurements as follows: 
 questionnaires will seek information concerning the child’s diet, 
physical activity, bone fractures, wheezing illnesses, food allergies, 
skin rash, immunisations, sun exposure, medication and 
supplement use, behaviour, physical and psychological 
symptoms/illnesses 
 the child will self-rate physical maturity by matching the 
appearance of their bodies to Tanner charts 
 a clinical assessment will include measurement of the child’s blood 
pressure, height, weight, circumference (waist, hip, head, limb), 
skinfold thicknesses, naevi (mole) counts, eczema 
 the child’s muscle strength will be measured by grasping a hand-
held meter (hand strength), resisting pressure on the legs using a 
manual muscle tester, and by asking them to complete some 
jumping and balance tests using a special plate on the floor 
(Ground Reaction Force Platform) 
 a scan will be which measures the child’s bone mass in the spine, 
hip, forearm and total body to measure the calcium content of the 
bones, and the amount of fat and lean tissue in your child’s body, 
using a dual energy x-ray densitometer. The painless procedure 
takes approximately half an hour while your child is lying on an x-
ray table 
 a more detailed scan which will measure your child’s bone structure 
in the lower leg and forearm, and the size and mass of muscles, 
using peripheral quantitative computed tomography (pQCT). This is 
a painless procedure performed while your child is lying on an x-ray 
table. The pQCT scans and use of the Ground Reaction Force 
Platform will be performed at the Royal Melbourne Hospital, in 
Melbourne. This is the only part of the project not conducted at 
Barwon Health in Geelong. This part of the project is optional, 
should you and your child not wish to travel to Melbourne. Travel 
expenses from Geelong to Melbourne (return) will be available 
upon request. 
 an ultrasound measurement for both yourself and your child at the 
heel. During this procedure your child will be required to place one 
foot in the ultrasound machine for a few minutes 
 a lung function test which involves your child breathing into a 
device that can measure the amount of gas they are able to 
breathe out in one second 
 mother’s diet, mental health and measured weight, height and 
waist circumference. 
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Data from this study may be used as reference data to identify risk 
factors for other diseases. Parts of this study may also be used for the 
purposes of obtaining an academic qualification. In the event that we 
establish collaborations (partnerships) with other researchers and/or 
commercial partners, your child’s and your information may be used 
for further research into health disorders. For such partnerships to 
work, it is important that you assign ownership of all the information 
to the research team. If you wish, you may decline to have the 
information used by collaborators. 
4. What are the possible benefits? 
We cannot guarantee or promise that you will receive any benefits 
from this project but the information from the study may benefit 
people in the future. 
5. What are the possible risks? 
As part of your inclusion in this research the child will undergo DXA 
and pQCT scans that he/she would not normally receive and is 
therefore considered to be in addition to standard care. These DXA, 
pQCT and x-rays of your child’s body involve exposure to a very small 
amount of radiation. As part of everyday living, everyone is exposed to 
naturally occurring background radiation and receives a dose of about 
2 millisieverts (mSv) each year. The effective dose from all these x-
rays is about 0.032 mSv. At this dose level, no harmful effects of 
radiation have been demonstrated, as any effect is too small to 
measure. The risk is believed to be minimal. As your child is under the 
age of 18 years, you (or your child) should inform us of any other 
studies that he/she has participated in that involves the use of 
radiation. The ultrasound measurement is a rapid, painless procedure, 
not involving x-rays. The lung function test is neither painful nor 
distressful. The use of the Ground Reaction Force Platform is neither 
painful nor distressful, and does not involve any radiation. 
6. Do I and my child have to take part in this research project? 
Participation in this research project is voluntary. If you do not wish 
your child to take part, he/she does not have to. Similarly, if you, as a 
parent do not wish to take part, you do not have to. If you and/or your 
child decide to take part and later change your mind, you are free to 
withdraw from the project at a later stage. If you decide that your 
child will leave the project, the researchers would like to keep the 
personal and/or health information about you and your child that has 
been collected. This is to help make sure that the results of the 
research are accurate. Similarly, if your child provides body scans as 
part of this project, the researchers would like to retain these. 
However, if you do not wish for your child’s and your information to be 
retained, you must tell a researcher before withdrawing from the 
project. Your decision whether your child will take part or not, or to 
take part and then withdraw, will not affect your child’s or your routine 
treatment, your or your child’s relationship with those treating you or 
your and your child’s relationship with Barwon Health or Deakin 
University. 
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Before deciding whether or not to take part, you may wish to discuss 
the project with a relative or friend or your local health worker, and 
also with your child. Similarly, before you make your decision, a 
member of the research team will be available so that you can ask any 
questions you or your child may have about the research project. Once 
you feel confident that you have all the required information, you may 
then sign the Consent Form. 
7. How will I be informed of the final results of this research 
project? 
Periodically you will be sent newsletters summarising research findings 
and informing you of the progress of the project. Bone mineral density 
(DXA) results will be routinely sent to you and your doctor if you 
request it. 
8. What will happen to information about me and my child? 
Any information obtained in connection with this research project that 
can identify you or your child will remain confidential and will only be 
used for the purpose of this research project. Use of any information 
obtained in connection with this research project for future studies can 
only be used upon further approval from the Human Research Ethics 
Committee. The information will be retained for a minimum of 7 years 
after the completion of the study, in accordance with the Australian 
Code for the Responsible Conduct of Research (2007). After this 
period, all hard copies of data will be shredded and destroyed, and all 
data files will be permanently deleted. 
Data will be de-identified prior to data analysis thereby preserving the 
privacy of all participants. Data will be collated into group findings for 
publication and at no time will any individual be identifiable. 
The information will be stored in a locked archive room based at 
Barwon Health. This is a secure facility with limited access to staff 
members. Electronic data will be stored in databases password 
protected and accessible only to research staff. 
9. Can I access research information kept about me and my child? 
In accordance with relevant Australian and/or Victorian privacy and 
other relevant laws, you have the right to access the information 
collected and stored by the researchers about you and your child. 
Please contact one of the researchers named at the end of this 
document if you would like to access your information. 
In addition, in accordance with regulatory guidelines, the information 
collected in this research project will be kept for a minimum of 7 
years. Access to information about you and your child after this point 
will not be possible. 
10. Is this research project approved? 
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This study has been approved by the Human Research Ethics 
Committee, Barwon Health. This project will be carried out according 
to the National Statement on Ethical Conduct in Human Research 
(2007) produced by the National Health and Medical Research Council 
of Australia. This statement has been developed to protect the 
interests of people who agree to participate in human research 
studies. 
11. Whom can I contact? 
If you want any further information concerning this project, please 
contact the Principal Investigator, Professor Julie Pasco on (03) 4215 
3331 or the research centre on (03) 4215 3333. 
If you have any complaints about any aspect of this project, please 
contact Bernice Davies, RGO/HREC Manager, (03) 4215 3372 or The 
Manager, Office of Research Integrity, Deakin University, (03) 9251 
7129. 




01/43_E2: Maternal vitamin D in pregnancy and childhood growth. 
 
Principal and Associate Researcher(s): 
Julie A Pasco, John D Wark, Sharon L Brennan, Peter Vuillermin, Lana J Williams 
          
   
I have read, or have had read to me in my first language, and I understand the Participant 
Information and Informed Consent Form Version 1C, Date: 5 Feb 2013. 
The researcher has agreed not to reveal my child’s or my identity and personal details if 
information about this project is published or presented in any public form. 
I freely agree/do not agree (strike out non-applicable) to my and my child’s participation in this 
project according to the conditions in the Participant Information and Informed Consent Form. 
I freely agree/do not agree (strike out non-applicable) to answer questions to determine the 
presence of psychological symptoms/disorders. 
I freely agree/do not agree (strike out non-applicable) to allow members of the research team 
access to my and my child’s medical records. 
I freely agree/do not agree (strike out non-applicable) to transfer ownership of my and my child’s 
questionnaire and clinical data to the research team. 
I freely agree/do not agree (strike out non-applicable) to allow transfer of my and my child’s de-
identified questionnaire and clinical data to collaborators. 
I freely agree/do not agree (strike out non-applicable) to allow transfer of my and my child’s de-
identified questionnaire and clinical data to commercial partners. 
I freely agree/do not agree (strike out non-applicable) to agree to be contacted in the future if 
there is a further follow-up study. 
Parent/Guardian Name (printed)   …………………………………………………… 
Signature      Date 
Declaration by researcher: I have given a verbal explanation of the research project, its 
procedures and risks and I believe that the participant has understood that explanation. 
Researcher’s name (printed)    …………………………………………………… 
Signature      Date 
Note: All parties signing the consent section must date their own signature. 
 
Assent (optional) 
Child’s Name (printed)     …………………………………………………… 
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Questionnaire: Maternal vitamin D in pregnancy and childhood growth 
(VIP) 
10-year follow-up 
Study number: ⁭⁭⁭ 
Mothers name: __________________________ Childs name:-
_________________________ 
Contact details- Home phone:  
   Mobile: 
   Email:       
Today’s date (dd/mm/yyyy):______/_______/_________ 
 
Mother’s clinical measures 
Height: ___________cm Weight: ___________kg 
Waist Circumference 
1  ___________cm  2 ___________cm 
Hip Circumference  




1  ___________   2 ___________ 
SOS  
1  ___________   2 ___________ 
SI 
1  ___________   2 ___________ 
 
 
Child’s clinical measures 
Height: ___________cm 
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Weight: ___________kg 
Blood Pressure (Left arm) 
Systolic   
1  ___________mmHg  2 ___________mmHg 
Diastolic   
1  ___________mmHg  2 ___________mmHg 
Pulse Rate   




1  ___________cm  2 ___________cm 
   
Hip  
1  ___________cm  2 ___________cm 
Right mid upper arm  
1  ___________cm  2 ___________cm 
Right mid-calf   
1  ___________cm  2 ___________cm 
Head    
1  ___________cm  2 ___________cm 
 
Skinfold thickness 
Right triceps  
1  ___________mm  2 ___________mm 
Right biceps  
1  ___________mm  2 ___________mm 
Right subscapular   
1  ___________mm  2 ___________mm 
Mid-abdominal   
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1  ___________mm  2 ___________mm 
 
Handgrip strength 
Left   
1  ___________kg  2 ___________kg 
Right 




1  ___________kg  2 ___________kg 
Left 
1  ___________kg  2 ___________kg 
Hip abduction 
1  ___________kg  2 ___________kg 
Left 
1  ___________kg  2 ___________kg 
Ultrasound 
BUA  
1  ___________   2 ___________ 
SOS  
1  ___________   2 ___________ 
SI 
1  ___________   2 ___________ 
Lung volume test 
1  ___________L  2 ___________L 
Naevi count 
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DXA 
Date (dd/mm/yyyy):   ⁭⁭/⁭⁭/⁭⁭ 
DXA measures    Exclusion code 
PA spine:   Yes / No  ________________ 
Proximal femur: Yes / No  ________________ 
Whole body:  Yes / No  ________________ 






















Study number: ⁭⁭⁭ 
        Initials:




Please mark which picture most closely resembles your appearance with a 1, 
followed by the second closets with a 2. 
 
 












The testes, scrotum, and penis are about the same size as 
when you were a child. There is no pubic hair. 
The penis, scrotum and testes are the size of that of an 
adult male. The hair has spread out to the thighs. The hair 
is now like that of an adult male. It covers the same area as 
that of an adult male. 
The penis has grown even larger. It is wider. The glans, the 
head of the penis, is bigger and the scrotum is darker than 
before. It is bigger because the testes have gotten bigger. 
The hair is now dark, curly and coarse as that of an adult 
male. The hair has not spread out to the thighs. 
The penis has grown, mainly in length. The testes and 
scrotum have grown and are dropped lower than in stage 
II. The hair is darker in this stage. It is coarser and more 
curled. It has spread out and thinly covers a somewhat 
larger area. 
The testes and scrotum have gotten a little larger. The skin 
of the scrotum has changed. The scrotum, the sack holding 
the testes has lowered a bit. The penis has gotten only a 
little larger. There is a little soft, long, lightly coloured hair. 
Most of the hair is at the base of the penis. This hair may 











        Initials:
 ⁭⁭  
 
 
Please mark which picture most closely resembles your appearance with a 1, 
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Questionnaire: Maternal vitamin D in pregnancy and childhood growth-VIP
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Date (dd/mm/yyyy):    /  / 
Study number: 165 
Mothers name:____________ 
Childs name: _____________ 
Q1. Child’s natural hair colour 
☐  Fair/blond/white   
☐  Light brown   
☐  Dark brown/black  
☐  Red    
Q2. Child’s eye colour 
☐  Blue/grey   
☐  Green/hazel   
☐  Brown/black   
Q3. Child’s facial freckles 
☐  None    
☐  Some       
☐  A lot   
Q4. Does the child have siblings (brothers or 
sisters)? 
☐  Yes    ☐  No      
Q5. Number of children living in the household 
(include this child) 
1 ☐  2 ☐  3 ☐  4 ☐  5☐   6 ☐ 
More than 6 ☐ 
Q6. Which best describes the current housing 
situation of the parent which the child lives with 
the majority of the time: 
☐ Buying or bought own home   
☐ Rented privately    
☐ Housing provided by family or friends  
☐  Living with family or friends   
☐ Government provided    
☐  Other (specify)__________ 
☐  Not applicable    
 
 
Q7. In the house which the child lives the 
majority of the time which best describes the 
outdoor access? 
☐  Free use of garden/yard   
☐  Limited use of garden/yard  
☐  No garden/yard but balcony access  
☐  No outdoor access at home  
8. In the house which the child lives the majority 
of the time is there a pet? 
☐  Yes    ☐  No      
9. The child’s usual living situation is: 
☐  Living with both parents   
☐  Living with mother as sole parent  
☐Living with father as sole parent   
☐Living with mother for some days and  
father on other days    
☐Living with mother and new partner  
☐Living with father and new partner  
☐Living with neither parent  
  
10. Are there smokers living in the child’s 
household(s)? 
 ☐  Yes    ☐  No      
11. Has the child used any of these services 
during the past week? 
☐  Doctor   ☐  Dentist ☐  Dietician  
☐  Psychologist ☐  Psychiatrist   ☐  Naturopath 
☐  Eye specialist   ☐  Hospital    
☐Other (specify)_____________________ 
12. Which best describes your child’s diet 
currently: 
☐  Omnivore (meat and vegetable products)  
☐  Vegetarian (no meat product)   
☐  Vegan (no animal products)   
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13. Does your child follow any of these special 
diets? (More than one can be crossed) 
☐  Wheat free     
☐  Gluten free     
☐  Dairy free     
☐  Lactose free     
☐  Milk protein free    
☐  Soya free     
☐  Yeast free     
☐  Nut free     
☐  Egg free     
☐  Preservative free    
☐  Colouring free    
☐  Other (specify) _________________________ 
______________________________________ 
______________________________________ 
14. Has the child ever had a fracture (broken 
bone, green stick fracture)? 
☐  Yes    ☐  No      
If yes please specify the bone/s and age/s when the 












15. Has the child had a rash in the joints and 
creases of their body (like behind knees, at 
elbow creases or under arms)? 
☐  Never     
☐  Occasionally     
☐  Frequently     
☐  Most of the time now    
16. Has the child’s doctor ever diagnosed 
eczema? 
☐  Yes    ☐  No      
17. Has the child’s doctor ever prescribed any 
treatment that they said was for eczema? 
☐  Yes    ☐  No      
 
18. Has the child suffered any serious illnesses? 
☐  Yes    ☐  No      




19. Has the child ever had a tooth filled because 
of decay? 
☐  Yes    ☐  No      
20. Has the child ever had a tooth removed 
because of decay? 
☐  Yes    ☐  No      
Q21. During weekends and school holidays, how 
much time do you usually spend outside each 
day? 
☐  2 hours or less   ☐  More than 2 hours 
 ☐  Just about all day  
  
Q22. Weekends and school holidays, where does 
your child spend his/her time? 
☐  Mostly indoors            ☐  Bit of each  
                    ☐  Mostly outdoors  
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Q23. During the summertime, does the child use 
sunscreen? 
☐  Always when outside    
☐  Sometimes     
☐  Never     
Q24. During the summertime, does the child 
wear a hat? 
☐  Always when outside    
☐  Sometimes     
☐  Never     
Q25. Does the child avoid sunshine during 
summer? 
☐  Yes    ☐  No      
Q26. Has the child ever had sunburn resulting 
in redness without peeling? 
☐  Yes    ☐  No      
Q27. Has the child ever had sunburn resulting 
in pain and blistering? 
☐  Yes    ☐  No      
Q28. Last summer, did the child have sunburn 
resulting in redness without peeling? 
☐  Yes    ☐  No      
Q29. Last summer, did the child have sunburn 
resulting in redness with peeling? 
☐  Yes    ☐  No      
Q30. If exposed to the summer sun, how easily 
does the child burn? 
☐  Very easily ☐  Quite easily ☐  Moderately 
☐  Not easily ☐  Hardly ever  
   
Q31. Does the child have immunisations offered 
by the school/doctor/council? 
☐  Yes, always ☐  Sometimes ☐  Never
  
Diet 
The following questions refer to the child’s dietary 
intake 
Q32. Which of the following has been eaten over 
the past 7 days? (More than one box can be 
crossed) 
Fruit (fresh, canned or stewed): 
☐ Fruit salad      ☐ Peach      ☐ Banana     
☐ Apricot    ☐ Pear      ☐ Nectarine/peacherine 
☐ Strawberries ☐ Mango  ☐ Melon (water, 
rock)   ☐ Grapes      ☐ Mandarin ☐ Plum 
☐ Orange     ☐ Dried fruit       ☐ Apple 
☐ Pineapple        ☐ Pawpaw       ☐Kiwi fruit 
☐ Other (please specify):____________________-
_____________________________________ 
Vegetables (cooked or raw): 
☐Pumpkin    ☐Cauliflower   ☐Potato (not hot 
chips) ☐Peas & beans ☐Lettuce 
☐Celery    ☐Eggplant      ☐Carrot   ☐Broccoli     
☐Corn    ☐Legumes (chickpeas, lentils, kidney 
beans) ⁭☐Tomato     ☐Capsicum  
☐Zucchini   ☐Cabbage    ☐Brussel sprouts 
☐Sweet potato ☐Spinach     ☐Cucumber 
☐Mushroom     ☐Squash   
☐Vegetables in mixed dishes (soups, stews) ⁭ 
☐Mixed frozen vegetables      ☐Olives  
☐Other (please specify):__________________ 
_____________________________________ 
Q33. How often each of the food/drink items 
were consumed in the past 24 hours: 
a) Fruit juice/fruit drink 
☐0 ☐1     ☐2 ☐3 ☐4 ☐5+ 
b) Water 
☐0 ☐1     ☐2 ☐3 ☐4 ☐5+ 
c) Full cream/full fat Milk (including flavoured 
milk) (as a drink or on cereal) 
☐0 ☐1     ☐2 ☐3 ☐4 ☐5+ 
d) Reduced fat milk (including flavoured milk) (as 
a drink or on cereal) 
☐0 ☐1     ☐2 ☐3 ☐4 ☐5+ 
e) Cheese and/or cheese spreads 
☐0 ☐1     ☐2 ☐3 ☐4 ☐5+ 
f) Regular yoghurt/custard 
☐0 ☐1     ☐2 ☐3 ☐4 ☐5+ 
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g) Reduced fat/low fat yoghurt/custard 
☐0 ☐1     ☐2 ☐3 ☐4 ☐5+ 
h) Vegetables (raw or cooked) (salad in sandwich 
and vegetables at evening meal = twice) 
☐0 ☐1     ☐2 ☐3 ☐4 ☐5+ 
i) Fruit (fresh, canned, stewed or dried) (eg. juice at 
b’fast and afternoon tea, apple at lunch = 3 times) 
☐0 ☐1     ☐2 ☐3 ☐4 ☐5+ 
Q34. How many different fruit and vegetables 
consumed in the past 24 hours? 
☐0 ☐1     ☐2 ☐3 ☐4 ☐5+ 
Q35. How many days in the last week have some 
fruit been eaten (fresh, canned, stewed, or dried, 
excluding juice)? 
☐0 ☐1     ☐2 ☐3 ☐4 ☐5+ 
Q36. How many days in the last week have some 
vegetables (raw or cooked) been eaten? 
☐0 ☐1     ☐2 ☐3 ☐4 ☐5+ 
Behaviour 
The following questions refer to the child’s 
behaviour. Choose the best response (1-5), 
comparing the child with typically developing 
children you know who are the same age and 
gender, according to the scale below. 
 
 
Q37. Does the child have difficulty ‘reading’ the 
signs of someone being embarrassed? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
    
Q38. Does the child have difficulty ‘reading’ the 
signs of someone’s facial expression? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q39. Does the child have difficulty ‘reading’ the 
signs of someone being bored? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q40. Does the child have difficulty ‘reading’ the 
emotion in someone’s eyes? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q41. Does the child have difficulty ‘reading’ the 
signs of someone being annoyed? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q42. Does the child lack subtlety or maturity in 
his or her expression of affection? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q43. Does the child lack subtlety or maturity in 
his or her expression of angry? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q44. Does the child lack subtlety or maturity in 
his or her expression of sadness? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q45. Does the child have difficulty 
understanding the emotional messages in 
someone’s body language? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q46. Is the child primarily interested in facts? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q47. Is the child interested in cataloguing 
information? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q48. Is the child interested in statistics? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
 
Q49. Is the child an expert in a specific topic? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q50. Does the child avidly read books, primarily 
for information about their special interest? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q51. Does the child’s speech give more 
information or technical detail than you need? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
 
1 2 3 4 5
Very much 
less often 
than a typical 
child
Much less 
often than a 
typical child
About as 
often as a 
typical child
Much more 




than a typical 
child
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Q52. Is the child’s speech overly formal or polite 
such that they talk like an adult? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q53. Does the child have exceptional long-term 
memory for events or facts that he or she finds 
interesting? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q54. Does the child tend to over focus on 
details? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q55. Does the child show distress due to noises 
of a specific pitch, e.g. the sound of a vacuum 
cleaner? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q56. Does the child show distress due to noises 
of specific volume? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q57. Does the child show distress due to sudden 
noises? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q58. Does the child show distress due to noises 
in crowded social situations? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q59. Does the child show distress due to bright 
lights? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q60. Does the child notice sounds that are not 
heard by others? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q61. Does the child startle easily e.g. when 
touched from behind, or when hearing a sudden 
noise? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q62.  Does the child show distress due to certain 
aromas or odours? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q63. Does the child show distress due to light 
touch on his or her skin? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q64.  Does the  chi ld show distress due 
to certa in textures e .g .  food?  
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q65.  Does the  chi ld ask soc ial ly  
embarrassing quest ions?  
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q66. Does the child speak his or her mind 
irrespective of social context? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q67. Does the child make up his or her rules 
and then insist that everyone follow those rules? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q68. Does the child point out other people’s 
mistakes? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q69. Does the child make inappropriate but true 
comments? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q70. Does the child expect others to see things 
from his or her point of view? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q71. Does the child enforce social rules to other 
children, i.e. is a social policeman? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q72. Does the child often interrupt a 
conversation? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q73. Does the child expect you to know what 
happened at school, even if you were not there to 
see? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q74. In social situations is the child likely to 
intrude of the conversations of others in a 
clumsy way? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q75. Do minor changes in routine or 
expectations cause the child distress? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
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Q76. Does the child have to be forewarned of 
minor changes in the daily routine of home or in 
the classroom? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q77. Do major changes upset the child e.g. 
moving house or a new teacher? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q78. Does the child have to do some things in a 
certain way or in a certain order, e.g. before 
going to bed? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q79. Does the child need an excessive amount of 
reassurance regarding change? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q80. Is the child distressed by trivial changes in 
the environment, e.g. rearranged furniture or 
new cutlery? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q81. Does the child insist on a limited range of 
clothing? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q82. Do the child’s clothes have to be made of 
specific fibre? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q83. Does the child fail to modify his or her 
behaviour according to social status of the 
person (peer compared to School Principal)? 
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q84.  Does the  chi ld have diff iculty 
understanding the  thoughts of  other  
people?  
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q85.  Does the  chi ld have diff iculty 
understanding the  emotional messages 
in so meone’s tone of  vo ice?  
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q86.  When you talk to  the child does 
he or she  appear uninterested in your  
side of  the conversat ion?  
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q87.  Does the  chi ld have diff iculty 
explaining his or  her thinking in 
words?  
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q88.  Does the  chi ld have problems with 
f lexible thinking,  e .g .  appears to  have a  
one-track mind?  
☐0    ☐1     ☐2     ☐3     ☐4    ☐5     
Q89.  Does the  chi ld switch topics in a  
conversation so that  others get  
confused?  
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Section B: Maternal vitamin D in pregnancy and childhood growth (VIP) 
Study number:           Date:   /  /     (dd/mm/yyyy) 
Mothers name: __________________________ Childs name:______________________ 
       
   Code (office use) 
B1. What is the child’s mother’s occupation 
now? 
  
    
B2. What is the child’s father’s occupation now? 
 
  
B3. Note the years in which the child’s grandparents were born (please write ‘unknown’ 
if date is not known): 
a) Maternal Grandmother  b) Maternal Grandfather  
c) Paternal Grandmother  d) Paternal Grandfather  
 
B4. How often each of the following food/drink items consumed in the past 7 days by 
your child: 
a) Peanut butter or nutella    
b) Pre-sugared cereals (eg Coco Pops) or sugar added to cereal  
c) Sweet biscuits/cakes/muffins/doughnuts/fruit pies  
d) Potato chips/crisps or savoury biscuits    
e) Confectionary/muesli or fruit bars   
f) Chocolate (bar/block/coated biscuits)  
g) Soft drink/cordial (not diet varities)   
h) Icecream/Ice-blocks  
i) Pie/pastry/sausage roll   
j) Pizza   
k) Hot chips/French fries  
l) Hot dog/fritz/processed meats  
m) Takeaway (eg McDonalds, KFC, Fish’n’ Chips/Chicken Shop)  
 
B5. How many cigarettes/cigars/pipes does the child’s mother smoke per 
day now? 
 
B6. How many cigarettes/cigars/pipes does the child’s father smoke per 
day now? 
 
B7. At what time does the child usually go to sleep at night? 
 
 
B8. At what time does the child usually wake up in the morning? 
 
 
B9. How many hours each week does the child watch TV or videos? 
 
 
B10. How many hours each week does the child spend using 
electronic/computer games? 
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B11. Please list all of the regular medications (tablets, pills, inhalers, injections, syrups) and 
supplements (vitamins and minerals) that the child uses on a regular basis: 
Name of 
medication 







    
 
 
    
 
 
    
 
 
    
 






























The following questions relate to your child’s behaviour in the last six months. For each 
item please mark the box for Not True, Somewhat True or Certainly True 




B13. Considerate of other people's feelings ☐ ☐ ☐ 
B14. Restless, overactive, cannot stay still for long ☐ ☐ ☐ 
B15. Often complains of headaches, stomach-aches or 
sickness 
☐ ☐ ☐ 
B16. Shares readily with other children, for example 
toys, treats, pencils 
☐ ☐ ☐ 
B17. Often loses temper ☐ ☐ ☐ 
B18. Rather solitary, prefers to play alone ☐ ☐ ☐ 
B19. Generally well behaved, usually does what adults 
request 
☐ ☐ ☐ 
B20. Many worries or often seems worried ☐ ☐ ☐ 
B21. Helpful if someone is hurt, upset or feeling ill ☐ ☐ ☐ 
B22. Constantly fidgeting or squirming ☐ ☐ ☐ 
B23. Has at least one good friend ☐ ☐ ☐ 
B24. Often fights with other children or bullies them ☐ ☐ ☐ 
B25. Often unhappy, depressed or tearful ☐ ☐ ☐ 
B26. Generally liked by other children ☐ ☐ ☐ 
B27. Easily distracted, concentration wanders ☐ ☐ ☐ 
B28. Nervous or clingy in new situations, easily loses 
confidence 
☐ ☐ ☐ 
B29. Kind to younger children ☐ ☐ ☐ 
B30. Often lies or cheats ☐ ☐ ☐ 
B31. Picked on or bullied by other children ☐ ☐ ☐ 
B32. Often volunteers to help others (parents, teachers, 
other children) 
☐ ☐ ☐ 
B33. Thinks things out before acting ☐ ☐ ☐ 
B34. Steals from home, school or elsewhere ☐ ☐ ☐ 
B35. Gets along better with adults than with other 
children 
☐ ☐ ☐ 
B36. Many fears, easily scared ☐ ☐ ☐ 
B37. Good attention span, sees chores or homework 
through to the end 
☐ ☐ ☐ 
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B38. Do you have any other comments or concerns? 
________________________________________________________
________________________________________________________ 
B39. Overall, do you think your child has 
difficulties in one or more of the 
following areas: emotions, concentration, 






















If you answered “Yes”, please answer the following questions about these difficulties 























Do these difficulties upset or distress 
your child? 
 








Quite a lot 
 










Do the difficulties interfere with your 
child’s everyday life in the following 
areas:   
         
 a)Home life  















 b)Friendships  















 c)Classroom learning  















 d)Leisure activity  















B43. Do the difficulties put a burden on you or 
the family as a whole? 
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The following refer to wheezing and asthma symptoms and episodes experienced by your 
child: 
B44. Has your child ever had wheezing 
or whistling in the chest at any time 
in the past? 




 IF YOU HAVE ANSWERED “NO” PLEASE GO TO QUESTION B49 
  
B45. Has your child ever had wheezing 
or whistling in the chest at any time 
in the past 12 months? 




 IF YOU HAVE ANSWERED “NO” PLEASE GO TO QUESTION B49 
  
  
B46. How many attacks of wheezing has 





1 to 3 
⁭ 
4 to 8 
⁭ 




B47. In the past 12 months, how often, 
on average, has your child’s sleep 
been disrupted due to wheezing?  
















B48. In the past 12 months, has 
wheezing ever been severe enough 
to limit your child’s speech to only 
one or two words at a time between 
breaths? 




       




B50. In the past 12 months, has your 
child had a dry cough at night, apart 
from a cough associated with a cold 
or chest infection? 
    
  Yes ☐ 
 
No  ☐ 
B51. In the past 12 months, has your 
child’s chest sounded wheezy 
during or after exercise? 
    
  Yes  ☐ 
 
No  ☐ 






B52. In the past 12 months, has asthma 
limited the amount of sport or 
physical activity your child does? 
    
Yes  ☐ 
 
No  ☐ 
B53. Do you sometimes try and stop      
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your child from taking part in 
sports or physical activity because 
your child has asthma? 
Yes  ☐ No  ☐ 
B54. Do the teachers at your child’s 
school exclude your child 
sometimes because your child has 
asthma 









  ☐ 
B55. Do you give your child any 
medication before he/she does 
exercise that may make him/her 
wheezy? 






 a)If you answered “yes” what 
medicine do you give your child 













IF YOU ANSWERED YES TO QUESTION B45 (HAS HAD WHEEZE IN THE LAST 
12 MONTHS) THEN ANSWER QUESTIONS B56 TO B60, OTHERWISE GO TO B55 
B56 In the past 12 months, has your 
child taken any medication 
(medicines/pills/puffers) for 
wheezing or asthma. 






If answered yes to B56  then 
please name the medications 
Name of 
medication 
When medication is taken 
(please pick one or both) 
  When wheezy/Regularly* 
 When wheezy/Regularly* 
 When wheezy/Regularly* 
 When wheezy/Regularly* 
*every day for at least 2 months in the year 
  
B57 Do you have a written plan that 
tells you how to look after your 
child’s asthma? 






B58 Some parents have been advised to 
give prednisolone syrup (also 
known as Redipred, Predsol) to 
their children when then have an 
asthma attack without waiting to 
see the doctor first, how often do 
you do this? 













      

















B59 In the past 12 months, how many 
visits has your child made to the 
doctor (family doctor, general 
practitioner or specialist) for his/her 
wheezing or asthma?  
     



































B60 In the past 12 months, how many 
visits has your child made to a 
hospital Casualty or Emergency 


















       
B61 In the past 12 months, how many 
times has your child been admitted 
to hospital because of his/her 
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